Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3011960	p-bnp	ng/l (ng/l)	28304	81270	0.00%
3011960	p-bnp	— (—)	5949	9303	100.00%	Distribution not available
3011960	p-bnp	ng/ml (ng/l)	14	14	0.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Amiodarone users

1101

3350

4.25

322.40

6.1

3.0

418.61

223.83

ng/l

17.01

1056

3066

Septicaemia

2909

13436

2.27

317.53

4.4

2.8

359.13

207.45

ng/l

30.09

2693

12245

Cardiac arrest

521

683

7.74

317.25

5.1

1.7

356.28

60.53

ng/l

24.00

491

602

Coronary artery bypass grafting

2191

7017

2.66

317.01

4.0

2.5

426.97

192.39

ng/l

37.68

2045

6392

Diseases of oesophagus, stomach and duodenum

6253

22558

1.75

315.89

3.2

2.8

207.12

200.38

ng/l

0.46

5652

20473

Other soft tissue disorders, not elsewhere classified

5301

18595

1.84

313.83

3.1

2.8

203.30

209.19

ng/l

0.35

4785

16876

Aortic valve malfunction, age under 60 years

841

2133

4.81

311.61

3.4

2.8

206.33

151.22

ng/l

3.25

793

1909

ILD differential diagnosis

4654

11902

2.04

307.65

3.1

2.2

188.02

166.49

ng/l

2.52

4194

10758

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

7046

21566

2.47

307.65

3.8

2.5

252.15

169.57

ng/l

31.11

6492

19443

Oral corticosteroids

6959

21931

2.03

307.65

3.8

2.5

202.60

200.31

ng/l

0.15

6315

19848

Parasetamol

4426

11451

2.05

307.65

3.0

2.5

197.42

189.28

ng/l

0.47

3977

10299

Calcific aortic valvular stenosis, including rheumatic fever

2890

11291

2.94

307.65

3.8

3.1

337.63

255.03

ng/l

10.93

2739

10325

Cardiomyopathies, Primary/intrinsic

1680

2443

9.60

307.65

6.0

1.9

429.73

89.83

ng/l

73.50

1627

2152

First line medication for Crohn's disease

6631

20481

1.84

307.65

3.7

2.5

206.99

196.97

ng/l

0.89

5976

18520

Calcific aortic valvular stenosis, operated

2896

11266

2.96

307.65

3.9

3.1

337.12

254.85

ng/l

10.89

2746

10303

Operations 2 for CAVS

2885

11251

2.95

307.65

3.8

3.1

337.92

254.76

ng/l

11.05

2735

10288

Ischemic heart diseases

6366

15415

2.87

307.65

3.6

2.4

235.52

156.29

ng/l

27.82

5921

13929

Hypertensive heart and/or renal disease

2115

5751

3.23

307.65

3.6

2.5

394.57

197.17

ng/l

27.96

1992

5230

Symptoms and signs involving cognition, perception, emotional state and behaviour

6157

22799

2.00

307.65

3.1

2.8

202.50

201.33

ng/l

0.06

5596

20684

Codeine

5707

16428

2.00

307.65

3.0

2.6

195.41

199.04

ng/l

0.19

5122

14896

Major coronary heart disease event

5672

17233

2.42

307.65

3.8

2.6

296.06

175.46

ng/l

46.64

5285

15685

Congenital malformations of the circulatory system

1116

3000

4.18

307.65

3.9

3.0

183.60

176.44

ng/l

0.22

1016

2679

Cardiomyopathy, other and unspecified

1016

1506

9.41

307.65

5.2

1.8

364.12

88.02

ng/l

32.72

986

1325

AV-block

1560

3622

4.61

307.65

5.0

1.9

347.77

93.23

ng/l

54.19

1469

3252

Codeine or tramadol medication

6820

22271

1.77

307.65

3.0

2.8

195.17

203.77

ng/l

0.68

6162

20212

Explicit Sepsis

2967

13533

2.28

307.65

4.5

2.6

357.73

198.84

ng/l

34.10

2749

12304

Complications of medical and surgical care

4495

23493

1.92

307.65

3.5

2.8

232.39

203.25

ng/l

3.55

4109

21393

Cerebrovascular diseases (FINNGEN)

1972

2668

5.83

307.65

3.4

1.6

220.70

59.45

ng/l

30.15

1780

2330

Asthma, excluding more controls

4802

9788

2.78

307.65

3.2

1.8

162.67

94.83

ng/l

29.32

4328

8780

Bacterial pneumonia (organism specified)

3708

14026

2.68

307.65

4.4

2.8

260.64

231.31

ng/l

2.77

3440

12745

Valvular heart disease excluding rheumatic fever

5075

8011

5.58

307.65

3.9

1.9

285.95

84.57

ng/l

114.43

4807

7102

Implicit bacterial Sepsis

3482

12667

2.87

307.65

4.8

2.7

365.62

208.04

ng/l

34.01

3250

11558

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

2224

3400

4.42

307.65

2.9

1.5

164.42

54.00

ng/l

22.28

2011

2930

Syncope and collapse

3057

12685

2.30

307.65

3.5

2.7

261.24

204.48

ng/l

5.09

2817

11590

Calcific aortic valvular stenosis

2896

11266

2.96

307.65

3.9

3.1

337.12

254.85

ng/l

10.89

2746

10303

Hypertension

4954

11433

2.61

307.65

3.2

2.4

188.03

146.13

ng/l

8.30

4507

10234

Myocarditis

405

432

11.35

307.65

7.0

1.8

196.28

53.13

ng/l

12.41

375

369

Hypertensive Heart Disease

1943

5496

3.29

307.65

3.6

2.5

371.40

199.46

ng/l

24.98

1832

5003

Hypothyroidism, drug reimbursement

634

657

7.36

307.65

3.2

1.4

138.86

75.04

ng/l

1.14

579

578

Asthma-related pneumonia

2703

11932

2.49

307.65

4.4

3.0

241.31

242.40

ng/l

0.04

2497

10857

Asthma (diagnoses ohter than nonallergic)

5332

24552

1.96

307.65

3.4

2.8

183.34

208.06

ng/l

3.78

4829

22277

Metabolic disorders

6712

19036

2.35

307.65

3.2

2.7

220.35

189.93

ng/l

4.65

6137

17187

All-cause Heart Failure

6354

14126

3.92

307.65

4.9

2.2

447.43

121.01

ng/l

247.90

6010

12850

Heart failure,strict

6082

11329

4.78

307.65

5.0

2.0

446.74

100.07

ng/l

263.47

5766

10296

Inflammatory bowel disease treatment related agents

7066

22239

1.89

307.65

3.8

2.5

204.42

198.88

ng/l

0.42

6395

20111

Other bacterial diseases

6824

21699

2.34

307.65

3.7

2.6

282.08

174.63

ng/l

44.71

6258

19649

ILD medications: prednisolone, methylprednisolone, prednisone

6883

21028

1.94

307.65

3.8

2.5

215.09

195.70

ng/l

2.36

6220

19031

Chronic lower respiratory diseases

7209

22293

1.82

307.65

3.2

2.7

190.76

200.42

ng/l

0.83

6523

20171

Atrial fibrillation and flutter with reimbursement

2742

2134

9.98

307.65

3.9

1.6

272.46

65.01

ng/l

48.43

2592

1874

Erysipelas

3790

17495

2.12

307.65

3.5

2.7

291.58

190.78

ng/l

20.50

3461

15944

ILD medications

6900

21191

1.87

307.65

3.8

2.5

211.48

195.08

ng/l

1.90

6227

19167

Speech therapy

2085

8628

2.71

307.65

3.3

2.9

202.81

202.33

ng/l

0.01

1864

7875

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

6577

23303

2.15

307.65

3.9

2.6

274.90

182.02

ng/l

32.45

6010

21122

Statin medication

3836

9906

2.28

307.65

3.2

2.4

194.75

154.87

ng/l

5.43

3465

8866

Disorders of lipoprotein metabolism and other lipidaemias

6066

17688

2.33

307.65

3.1

2.7

219.01

197.44

ng/l

2.34

5580

16044

Bacterial pneumonia, not elsewhere classified

3485

11189

3.13

307.65

4.5

2.6

262.53

201.04

ng/l

9.50

3239

10166

Paroxysmal tachycardia

1795

2215

7.88

307.65

4.5

1.6

269.86

63.30

ng/l

33.46

1665

1928

Unstable angina pectoris

2971

11766

2.31

307.65

4.1

2.7

298.27

196.86

ng/l

15.84

2749

10743

Heart failure, strict

6525

14371

3.96

307.65

5.0

2.2

451.07

121.19

ng/l

255.87

6180

13075

Asthma/COPD (KELA code 203)

5602

22242

1.85

307.65

3.2

2.7

175.96

200.32

ng/l

4.00

5071

20128

Antihypertensive medication - note that there are other indications

2926

4536

3.71

307.65

3.3

1.8

151.13

69.88

ng/l

19.33

2598

3907

Pure hypercholesterolaemia

5765

16868

2.51

307.65

3.2

2.7

212.95

201.08

ng/l

0.85

5326

15325

Asthma-related infections

3790

18190

2.19

307.65

3.9

2.9

207.95

218.56

ng/l

0.69

3455

16514

Cardiodefibrillation

3219

13604

2.71

307.65

4.0

2.9

329.25

215.88

ng/l

29.63

2997

12487

Type 2 diabetes, wide definition

5254

18573

1.96

307.65

3.5

2.7

240.63

194.31

ng/l

8.64

4796

16923

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

945

1697

4.74

307.65

4.1

2.4

218.39

231.27

ng/l

0.29

883

1565

Persons encountering health services for specific procedures and health care

8168

20306

2.69

307.65

3.6

2.5

224.97

178.89

ng/l

12.10

7454

18303

Cardiac arrhythmias

5063

6857

5.47

307.65

3.6

1.8

203.89

82.26

ng/l

64.23

4684

6029

Conduction disorders

2473

5553

4.27

307.65

4.3

1.9

316.27

84.36

ng/l

79.66

2319

4939

Renal failure

3368

15070

2.25

307.65

5.1

2.9

507.60

209.97

ng/l

75.98

3137

13767

Other heart diseases

4820

3600

10.36

307.65

3.9

1.6

204.98

54.29

ng/l

61.56

4473

3085

Presence of cardiac and vascular implants and grafts

5334

12428

3.96

307.65

5.0

2.5

347.81

205.92

ng/l

44.38

5064

11290

Ischaemic heart disease, wide definition

6401

15161

2.94

307.65

3.6

2.4

234.86

156.56

ng/l

27.20

5956

13704

COPD differential diagnosis

4656

11907

2.04

307.65

3.1

2.2

188.10

166.50

ng/l

2.53

4198

10761

COPD/asthma/ILD related infections

6187

17306

1.87

307.65

3.3

2.4

218.97

171.67

ng/l

10.37

5617

15666

6580

17296

2.57

307.65

3.7

2.4

247.38

171.74

ng/l

23.56

6068

15659

Adjustment and management of implanted device

2229

6191

4.62

307.65

4.3

2.8

348.86

231.87

ng/l

18.97

2097

5681

Renal tubulo-interstitial diseases

5813

22100

2.15

307.65

4.0

2.6

341.34

169.36

ng/l

70.99

5327

20092

COPD (mode)

2381

7670

2.73

307.65

3.7

2.4

298.65

192.56

ng/l

12.35

2218

7018

Nonischemic cardiomyopathy

720

1183

8.63

307.65

5.4

2.3

327.03

133.58

ng/l

16.84

692

1063

Pacemaker

3551

12309

3.40

307.65

5.0

2.9

371.07

237.36

ng/l

34.69

3358

11258

Hypertensive diseases

4971

11435

2.62

307.65

3.3

2.4

188.22

146.14

ng/l

8.37

4523

10236

Other CVD (FINNGEN)

816

1095

6.80

307.65

3.9

1.6

281.63

63.55

ng/l

26.14

751

967

Bacterial infection, other or unspecified

3779

16253

2.28

307.65

4.0

2.7

331.35

195.98

ng/l

31.04

3458

14829

Other pulmonary diagnosis

4700

11939

2.06

307.65

3.1

2.2

190.33

163.93

ng/l

3.82

4240

10791

Hypothyroidism (congenital or acquired)

899

979

5.49

307.65

3.4

1.4

122.67

62.24

ng/l

1.83

798

854

Hypertensive diseases (excluding secondary)

3174

3605

5.55

307.65

3.2

1.6

163.32

53.65

ng/l

29.52

2864

3087

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

6939

19913

2.55

307.65

4.2

2.3

255.48

164.78

ng/l

37.36

6444

17856

Hypothyroidism and >3 levothyroxin purchases

889

973

5.47

307.65

3.4

1.4

122.49

61.95

ng/l

1.82

788

849

Asthma (only as main-diagnosis)

4361

11833

2.35

307.65

3.3

2.2

173.26

164.38

ng/l

0.64

3925

10698

Pneumonia, organism unspecified

6299

20302

2.41

307.65

3.8

2.5

263.97

170.27

ng/l

34.08

5806

18337

Depression medications

1055

1035

5.33

307.65

2.7

1.4

114.86

59.70

ng/l

1.70

908

896

Malaise and fatigue

3675

12807

2.61

307.65

3.6

2.7

290.27

202.10

ng/l

13.43

3326

11711

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

6580

17296

2.57

307.65

3.7

2.4

247.38

171.74

ng/l

23.56

6068

15659

Diseases of arteries, arterioles and capillaries

4891

18889

2.09

307.65

3.5

2.9

315.46

203.92

ng/l

33.60

4526

17246

Bacterial Sepsis

3851

13849

2.79

307.65

4.7

2.6

356.85

201.47

ng/l

38.17

3586

12627

Heart failure and antihypertensive medication

3318

2374

12.06

307.65

5.3

1.8

412.49

90.55

ng/l

92.85

3169

2101

Other heart diseases, wide

8241

11942

4.83

307.65

3.6

1.8

214.32

73.09

ng/l

122.86

7605

10458

Myocardial infarction

4109

11878

2.78

307.65

3.9

2.5

329.94

171.88

ng/l

50.57

3837

10749

Myocardial infarction, without ST-elevation

3283

14409

2.34

307.65

4.0

3.0

382.32

232.97

ng/l

27.59

3063

13191

Asthma (only as main-diagnosis), excluding more controls

4195

9788

2.71

307.65

3.3

1.8

167.81

94.83

ng/l

27.24

3774

8780

Dizziness and giddiness

4783

20541

2.00

307.65

3.3

2.8

199.80

210.03

ng/l

0.76

4368

18725

Opioids

5664

16585

1.86

307.65

3.0

2.6

192.23

199.56

ng/l

0.50

5085

15024

Condition for Implicit Sepsis (Organ dysfunction codes)

6304

19999

2.48

307.65

3.9

2.5

274.40

172.45

ng/l

34.00

5812

18087

Left ventricular outflow tract obstruction (LVOTO), broad definition

936

2280

5.04

307.65

3.6

2.8

202.45

153.45

ng/l

2.95

883

2035

Pneumonias (Asthma/COPD co-morbidities)

7153

21521

2.48

307.65

3.8

2.5

248.88

168.48

ng/l

30.37

6592

19389

Cardiovascular diseases (excluding rheumatic etc)

4016

4252

5.91

307.65

3.4

1.6

144.18

52.69

ng/l

28.46

3592

3614

Dyspnoea

7681

21525

3.04

307.65

3.9

2.6

245.84

192.44

ng/l

13.47

7060

19490

Asthma

5028

11833

2.41

307.65

3.2

2.2

169.17

164.38

ng/l

0.32

4537

10698

All pneumoniae

7187

21501

2.48

307.65

3.8

2.5

247.24

168.49

ng/l

29.40

6618

19372

Cardiovascular diseases

3381

3351

5.88

307.65

3.4

1.5

134.54

54.78

ng/l

16.99

2982

2852

Implicit Sepsis

5773

19185

2.56

307.65

4.2

2.5

304.26

180.55

ng/l

39.14

5330

17426

Atrial fibrillation and flutter

3148

2552

9.54

307.65

3.8

1.6

242.10

59.71

ng/l

56.35

2977

2225

Hypothyroidism, levothyroxine purchases

889

973

5.47

307.65

3.4

1.4

122.49

61.95

ng/l

1.82

788

849

Bacterial pneumoniae

3572

11718

3.04

307.65

4.5

2.6

261.89

198.94

ng/l

10.24

3316

10658

Non-rheumatic valve diseases

5015

7968

5.53

307.65

3.8

1.9

285.85

84.65

ng/l

112.78

4747

7070

Asthma, hospital admission 2, infections

3790

18190

2.19

307.65

3.9

2.9

207.95

218.56

ng/l

0.69

3455

16514

Influenza and pneumonia

7470

21146

2.49

307.65

3.7

2.4

242.17

166.10

ng/l

27.97

6848

19058

Cardiomyopathy (excluding other)

1699

2643

8.86

307.65

5.9

1.9

429.23

89.52

ng/l

74.90

1646

2331

Diseases of arteries, arterioles and capillaries (FINNGEN)

2167

2089

8.52

307.65

3.3

1.6

297.60

65.33

ng/l

42.92

2022

1825

Non-ischemic cardiomyopathy

3015

6603

4.54

307.65

4.3

2.1

374.39

112.95

ng/l

107.29

2832

5948

Valvular operations

1722

2987

7.56

307.65

4.1

1.9

319.70

89.04

ng/l

62.69

1634

2641

Abnormalities of breathing

7244

13099

3.60

307.65

3.6

2.4

215.90

187.64

ng/l

3.83

6587

11766

Congenital malformations of heart and great arteries

1078

2644

4.66

307.65

4.1

3.0

189.86

177.20

ng/l

0.43

983

2352

Bleeding

5355

21794

1.89

307.65

3.6

2.8

275.09

197.91

ng/l

19.11

4914

19843

Coronary atherosclerosis

5715

14125

2.92

307.65

3.7

2.4

265.31

163.20

ng/l

35.28

5312

12781

Excluding asthma or asthma-COPD overlap

4692

11939

2.06

307.65

3.1

2.2

187.74

163.93

ng/l

3.20

4235

10791

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

1193

3544

3.70

307.65

4.0

3.0

216.00

175.32

ng/l

2.31

1092

3152

Asthma, hospital admissions 3, pneumonia

2704

11960

2.49

307.65

4.4

3.0

241.22

242.06

ng/l

0.03

2498

10882

Asthma (mode)

4731

11902

2.30

307.65

3.2

2.2

164.08

166.49

ng/l

0.13

4267

10758

Haemorrhage from respiratory passages

2526

8761

2.96

307.65

3.8

2.5

289.62

217.29

ng/l

7.93

2320

7951

Abnormalities of heart beat

2456

8252

3.25

307.65

3.6

2.4

205.15

197.98

ng/l

0.36

2242

7488

Asthma, unspecified (mode)

3630

11089

2.80

307.65

3.4

2.2

195.05

167.83

ng/l

3.07

3316

10059

Non-invasive ventilation

3603

2667

18.16

307.65

3.8

1.7

166.21

85.85

ng/l

23.79

3391

2381

Emergency coronary revascularization (for ACS)

4144

15719

2.06

307.65

4.0

2.8

364.39

216.78

ng/l

32.09

3849

14365

Any reimbursement code in KELA

2603

5035

2.69

307.65

3.1

1.8

152.08

96.61

ng/l

8.68

2313

4385

Major coronary heart disease event excluding revascularizations

5225

16439

2.42

307.65

3.9

2.6

308.20

176.68

ng/l

47.49

4858

14970

Asthma-related pneumonia or sepsis

2704

11960

2.49

307.65

4.4

3.0

241.22

242.06

ng/l

0.03

2498

10882

Pain in throat and chest

6512

12860

3.38

307.65

3.1

2.4

190.15

188.00

ng/l

0.11

5921

11564

Cardiomyopathy

2323

3581

8.79

307.65

5.5

1.9

405.95

84.39

ng/l

95.63

2250

3150

Symptoms and signs involving the circulatory and respiratory systems

6831

13133

2.78

307.65

3.1

2.4

192.14

187.30

ng/l

0.31

6121

11793

COPD/asthma related infections

6187

17306

1.87

307.65

3.3

2.4

218.97

171.67

ng/l

10.37

5617

15666

Anaemias

1287

933

9.97

307.65

4.1

1.4

238.42

70.15

ng/l

8.86

1174

816

Myocardial infarction, strict

3808

11325

2.74

307.65

4.0

2.5

323.93

175.09

ng/l

41.79

3550

10248

Heart failure, not strict

8124

14745

4.52

307.65

4.4

2.0

329.13

93.77

ng/l

214.32

7607

13337

Angina pectoris

5077

13311

2.89

307.65

3.8

2.4

251.45

166.42

ng/l

23.01

4751

12059

Calcific aortic valvular stenosis, diagnosis (helper)

2885

11251

2.95

307.65

3.8

3.1

337.92

254.76

ng/l

11.05

2735

10288

Coronary revascularization (ANGIO or CABG)

3552

10802

2.54

307.65

4.0

2.5

347.66

178.65

ng/l

44.01

3303

9795

STROKE

3754

10637

2.64

307.65

3.4

2.2

220.36

133.75

ng/l

21.36

3393

9606

General symptoms and signs

6784

17520

2.03

307.65

3.2

2.6

202.80

180.81

ng/l

2.89

6130

15856

Hypertension, essential

5104

11234

2.78

307.65

2.8

2.3

184.52

146.37

ng/l

7.22

4651

10059

Complications of surgical and medical care, not elsewhere classified

6014

24208

1.87

307.65

3.4

2.8

240.21

195.67

ng/l

8.19

5518

21932

Heart failure and coronary heart disease

3111

9314

2.89

307.65

5.7

2.8

572.38

211.10

ng/l

106.21

2933

8518

Tramadol

4947

15932

2.11

307.65

3.0

2.7

193.63

204.71

ng/l

0.88

4458

14482

Pain in limb

4725

18161

1.98

307.65

3.1

2.8

209.91

209.04

ng/l

0.04

4289

16514

Care involving use of rehabilitation procedures

5388

18299

3.12

307.65

3.7

2.6

188.22

185.12

ng/l

0.17

4915

16601

Continuous positive airway pressure

1271

2400

5.11

307.65

3.6

1.8

472.77

96.22

ng/l

48.57

1174

2141

Hard cardiovascular diseases

5964

16747

2.50

307.65

3.5

2.5

254.27

158.23

ng/l

35.24

5498

15216

Asthma, unspecified (mode), excluding more controls

3514

9185

3.26

307.65

3.4

1.8

187.27

96.82

ng/l

34.01

3210

8270

Other arrhythmias

5278

10343

4.40

307.65

3.5

1.8

215.57

76.74

ng/l

67.81

4910

9144

Heart failure and bmi 25plus

3597

8048

3.70

307.65

5.0

2.3

410.80

117.60

ng/l

147.16

3419

7303

Coronary angioplasty

2690

9646

2.34

303.14

4.2

2.5

325.40

184.30

ng/l

23.16

2494

8749

Other special examinations and investigations of persons without complaint or reported diagnosis

4092

10789

2.00

300.19

3.3

2.6

199.09

208.42

ng/l

0.56

3679

9751

Fever of other and unknown origin

3190

14850

2.10

299.51

3.6

2.6

244.96

192.57

ng/l

5.93

2910

13534

Asthma, including avohilmo

6745

24012

1.69

298.97

3.2

2.8

181.99

208.27

ng/l

4.67

6085

21768

All influenza

1729

6829

2.79

298.11

4.2

2.6

265.50

187.81

ng/l

7.32

1549

6152

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

1855

3409

2.84

295.58

3.0

2.1

171.22

164.21

ng/l

0.27

1660

3042

Viral Sepsis

1497

5662

3.00

285.89

5.1

2.7

290.55

198.13

ng/l

9.03

1387

5152

Implicit viral Sepsis

1495

5654

3.00

285.57

5.1

2.7

290.94

198.30

ng/l

9.05

1385

5145

Infections, IBD-co-morbidities

1037

2180

3.78

280.55

3.9

2.4

259.83

200.58

ng/l

2.49

955

2002

Endocrine, nutritional and metabolic diseases

4207

11517

1.92

278.92

3.1

2.5

186.74

164.83

ng/l

2.40

3758

10327

Conotruncal defects

241

182

24.50

276.21

5.8

4.4

166.06

186.73

ng/l

0.23

226

162

Polyarthropathies

3987

14507

1.92

273.53

3.5

2.8

279.46

202.59

ng/l

12.51

3609

13187

Medical observation and evaluation for suspected diseases and conditions

3952

10786

1.96

272.20

3.1

2.6

207.98

207.99

ng/l

0.00

3605

9748

Oedema, not elsewhere classified

2067

9202

2.43

269.48

3.4

2.7

235.87

199.03

ng/l

2.61

1853

8408

Other septicaemia

2565

12313

2.22

267.90

4.5

2.8

369.83

209.95

ng/l

28.03

2379

11236

Complications of procedures, not elsewhere classified

4637

23491

1.79

263.61

3.4

2.8

245.08

195.28

ng/l

7.69

4248

21309

Congenital malformations of cardiac chambers and connections

155

95.58

259.38

6.8

7.0

156.19

164.77

ng/l

0.05

146

Early onset COPD, excluding more controls

1374

5191

2.91

258.38

3.7

2.3

235.98

185.63

ng/l

2.55

1252

4726

COPD

3135

13643

2.05

256.73

3.7

2.8

287.85

234.89

ng/l

4.77

2907

12498

2511

12277

2.15

251.95

3.8

2.8

187.78

201.99

ng/l

0.88

2256

11076

Pulmonary heart disease, diseases of pulmonary circulation

2333

11324

2.26

251.92

4.0

2.9

221.57

232.13

ng/l

0.50

2141

10313

Other intervertebral disc disorders

4884

17674

1.76

251.49

2.8

148.29

220.27

ng/l

28.12

4443

16021

Headache

3333

14929

1.94

251.34

2.9

2.5

138.47

172.96

ng/l

5.39

2992

13517

Other diseases of intestines

5731

20522

1.68

247.80

3.2

2.8

203.96

194.13

ng/l

0.77

5179

18584

Cough

2106

9346

2.29

246.50

3.2

2.5

199.89

194.31

ng/l

0.19

1907

8486

Left ventricular outflow tract obstruction, narrow definition

490

981

6.43

245.26

4.2

2.9

166.57

177.31

ng/l

0.23

456

878

Other chronic obstructive pulmonary disease

3020

13309

2.04

244.46

3.8

2.8

290.28

235.24

ng/l

4.92

2802

12191

Asthma, hospital admissions , main diagnosis only

4585

24574

1.74

241.62

3.4

2.8

176.89

205.23

ng/l

4.23

4137

22284

Type 2 diabetes

5559

20373

1.68

241.19

3.2

2.6

220.21

184.41

ng/l

6.40

5035

18467

Other diseases of pleura

3134

15071

1.99

238.94

4.3

2.9

311.94

235.06

ng/l

8.16

2932

13774

Certain infectious and parasitic diseases

5537

16936

1.69

238.83

3.3

2.5

224.27

169.68

ng/l

12.57

5042

15315

Episodal and paroxysmal disorders

6166

19894

1.64

237.26

3.2

2.8

173.46

217.45

ng/l

10.95

5529

18062

Intracranial trauma

2955

11501

2.00

237.21

3.2

2.6

212.99

204.29

ng/l

0.34

2652

10484

Other nutritional deficiencies

3308

17826

1.90

235.74

3.1

2.7

173.30

172.24

ng/l

0.05

2931

16184

Diabetes, varying definitions

5626

20929

1.66

235.43

3.3

2.6

221.53

181.97

ng/l

7.64

5096

18929

Diabetes mellitus

5636

20962

1.66

234.73

3.2

2.6

221.23

181.69

ng/l

7.66

5106

18955

Diseases of the respiratory system

3639

9926

1.91

233.07

3.0

2.3

192.92

173.09

ng/l

1.93

3285

9014

Acute renal failure

1593

6882

2.61

231.62

5.4

2.9

472.22

204.01

ng/l

36.09

1493

6266

Any gastric operation

4340

12568

1.79

228.97

3.3

2.4

204.82

173.84

ng/l

3.53

3869

11372

GASTRO-related operations

4340

12568

1.79

228.97

3.3

2.4

204.82

173.84

ng/l

3.53

3869

11372

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3629

20779

1.84

228.42

3.5

2.8

235.64

202.26

ng/l

3.76

3321

18956

Aplastic and other anaemias

3061

15957

1.95

225.80

4.1

2.9

340.72

230.43

ng/l

20.54

2818

14603

Diverticular disease of intestine

4372

17290

1.76

225.57

3.1

2.8

228.58

212.07

ng/l

1.23

3976

15818

Congenital malformations of cardiac septa

536

1173

5.26

225.52

4.3

3.3

206.84

177.64

ng/l

0.68

484

1049

Non-allergic asthma (mode), excluding more controls

1147

4200

2.93

222.34

3.3

1.9

183.97

108.15

ng/l

8.59

1044

3803

Obesity

3134

17192

1.89

220.66

3.1

2.7

166.09

171.39

ng/l

0.33

2771

15596

Obesity and other hyperalimentation

3149

17296

1.89

220.26

3.1

2.7

166.11

171.59

ng/l

0.35

2785

15694

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

3942

21673

1.78

220.05

3.6

2.8

216.87

219.28

ng/l

0.11

3672

19767

Congenital malformations of aortic and mitral valves

410

780

6.81

217.27

4.2

2.8

157.22

173.25

ng/l

0.35

384

696

Transplanted organ and tissue status

710

2043

4.03

216.74

8.1

2.3

415.25

134.92

ng/l

20.81

684

1827

Other chronic obstructive pulmonary disease, including avohilmo

3525

16960

1.84

214.16

3.6

2.9

281.35

222.54

ng/l

6.56

3244

15528

Endocarditis

354

598

7.70

211.94

4.0

1.9

401.63

91.63

ng/l

11.89

337

528

Dialysis, with operation codes

999

3595

3.21

211.71

6.9

2.8

629.80

170.38

ng/l

36.57

964

3252

Nerve, nerve root and plexus disorders

5916

24094

1.60

211.49

3.1

2.8

171.16

213.15

ng/l

10.80

5354

21891

Other and unspecified anaemias

2829

15018

1.96

210.97

4.1

3.0

339.00

233.51

ng/l

17.78

2604

13739

Other anaemias

2848

15107

1.96

210.95

4.1

3.0

338.85

233.49

ng/l

17.81

2620

13819

Oxycodone

2288

11335

2.10

208.51

3.4

2.8

228.54

230.36

ng/l

0.06

2111

10386

Type 2 diabetes, definitions combined

5295

20003

1.64

207.69

3.2

2.6

213.98

186.45

ng/l

4.04

4784

18166

Cerebrovascular diseases

4577

20304

1.70

207.66

3.4

2.8

268.83

208.00

ng/l

11.12

4191

18572

Type 2 diabetes, strict (exclude DM1)

5306

20101

1.63

206.07

3.2

2.6

213.78

187.18

ng/l

3.80

4794

18259

Obesity related asthma

1938

9416

2.21

204.72

3.5

2.7

155.28

184.34

ng/l

2.68

1744

8552

Other acute lower respiratory infections

3128

16910

1.86

204.65

4.0

2.9

243.71

222.65

ng/l

1.63

2802

15357

Dorsalgia

5354

18347

1.63

204.38

2.9

2.8

173.41

218.26

ng/l

8.80

4839

16588

Other disorders of fluid, electrolyte and acid-base balance

1975

9349

2.21

203.72

4.1

2.8

326.26

218.32

ng/l

10.42

1826

8492

Type 2 diabetes, definitions combined, including avohilmo

5274

19825

1.63

203.69

3.2

2.6

211.88

186.34

ng/l

3.52

4760

17997

Finngen Rheumatological endpoints

5123

18348

1.64

203.66

3.1

2.7

199.11

194.39

ng/l

0.28

4611

16578

Acute tubulo-interstitial nephritis

3538

18378

1.79

203.47

3.5

2.7

268.20

180.18

ng/l

16.41

3208

16771

COPD-related respiratory insufficiency

1052

4008

3.10

203.13

4.7

3.0

331.10

252.32

ng/l

3.65

997

3667

Other neurological diseases

4354

21617

1.70

202.90

3.6

2.8

225.66

220.65

ng/l

0.27

3996

19735

Other disorders of skin and subcutaneous tissue

3985

22144

1.73

202.88

3.4

2.8

271.95

205.93

ng/l

10.57

3644

20203

Congenital malformations of great arteries

233

249

12.58

202.58

5.0

5.1

193.58

200.52

ng/l

0.06

213

224

Other dorsopathies, not elsewhere classified

5468

18383

1.62

201.33

2.9

2.8

168.93

217.85

ng/l

12.75

4930

16618

6247

21686

1.57

201.23

3.5

2.6

218.88

200.19

ng/l

2.09

5641

19686

Symptoms and signs involving the nervous and musculoskeletal systems

3318

19261

1.81

201.19

3.2

2.9

188.22

211.09

ng/l

1.47

2993

17579

Chronic kidney disease

2105

10640

2.15

200.91

5.5

2.9

560.79

223.41

ng/l

54.83

1968

9698

ILD medications: immunosuppressive drugs

3164

17425

1.82

195.68

4.2

2.4

210.57

174.16

ng/l

4.39

2899

15816

Pulmonary embolism

2014

10171

2.16

194.60

3.5

2.9

185.95

229.26

ng/l

4.76

1840

9258

Fall on same level

6094

22473

1.56

194.52

3.0

2.8

221.59

182.50

ng/l

5.85

5534

20332

Pain, not elsewhere classified

1507

6748

2.39

194.05

3.1

2.6

183.38

173.84

ng/l

0.35

1358

6123

Dental caries

1549

6970

2.37

193.32

4.7

2.8

292.78

193.38

ng/l

9.16

1445

6340

COPD related to multimorbidity

2733

12791

1.94

192.45

4.0

2.9

314.59

241.86

ng/l

6.76

2539

11735

Disorders of thyroid, IBD co-morbidities

913

2241

3.15

191.79

4.0

2.3

235.21

186.35

ng/l

1.11

831

2048

Neurological diseases

4539

14028

1.68

191.58

3.0

2.7

169.22

218.79

ng/l

9.37

4047

12763

Diabetes medication

5525

21886

1.58

190.94

3.2

2.7

210.86

188.95

ng/l

2.92

5007

19814

Pulmonary heart disease

2014

10249

2.14

190.48

3.5

3.0

185.95

232.93

ng/l

5.48

1840

9336

COPD, hospital admissions

3043

14803

1.86

190.46

3.8

2.9

289.33

233.29

ng/l

5.00

2820

13572

Venous thromboembolism

3376

19444

1.78

190.31

3.2

2.9

202.47

227.63

ng/l

2.39

3090

17777

Examination and observation for other reasons

3107

10599

1.85

189.85

2.8

2.5

232.69

204.22

ng/l

1.94

2783

9588

Low back pain

3839

17865

1.72

189.73

3.1

2.8

176.02

215.23

ng/l

4.95

3481

16184

COPD, early/later onset

3057

14893

1.86

188.61

3.8

2.9

293.09

232.44

ng/l

5.74

2835

13654

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

5195

20475

1.60

188.04

3.3

2.7

218.41

184.76

ng/l

5.75

4719

18542

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3311

19604

1.78

187.15

3.4

2.8

232.52

205.72

ng/l

2.46

3025

17909

Concussion

2435

11304

1.94

184.07

3.3

2.6

201.38

205.86

ng/l

0.14

2182

10313

Pain in joint

3078

11603

1.82

182.72

2.7

166.38

202.88

ng/l

4.38

2733

10616

Gout

1912

8791

2.16

182.39

4.3

2.9

393.11

247.29

ng/l

14.36

1760

8048

Covid-19 confirmed case

1730

8433

2.21

181.91

4.5

2.8

193.90

204.49

ng/l

0.53

1619

7630

Other (not insulin) diabetes medications

5325

21022

1.58

180.64

3.2

2.7

209.62

193.90

ng/l

1.64

4818

19107

Glucagon-like peptide-1 (GLP-1) analogues

3467

17191

1.76

180.27

3.8

2.8

284.77

215.75

ng/l

11.14

3188

15761

Use of hypnotics and sedatives

5765

22221

1.55

178.03

3.0

2.8

200.13

199.14

ng/l

0.05

5249

20136

Dentinal caries

1380

6168

2.40

177.57

4.6

2.8

296.09

189.57

ng/l

9.04

1280

5611

Thoracic aortic aneurysm

1057

4294

2.83

177.33

2.8

2.9

218.66

196.35

ng/l

0.84

992

3932

Nephropathy related operations

926

3525

3.01

176.28

6.7

2.9

629.10

196.10

ng/l

29.59

892

3199

Later onset COPD, excluding more controls

1536

5592

2.37

175.92

3.7

2.5

327.21

219.84

ng/l

7.81

1449

5147

Persons encountering health services for examination and investigation

3634

10789

1.74

175.63

3.1

2.6

208.23

208.42

ng/l

0.01

3249

9751

Spondylopathies

4460

17158

1.64

175.42

3.0

2.8

181.74

227.20

ng/l

9.57

4099

15587

Bronchitis

5657

24826

1.54

175.29

3.7

2.7

224.98

198.22

ng/l

3.79

5089

22540

Left bundle-branch block

523

1419

4.29

174.20

3.1

1.9

278.68

89.38

ng/l

12.79

489

1259

DVT of lower extremities and pulmonary embolism

2672

15279

1.86

171.84

3.3

3.0

197.01

235.76

ng/l

4.08

2449

13929

Vocal cord dysfunction

619

1700

3.61

171.78

3.2

1.7

164.18

88.62

ng/l

6.17

566

1506

COPD, hospital admission 2, with asthma infections

2235

10322

2.00

171.55

4.2

3.0

304.33

249.69

ng/l

4.19

2085

9441

Biguanides

5228

21275

1.57

171.54

3.2

2.7

206.86

197.97

ng/l

0.73

4712

19372

Constipation

4853

22750

1.58

171.14

3.1

2.9

206.34

213.16

ng/l

0.43

4388

20754

Special screening examination for other diseases and disorders

604

1819

3.72

169.79

3.4

2.5

206.09

176.93

ng/l

0.88

504

1652

L04AD Calcineurin inhibitors

708

2368

3.39

168.88

8.5

2.7

377.71

151.32

ng/l

16.36

680

2121

Sleep disorders (combined)

5236

22795

1.55

168.71

3.1

2.8

159.16

201.27

ng/l

10.83

4678

20765

Neurological diseases, wide definition

1373

2890

2.47

168.69

3.3

2.6

147.79

176.73

ng/l

1.51

1191

2616

Peripheral artery disease

2961

14043

1.81

168.33

3.8

2.9

404.91

225.17

ng/l

35.85

2742

12860

Non-allergic asthma (mode)

1147

4811

2.54

168.28

3.3

2.3

183.97

180.66

ng/l

0.09

1044

4371

Transient ischemic attack

3327

16782

1.74

167.10

3.7

2.8

242.42

224.15

ng/l

1.23

3063

15358

Ulcer of lower limb, not elsewhere classified

1086

4598

2.70

166.55

3.5

3.1

464.31

230.67

ng/l

17.54

1007

4196

Obesity due to excess calories

2260

12368

1.92

166.21

3.1

2.7

168.76

170.86

ng/l

0.09

2005

11229

Diabetes, insulin treatment (Kela reimbursement)

5468

22475

1.54

164.59

3.4

2.7

222.20

193.17

ng/l

4.57

4973

20378

Other disorders of urethra and urinary system

3758

17553

1.67

164.33

3.1

2.8

199.93

210.89

ng/l

0.74

3422

15984

Secondary hypertension

375

801

5.07

164.11

3.3

1.8

438.03

60.33

ng/l

16.54

343

700

Congenital malformations of pulmonary and tricuspid valves

123

31.56

163.69

6.5

5.4

155.46

130.47

ng/l

0.20

117

Hypertrophic cardiomyopathy

438

1129

5.14

163.57

5.5

3.0

365.68

213.60

ng/l

5.20

426

1032

Mouth breathing

2227

12226

1.93

163.39

3.0

2.9

152.12

184.48

ng/l

4.06

2006

11118

Spinal stenosis

3137

14797

1.75

161.68

3.2

2.8

201.64

243.08

ng/l

5.12

2886

13532

Atherosclerosis, excluding cerebral and coronary sclerosis

2831

13322

1.82

161.60

3.8

3.0

417.32

229.30

ng/l

35.65

2625

12217

Symptoms and signs involving the urinary system

4338

21771

1.60

161.43

3.2

2.9

233.73

209.74

ng/l

2.31

3942

19836

Abnormal findings on diagnostic imaging of lung

2982

17447

1.77

161.40

3.7

2.9

224.02

229.53

ng/l

0.25

2790

15926

Short Achilles tendon (acquired)

293

549

6.99

158.39

3.5

2.8

107.28

173.73

ng/l

2.89

284

488

Congenital malformations, deformations and chromosomal abnormalities

2695

15032

1.78

157.87

3.1

2.8

186.77

167.77

ng/l

1.12

2427

13466

Lower back pain or/and sciatica

5357

25203

1.52

157.29

3.0

2.8

171.48

205.93

ng/l

5.87

4864

22844

Obesity, other/unspecified

1644

8257

2.10

156.63

2.9

2.7

142.34

165.92

ng/l

2.19

1417

7457

Abdominal and pelvic pain

5510

18651

1.53

156.52

3.3

2.7

194.26

208.28

ng/l

1.23

4955

16921

Pain (limb, back, neck, head abdominally)

4044

12731

1.64

155.77

3.1

2.8

199.62

219.82

ng/l

1.70

3635

11624

Factors influencing health status and contact with health services

1741

4225

2.15

154.98

3.0

2.0

219.08

182.01

ng/l

2.21

1572

3795

Stroke, excluding SAH

3682

17352

1.66

153.03

3.6

2.8

276.47

222.82

ng/l

7.40

3375

15883

Benign neoplasm of colon, rectum, anus and anal canal

3193

13919

1.72

152.95

3.2

2.9

233.98

207.32

ng/l

2.14

2912

12717

Right ventricular outflow tract obstruction

133

23.11

152.57

7.4

4.7

180.40

207.29

ng/l

0.18

127

Other diseases of pericardium

347

767

5.45

152.54

4.2

1.9

317.63

80.59

ng/l

4.65

327

672

COPD, hospital admissions 3, with asthma pneumonia sepsis

1931

8846

2.02

151.14

4.4

3.0

316.61

261.53

ng/l

3.57

1802

8101

Sleep apnoea

4842

22028

1.54

150.44

3.1

2.8

158.34

199.52

ng/l

10.61

4342

20076

Symptoms and signs involving the digestive system and abdomen

5488

18656

1.51

150.13

3.4

2.7

203.64

208.32

ng/l

0.27

4942

16926

Other symptoms and signs involving the nervous and musculoskeletal systems

2251

12738

1.86

149.26

3.3

2.9

155.97

199.58

ng/l

3.30

2032

11594

Viral pneumonia

812

3121

2.88

148.86

4.4

2.6

257.89

177.56

ng/l

4.47

744

2805

Aortic aneurysm

1600

8062

2.13

148.29

2.9

3.0

264.33

241.41

ng/l

0.99

1498

7385

Acute bronchitis

2375

13406

1.83

147.94

4.1

2.9

256.21

228.86

ng/l

1.85

2123

12168

Stroke, including SAH

3795

18068

1.63

147.88

3.5

2.8

276.51

218.30

ng/l

8.72

3470

16546

Diseases of the skin and subcutaneous tissue

5495

18768

1.51

147.37

3.1

2.8

215.29

195.63

ng/l

1.98

4972

16981

Soft tissue disorders

5351

18854

1.51

147.35

3.0

2.8

191.04

210.17

ng/l

2.25

4792

17086

Other antidepressants

5572

19933

1.50

146.19

3.0

2.9

186.31

216.30

ng/l

4.80

5011

18151

Disorders of gallbladder, biliary tract and pancreas

5279

23325

1.50

145.43

3.1

2.8

207.33

205.76

ng/l

0.08

4806

21227

Nutritional anaemias

2862

16968

1.73

145.38

4.2

2.9

315.12

221.48

ng/l

15.65

2626

15496

Other specific joint derangements/joint disorders

3487

14643

1.65

145.04

2.7

2.8

161.39

183.30

ng/l

2.62

3102

13262

Disorders of lens

3757

15147

1.63

144.43

3.2

2.7

231.70

194.87

ng/l

4.55

3454

13802

Iron deficiency anaemia

2438

14167

1.80

143.50

4.4

2.9

320.21

218.08

ng/l

16.79

2240

12909

Injuries to the head

5590

25357

1.47

141.19

3.2

2.8

228.05

195.09

ng/l

4.57

5081

22955

Direct fill therapy

816

3234

2.78

140.19

4.8

2.9

253.36

168.68

ng/l

4.30

755

2905

Bicuspidal aortic valve syndrome

316

699

5.63

140.17

3.1

2.8

166.71

175.57

ng/l

0.15

296

624

Benign neoplasm: Colon

2854

13334

1.73

139.57

3.2

2.9

238.86

212.95

ng/l

1.82

2599

12198

Sleep apnoea, including avohilmo

5023

22326

1.50

139.24

3.1

2.7

155.37

200.04

ng/l

12.50

4510

20323

Lumbar disc prolapse

3282

16421

1.65

139.03

2.8

140.87

206.51

ng/l

19.33

2986

14901

Other and unspecified nerve root and plexus disorders, also in other diseases

1094

4961

2.39

138.53

3.2

2.8

102.79

174.44

ng/l

14.78

1006

4493

Ischaemic Stroke, excluding all haemorrhages

3456

16738

1.64

138.24

3.6

2.8

283.11

226.88

ng/l

7.47

3173

15312

ILD, hospital admission 2, with pulmonary infections

729

2791

3.00

137.65

4.8

2.6

252.40

209.94

ng/l

1.69

683

2558

Respiratory insufficiency

626

2201

3.25

137.47

5.7

2.5

283.24

243.75

ng/l

0.99

593

2010

Other respiratory diseases principally affecting the interstitium

1275

6224

2.27

137.35

4.3

3.0

273.98

243.94

ng/l

1.25

1192

5703

Other functional intestinal disorders

2472

13975

1.76

137.02

3.5

2.9

216.60

218.95

ng/l

0.06

2258

12755

Gastro-oesophageal reflux disease

3573

20499

1.60

136.68

3.2

2.8

171.35

200.54

ng/l

3.82

3211

18707

Insulin medication

3284

17868

1.63

135.51

3.9

2.8

280.00

209.24

ng/l

11.27

3040

16233

Dorsopathies

5261

18445

1.49

135.37

2.9

2.8

169.27

217.62

ng/l

12.41

4721

16674

Septal defects

422

1147

4.12

134.45

4.0

3.7

188.69

183.26

ng/l

0.09

377

1031

Other or ill-defined heart diseases

347

839

4.70

133.95

5.1

1.9

315.12

89.85

ng/l

8.23

319

727

Exposure to unspecified factor

4865

26037

1.49

133.43

2.9

212.40

195.79

ng/l

1.55

4346

23662

Early onset COPD

1374

6930

2.14

132.69

3.7

2.7

235.98

199.25

ng/l

1.58

1252

6306

Other symptoms and signs involving cognitive functions and awareness

2582

14703

1.73

132.54

3.0

2.9

240.77

232.73

ng/l

0.28

2335

13436

Falls/tendency to fall

5600

19570

1.47

132.14

3.0

2.8

201.76

183.39

ng/l

2.10

5061

17720

Intestinal infectious diseases

4726

25295

1.49

131.62

3.8

2.7

238.76

196.50

ng/l

5.61

4274

22923

Senile cataract

3533

14113

1.62

131.43

3.2

2.7

236.05

201.76

ng/l

3.68

3253

12883

Gout, FINNGEN

1912

10800

1.91

131.37

4.3

3.0

393.11

236.36

ng/l

16.84

1760

9912

Atrial septal defect

297

651

5.43

130.38

3.6

3.4

220.96

174.96

ng/l

0.74

260

582

Gout, idiopatic and unspecified

1632

8837

2.01

129.59

4.4

3.0

391.82

232.03

ng/l

15.79

1509

8093

Allergic asthma (mode), excluding more controls

934

3939

2.42

129.46

2.8

1.8

128.77

87.87

ng/l

3.53

817

3508

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

5069

22997

1.48

128.55

3.1

2.8

212.96

205.22

ng/l

0.50

4593

20925

Other headache syndromes

2010

11463

1.83

128.39

2.8

2.6

125.53

185.42

ng/l

14.92

1812

10431

Disorders of eyelid, lacrimal system and orbit

4427

23805

1.51

126.53

3.0

2.9

183.97

213.50

ng/l

4.33

4014

21700

Other diseases of the respiratory system

1384

7164

2.11

125.40

4.8

3.1

283.77

255.35

ng/l

1.21

1293

6553

Other respiratory disorders and diseases

1384

7164

2.11

125.40

4.8

3.1

283.77

255.35

ng/l

1.21

1293

6553

Undetermined asthma, excluding more controls

657

2456

2.88

124.88

3.3

1.9

165.78

100.31

ng/l

4.90

595

2224

Other pulmonary heart/vessel disease

449

1405

3.99

124.82

7.2

3.1

394.90

247.05

ng/l

5.41

424

1291

Gonarthrosis [arthrosis of knee](FG)

4162

16481

1.53

124.16

2.9

2.7

183.11

205.31

ng/l

2.77

3794

15023

Peripheral arterial reconstruction

1257

6362

2.19

123.34

4.0

3.1

433.19

251.68

ng/l

19.64

1174

5827

Abnormal findings on examination of blood, without diagnosis

2669

15589

1.68

122.86

3.4

3.0

235.68

229.60

ng/l

0.23

2450

14251

COPD, hospital admissions 1, only main diagnosis

2261

11527

1.78

122.64

3.9

3.0

294.90

248.26

ng/l

2.65

2100

10567

Gastrointestinal diseases

2813

8583

1.68

121.82

3.1

2.5

183.84

173.42

ng/l

0.58

2494

7820

Diarrhoea and gastroenteritis of presumed infectious origin

3483

20915

1.56

121.06

3.9

2.8

245.10

198.67

ng/l

5.60

3157

18908

Secondary right heart disease

413

1254

4.16

120.78

7.4

3.1

396.67

244.37

ng/l

5.37

389

1152

Hernia

4829

22946

1.47

119.62

3.1

2.8

217.10

198.00

ng/l

1.92

4361

20829

Codes for special purposes

2148

12758

1.75

118.98

4.2

2.8

196.82

197.16

ng/l

0.01

1995

11522

Provisional assignment of new diseases of uncertain etiology

2144

12731

1.75

118.87

4.2

2.8

196.87

197.15

ng/l

0.01

1991

11495

Other and unspecified iron deficiency

1857

10675

1.84

117.91

4.1

2.9

315.38

214.44

ng/l

12.76

1706

9737

Systemic sclerosis (FG)

235

477

6.36

116.26

4.4

2.7

113.11

168.49

ng/l

1.93

226

437

Other medical care

2186

12847

1.74

116.21

3.8

2.6

258.64

208.93

ng/l

4.32

2005

11743

Shoulder lesions

4103

17112

1.51

115.91

2.9

2.8

163.37

212.19

ng/l

10.97

3718

15615

Any operation in hilmo

151

17.69

115.54

3.0

1.4

111.82

125.61

ng/l

0.10

126

Gonarthrosis

3583

13592

1.56

115.40

2.9

2.8

183.25

209.77

ng/l

3.43

3269

12404

Dental operations

3807

13025

1.55

115.09

3.1

2.9

222.30

245.30

ng/l

1.87

3434

11885

Insulin, intermediate and long-acting

3043

19492

1.60

115.02

3.9

2.9

277.67

213.75

ng/l

8.91

2816

17722

Certain disorders involving the immune mechanism

1103

5404

2.20

114.96

4.5

2.8

190.53

181.61

ng/l

0.27

1000

4894

Autoimmune diseases excluding thyroid diseases

5318

21100

1.43

112.59

3.2

2.8

214.87

201.45

ng/l

1.09

4850

19049

ILD, hospital admissions 3, with pneumonia sepsis

631

2495

2.91

112.30

5.0

2.8

266.31

215.99

ng/l

1.96

591

2280

Arthrosis

3813

14123

1.53

110.87

2.9

2.8

182.32

205.26

ng/l

2.69

3461

12856

ILD, hospital admissions

1038

5102

2.26

110.22

4.3

3.0

238.24

239.68

ng/l

0.03

978

4677

Benign neoplasm of colon, rectum, anus and anal canal

3479

21258

1.54

110.19

3.2

2.9

241.28

218.93

ng/l

1.74

3173

19502

Cholelithiasis, broad definition with cholecystitis

4542

21928

1.46

109.79

3.1

2.8

207.75

210.61

ng/l

0.15

4124

19986

Autoimmune diseases excluding thyroid diseases, strict definition

5148

20526

1.43

108.44

3.1

2.8

213.71

200.23

ng/l

1.07

4701

18529

Other interstitial pulmonary diseases

1048

5201

2.23

108.33

4.2

3.0

239.41

240.52

ng/l

0.03

986

4774

Nausea and vomiting

1467

7911

1.92

108.04

3.8

2.8

248.24

221.92

ng/l

1.05

1343

7204

L04AA Selective immunosuppressants

1131

5706

2.11

107.89

5.8

2.7

285.23

157.63

ng/l

11.61

1063

5146

Interstitial lung disease

1048

5210

2.23

107.83

4.2

3.0

239.41

242.96

ng/l

0.09

986

4780

Interstitial lung disease endpoints

1048

5210

2.23

107.83

4.2

3.0

239.41

242.96

ng/l

0.09

986

4780

ILD-related respiratory insufficiency

338

986

4.53

106.71

5.9

3.1

279.06

249.86

ng/l

0.47

317

908

Gout, strict definition

1190

6234

2.10

105.28

4.7

3.0

396.69

238.81

ng/l

10.97

1113

5720

Disorders of choroid and retina

4322

22219

1.46

104.98

3.3

2.9

253.04

211.15

ng/l

5.59

3962

20254

Other external causes of accidental injury

4275

14846

1.48

104.53

2.9

2.8

198.94

186.11

ng/l

1.03

3858

13516

Gout, unspecified

1316

7131

2.01

104.51

4.6

3.0

401.76

230.83

ng/l

13.28

1217

6525

Unspecified haematuria

2407

13014

1.66

104.48

3.5

3.0

279.54

234.08

ng/l

3.44

2215

11864

Unspecified acute lower respiratory infection

867

4020

2.33

104.12

4.6

2.9

239.15

197.78

ng/l

1.96

769

3611

Systemic sclerosis

235

529

5.69

103.13

4.4

2.9

113.11

168.37

ng/l

1.99

226

481

Persons encountering health services for other counselling and medical advice, not elsewhere classified

5625

23515

1.39

103.12

3.2

2.8

206.20

195.99

ng/l

0.87

5056

21392

ILD, hospital admissions 1, main diag only

936

4566

2.29

101.78

4.3

3.0

241.14

235.38

ng/l

0.14

879

4191

Sciatica+with lumbago

2433

14690

1.63

101.63

2.9

2.7

155.35

206.38

ng/l

7.69

2211

13346

Other joint disorders

4167

15428

1.47

101.59

2.8

180.58

195.51

ng/l

1.32

3727

13950

Cholelithiasis

4346

21632

1.45

101.17

3.1

2.8

209.86

211.24

ng/l

0.06

3952

19714

Systemic connective tissue disorders

1929

11698

1.73

100.55

3.3

2.8

188.68

204.00

ng/l

0.87

1755

10675

Other CVD

1279

6950

2.00

100.49

4.2

3.1

290.64

253.01

ng/l

1.78

1177

6357

705

3036

2.50

100.30

4.5

2.7

238.99

157.47

ng/l

3.23

631

2753

Systemic sclerosis, icd10

232

529

5.62

100.28

4.4

3.0

113.54

163.23

ng/l

1.68

224

482

Visual disturbances

2398

15313

1.63

100.27

3.3

2.9

182.66

200.88

ng/l

1.37

2178

13966

Operations for atrial fibrillation

194

394

7.42

99.58

3.1

2.8

288.42

205.49

ng/l

1.79

183

356

Osteopathies and chondropathies

2838

17868

1.56

98.61

3.4

2.9

220.63

202.61

ng/l

0.93

2599

16255

Accidents

4234

14846

1.46

98.37

3.0

2.8

198.73

186.11

ng/l

1.00

3816

13516

Diseases of the digestive system

2528

16390

1.61

98.28

3.8

3.0

275.75

230.61

ng/l

3.94

2317

14938

Infections of the skin and subcutaneous tissue

2664

17370

1.58

98.22

3.4

2.8

230.34

186.19

ng/l

4.73

2396

15701

GI-bleeding

1920

11724

1.73

98.12

4.0

3.1

308.39

244.22

ng/l

5.10

1775

10679

Allergic asthma (mode)

934

4417

2.15

97.96

2.8

2.2

128.77

142.17

ng/l

0.56

817

3951

Other arthrosis

2752

12912

1.58

96.47

2.8

171.37

201.18

ng/l

3.47

2506

11823

Other diseases of urinary system

5089

20876

1.40

96.38

3.1

2.8

215.94

204.75

ng/l

0.82

4632

18958

Hernia of abdominal wall, postoperative

984

4935

2.13

95.51

3.5

2.5

239.40

180.31

ng/l

2.92

893

4520

Undetermined asthma

657

2799

2.51

95.28

3.3

2.4

165.78

161.28

ng/l

0.11

595

2543

Other diseases of the digestive system

1896

11630

1.72

95.23

4.0

3.1

306.07

241.53

ng/l

5.24

1753

10599

Sequelae of external causes of morbidity and mortality

1405

7946

1.88

95.01

3.6

2.9

228.19

203.49

ng/l

1.43

1300

7229

General examination and investigation of persons without complaint and reported diagnosis

3050

10746

1.55

94.84

3.8

2.5

183.47

206.64

ng/l

2.03

2774

9716

Diseases of the musculoskeletal system and connective tissue

2503

7911

1.62

94.83

2.9

2.8

173.02

208.32

ng/l

3.79

2238

7119

Injuries to the knee and lower leg

5808

24819

1.37

94.81

2.9

197.07

199.63

ng/l

0.16

5289

22475

Insulin, combination of fast acting with intermediate-acting or long-acting

3293

20913

1.50

94.71

3.9

2.9

280.14

218.28

ng/l

9.00

3048

18991

All influenza (not pneumonia)

781

3601

2.31

94.17

3.9

2.7

228.50

176.42

ng/l

2.02

690

3202

Other/unspecified dorsalgia

1869

11329

1.71

94.15

3.1

2.8

182.75

222.10

ng/l

3.91

1691

10302

Other cataract

2372

11779

1.63

94.08

3.1

2.7

243.66

209.50

ng/l

2.46

2175

10754

Sarcoidosis

799

3748

2.32

94.02

4.8

2.8

160.29

184.32

ng/l

1.01

727

3398

Dental operations, only avohilmo

3942

14136

1.47

93.27

3.0

218.60

244.99

ng/l

2.53

3557

12917

Other systemic involvement of connective tissue (FG)

1383

7766

1.87

92.59

3.1

2.7

183.94

201.05

ng/l

0.82

1253

7106

Pericarditis

237

572

4.78

92.42

3.8

1.9

217.12

87.29

ng/l

4.92

216

499

Care involving dialysis

501

1930

2.91

92.40

5.3

2.7

837.69

183.01

ng/l

23.52

483

1754

Heart failure and hypertrophic cardiomyopathy

206

467

6.28

92.26

8.2

3.3

561.17

233.45

ng/l

6.49

201

423

Diagnoses used for exclusion with ILD

1487

8625

1.83

92.08

4.4

3.0

210.15

226.45

ng/l

0.70

1357

7848

Psychiatric diseases

5548

20604

1.38

92.07

3.0

2.8

184.32

199.85

ng/l

1.63

5017

18755

Visual disturbances and blindness

2559

16916

1.57

91.48

3.3

2.9

193.31

208.01

ng/l

0.97

2327

15419

Lung transplant status

107

128

13.87

90.02

7.8

3.5

142.81

180.34

ng/l

0.47

102

110

Lung transplantation

107

128

13.83

89.98

7.8

3.5

142.81

180.34

ng/l

0.47

102

110

Gonarthrosis,primary

4775

22087

1.40

88.83

2.9

180.46

220.39

ng/l

9.46

4363

20165

Hypokalaemia

695

3163

2.40

88.26

3.9

2.7

268.48

192.58

ng/l

2.46

635

2866

Diseases of pulp and periapical tissues

1692

10224

1.72

88.18

4.0

2.7

237.74

188.24

ng/l

3.75

1543

9321

Persons encountering health services in other circumstances, wide

6059

23806

1.35

88.16

3.3

2.8

217.74

199.70

ng/l

1.93

5446

21638

Coxarthrosis [arthrosis of hip](FG)

2956

14541

1.52

87.68

3.1

2.8

205.13

219.33

ng/l

0.98

2705

13312

Coxarthrosis

2737

12420

1.55

86.92

3.1

2.8

206.30

219.44

ng/l

0.84

2502

11374

External causes of morbidity and mortality

3332

11455

1.49

85.89

3.0

2.7

197.04

183.15

ng/l

0.96

3015

10430

Benign neoplasms

4718

19311

1.39

85.87

3.1

2.8

202.14

201.14

ng/l

0.05

4270

17447

Benign neoplasm: Colon

2916

19686

1.51

85.70

3.3

2.9

240.26

221.58

ng/l

1.18

2657

18077

Diseases of the eye and adnexa

3644

12751

1.46

85.08

2.9

2.6

173.97

177.99

ng/l

0.21

3257

11438

Unspecified kidney failure

697

3252

2.39

84.88

4.7

2.8

567.58

217.97

ng/l

18.63

655

2956

Other pleural conditions

717

3381

2.36

84.87

4.0

2.9

381.89

248.70

ng/l

4.67

675

3100

Any mental disorder

5646

21327

1.35

83.70

3.1

2.8

189.95

201.70

ng/l

1.02

5112

19416

Diseases of oral cavity, salivary glands and jaws

4807

18196

1.39

83.09

3.2

2.8

210.19

216.63

ng/l

0.38

4319

16573

Other symptoms and signs involving the circulatory and respiratory systems

366

1256

3.21

82.78

4.4

2.5

166.71

189.62

ng/l

0.48

332

1126

Dronedarone medication

228

592

4.67

82.25

3.6

1.9

254.97

94.76

ng/l

12.71

215

515

Subjective visual disturbances

1246

7086

1.86

82.14

3.1

2.8

165.12

184.73

ng/l

0.97

1130

6449

Functional dyspepsia

1339

7780

1.81

81.43

3.4

2.7

158.83

184.01

ng/l

1.27

1213

7090

Other disorders of ear

4614

22828

1.38

80.85

3.1

2.8

180.70

215.30

ng/l

6.80

4238

20724

Intracranial injury

2838

18929

1.49

80.77

3.4

2.9

235.80

213.01

ng/l

1.34

2551

17186

Other diseases of intestine

747

3640

2.23

79.97

3.7

2.8

242.02

210.71

ng/l

1.09

690

3330

Benzodiazepine use

4822

25744

1.36

79.31

3.0

2.8

192.30

204.73

ng/l

1.05

4343

23368

Hyperlipidaemia, other/unspecified

2069

12762

1.60

79.22

3.0

2.8

274.26

214.99

ng/l

5.08

1931

11635

Chronic periapical parodontitis

1075

5910

1.92

79.22

4.6

2.7

269.84

195.71

ng/l

4.48

992

5399

Deforming dorsopathies

1354

7965

1.78

78.34

3.0

2.7

159.88

194.62

ng/l

1.23

1238

7228

Enlarged lymph nodes

783

3880

2.14

78.19

3.6

2.6

206.55

173.83

ng/l

1.16

714

3518

Hypo-osmolality and hyponatraemia

995

5372

1.98

78.03

3.9

2.8

264.64

222.19

ng/l

1.87

918

4885

Explicit bacterial Sepsis

614

2795

2.39

77.83

4.7

2.6

345.48

191.89

ng/l

8.61

562

2529

Streptococcal septicaemia

543

2357

2.55

77.82

4.7

2.7

353.19

192.29

ng/l

7.98

496

2152

Gingivitis and periodontal diseases

4677

17931

1.38

77.78

2.9

2.8

196.63

212.11

ng/l

1.34

4199

16341

Arthropathies

4174

15466

1.40

77.54

2.8

193.38

195.92

ng/l

0.13

3720

13984

Rotator cuff syndrome

3115

16276

1.46

77.28

2.8

165.65

210.62

ng/l

7.79

2810

14903

Dental caries 3 and operation codes

4760

18227

1.37

76.65

3.0

2.9

207.87

221.56

ng/l

1.11

4268

16641

Personality disorders, excluding more controls

950

5042

1.95

76.22

2.5

2.6

121.75

141.21

ng/l

0.96

840

4486

Symptoms and signs involving the skin and subcutaneous tissue

3233

23025

1.44

75.59

3.0

2.9

177.88

199.82

ng/l

2.39

2925

20977

Presence of other devices

1319

7830

1.78

75.08

3.4

2.6

233.06

221.99

ng/l

0.41

1197

7137

Carpal tunnel syndrome

2888

18287

1.47

74.85

3.1

2.7

158.53

197.94

ng/l

6.42

2608

16676

Other diseases of anus and rectum

1580

9807

1.68

74.70

3.4

2.8

244.25

218.72

ng/l

1.13

1465

8949

Dysphagia

1319

7850

1.77

74.14

3.6

2.7

191.12

220.40

ng/l

1.69

1225

7170

CR(E)ST syndrome

151

311

6.38

74.04

3.8

2.7

97.63

136.80

ng/l

1.17

146

287

Dental caries 1 and operation codes

4606

17675

1.37

73.15

3.0

2.9

211.02

224.51

ng/l

1.05

4143

16143

Familial hypercholesterolemia, with ischemic heart disease

608

2844

2.36

73.11

3.6

2.5

294.80

193.81

ng/l

3.64

569

2586

Other gastritis (incl. Duodenitis)

1258

7436

1.79

72.70

3.4

2.8

225.72

210.76

ng/l

0.56

1164

6792

Asthma and allergy, excluding more controls

419

1608

2.67

72.36

2.4

1.8

84.78

75.90

ng/l

0.33

364

1417

Benign neoplasm: Colon, unspecified

1392

8465

1.74

71.64

3.2

3.1

240.89

228.50

ng/l

0.39

1268

7794

Diaphragmatic hernia

1938

12776

1.59

71.23

2.9

220.76

206.57

ng/l

0.59

1756

11708

Parodontitis or operation codes

4367

24214

1.36

71.09

2.9

2.8

198.12

195.03

ng/l

0.15

3941

22078

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

505

2201

2.51

71.01

3.9

2.9

199.33

184.15

ng/l

0.35

457

1985

Chronic sinusitis

1944

12767

1.57

70.88

2.9

2.8

158.89

192.32

ng/l

3.16

1754

11637

Genitourinary diseases

2873

9974

1.48

70.78

3.4

2.6

211.83

167.45

ng/l

5.23

2575

8967

Parodontitis

4360

24215

1.36

70.58

2.9

2.8

197.63

195.12

ng/l

0.12

3936

22078

Other retinal disorders

3338

19483

1.42

70.24

3.4

2.9

275.73

221.45

ng/l

6.42

3056

17786

Retention of urine

1896

10498

1.60

70.15

3.2

3.0

291.13

248.22

ng/l

2.27

1727

9602

Hypotension

1046

5971

1.89

70.07

4.1

3.1

296.06

261.42

ng/l

1.30

966

5460

Sequelae with surgical and medical care as external cause

1101

6352

1.85

70.04

3.6

2.9

231.12

199.70

ng/l

1.77

1026

5781

Idiopathic pulmonary fibrosis

563

2621

2.44

70.00

4.7

3.0

230.10

265.63

ng/l

1.02

538

2406

Pleural effusion

948

5255

1.95

69.78

4.5

2.9

366.43

245.55

ng/l

8.34

887

4814

Chronic gastritis

1594

10115

1.66

69.76

3.1

2.9

251.77

225.71

ng/l

1.13

1446

9272

Chronic periodontitis, including avohilmo

4336

24207

1.36

69.56

2.9

2.8

197.82

195.08

ng/l

0.13

3914

22071

Disorders of synovium and tendon

2380

14682

1.50

69.55

3.0

2.7

168.48

195.97

ng/l

1.51

2178

13369

Benign neoplasms

3305

13409

1.42

68.72

3.0

2.8

181.82

187.41

ng/l

0.27

2974

12035

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

576

2704

2.34

68.27

3.9

3.0

263.52

211.37

ng/l

1.21

530

2458

Cholecystectomy

3454

22435

1.40

68.09

3.0

2.8

189.60

213.08

ng/l

2.32

3140

20456

Used for control exclusion in common control thyroid runs

5104

19815

1.33

68.08

3.3

2.8

200.77

200.44

ng/l

0.02

4606

17884

Peripheral artery operations in Hilmo

813

4343

2.02

67.05

4.2

3.0

480.18

242.54

ng/l

16.85

759

3964

Other and unspecified drugs and medicaments

481

2109

2.50

67.00

3.9

3.0

200.22

192.18

ng/l

0.16

434

1903

Other bacterial intestinal infections

994

5646

1.87

66.38

4.0

2.8

293.96

214.41

ng/l

4.43

914

5126

Dental caries 1

4231

16212

1.36

66.34

3.0

216.94

225.73

ng/l

0.53

3820

14802

Dental caries, including avohilmo

4227

16201

1.36

66.24

3.0

217.02

225.51

ng/l

0.51

3817

14790

Migraine with aura

836

4461

1.94

66.01

2.9

2.5

101.95

155.20

ng/l

6.12

732

4026

Chronic periodontitis

804

4287

2.00

65.96

4.1

2.8

319.81

198.69

ng/l

4.28

746

3922

Dental caries 3

4376

16865

1.35

65.90

3.0

218.48

222.96

ng/l

0.23

3940

15393

Abnormal serum enzyme levels

1641

10495

1.62

65.67

2.9

3.0

208.96

237.83

ng/l

1.59

1500

9645

L04AX Other immunosuppressants

2460

17217

1.47

65.31

3.6

2.8

178.14

178.29

ng/l

0.01

2238

15627

Convulsions, not elsewhere classified

992

5543

1.83

65.10

3.1

2.7

216.64

183.32

ng/l

1.33

891

4986

Second line medication for Crohn's disease

2504

17598

1.46

64.92

3.5

2.8

176.78

178.35

ng/l

0.07

2278

15967

Neoplasms

3243

12527

1.41

64.63

2.9

2.8

173.87

186.49

ng/l

0.84

2878

11223

Conductive and sensorineural hearing loss

4070

21288

1.36

64.60

3.1

2.8

190.51

222.94

ng/l

4.89

3764

19394

Artrosis, including avohilmo

4141

17095

1.36

63.98

2.8

2.9

184.53

216.78

ng/l

4.85

3743

15543

Follow-up examination after treatment for conditions other than malignant neoplasms

1926

8333

1.55

63.43

2.3

2.5

190.94

199.80

ng/l

0.37

1735

7558

Other disorders of teeth and supporting structures

1061

6204

1.80

63.35

4.2

2.8

228.40

197.74

ng/l

1.10

980

5655

Parodontitis and operation codes

4050

23875

1.35

63.26

2.9

2.8

184.84

195.12

ng/l

0.81

3651

21786

Migraine

1695

9345

1.58

63.23

2.9

2.4

109.40

152.48

ng/l

5.90

1483

8413

Dental pulpitis 2, only avohilmo

3919

14974

1.37

63.23

3.0

220.75

231.95

ng/l

0.68

3548

13682

Other arthritis (FG)

1420

8954

1.65

62.55

3.1

2.7

242.90

191.79

ng/l

3.37

1289

8140

Injuries to the abdomen, lower back, lumbar spine and pelvis

1934

12972

1.53

62.54

3.4

3.0

248.42

222.89

ng/l

1.35

1748

11766

Benign neoplasm: Colon, unspecified

1392

8803

1.67

62.54

3.2

3.0

240.89

225.21

ng/l

0.54

1268

8083

Dental pulpitis 2

3844

14682

1.37

62.38

3.0

225.05

231.75

ng/l

0.34

3484

13404

Autoimmune diseases

5320

21192

1.30

61.94

3.2

2.8

202.91

201.15

ng/l

0.10

4817

19127

Other specified/unspecified arthritis

1246

7634

1.70

61.82

3.2

2.7

239.98

195.26

ng/l

2.59

1132

6961

Injuries to the thorax

2219

15460

1.48

61.12

3.3

3.0

235.97

221.54

ng/l

0.49

2018

14062

Chronic rhinitis, nasopharyngitis and pharyngitis

1381

8707

1.64

60.68

2.5

2.9

134.84

178.70

ng/l

4.93

1207

7931

Unspecified fall

2348

16426

1.46

60.23

3.2

3.0

220.22

215.23

ng/l

0.19

2126

14926

Artificial opening status

333

1302

2.88

60.14

3.0

2.5

227.29

175.64

ng/l

1.39

296

1180

Asthma and allergy

418

1752

2.44

59.91

2.4

2.3

84.26

118.99

ng/l

1.90

363

1562

Diseases of liver

1641

10822

1.58

59.85

3.3

2.8

248.57

198.65

ng/l

3.40

1495

9819

Polyuria

1200

7392

1.71

59.54

3.1

3.0

229.68

227.76

ng/l

0.04

1099

6761

Bacterial intestinal infections, IBD co-morbidities

988

5791

1.81

59.17

4.0

3.0

299.94

222.47

ng/l

4.07

907

5258

Injury, poisoning and certain other consequences of external causes

2573

9077

1.45

58.08

3.1

2.7

193.77

179.39

ng/l

0.94

2325

8247

Cutaneous abscess, furuncle and carbuncle

1120

6790

1.72

57.95

3.4

2.8

220.38

176.61

ng/l

2.59

1026

6106

Unspecified privation

582

2917

2.14

57.42

2.7

2.9

326.53

205.49

ng/l

4.81

526

2638

Idiopathic gout

585

2969

2.18

57.24

3.9

2.9

401.07

219.74

ng/l

5.91

544

2731

Artificial joint operation, meniscal resection

4555

23605

1.31

57.21

2.9

176.17

214.85

ng/l

8.45

4158

21509

Mixed connective tissue disease

361

1498

2.65

56.91

3.3

2.9

124.27

184.09

ng/l

2.91

338

1354

Other systemic involvement of connective tissue

1398

9017

1.62

56.70

3.1

2.8

183.45

203.28

ng/l

1.05

1265

8234

Deposits [accretions] on teeth

373

1511

2.59

56.54

6.4

2.9

310.28

181.77

ng/l

4.14

347

1348

Sequelae of cerebrovascular disease

1979

12035

1.50

56.22

3.9

3.0

297.23

243.84

ng/l

4.16

1807

11022

Dental caries 3, only avohilmo

4405

17389

1.32

56.16

2.9

3.0

215.21

226.46

ng/l

0.78

3957

15888

Cardiac murmurs and other cardiac sounds

368

1510

2.54

56.12

3.1

2.9

166.68

175.17

ng/l

0.14

336

1349

Other diseases of upper respiratory tract

5488

22714

1.28

55.99

2.8

3.0

174.36

218.37

ng/l

11.80

4941

20659

Invasive ventilation

439

2013

2.40

55.44

3.3

3.0

363.04

216.75

ng/l

4.43

408

1850

Amputation

627

3284

2.08

55.39

4.7

3.0

503.08

246.38

ng/l

14.71

583

3001

Procreative management

1154

5957

1.68

55.20

3.3

2.7

112.94

134.76

ng/l

1.49

1035

5264

ILD medications: azathioprine

639

3330

2.01

55.12

5.7

2.6

219.45

157.38

ng/l

2.97

593

3003

Spondylosis

2538

15761

1.42

54.68

2.9

2.8

161.72

222.15

ng/l

13.73

2317

14381

Insulin, fast-acting

1702

11507

1.53

54.56

4.0

2.9

280.97

201.73

ng/l

7.26

1581

10388

Rheumatoid arthritis

1549

9322

1.56

54.32

3.0

2.7

202.31

205.72

ng/l

0.12

1422

8538

Disturbances of skin sensation

1112

6838

1.68

54.19

2.8

2.7

121.17

164.91

ng/l

5.67

972

6172

Meniscus derangement

2685

13365

1.41

54.07

2.7

2.8

181.34

198.10

ng/l

1.15

2433

12206

Soft tissue disorders related to use, overuse and pressure

1276

8137

1.63

54.05

3.1

2.8

189.43

202.10

ng/l

0.52

1154

7410

Primary gonarthrosis, bilateral

2626

16823

1.41

53.78

2.9

180.44

227.63

ng/l

8.00

2410

15440

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

1087

6691

1.70

53.36

3.1

2.6

127.70

161.90

ng/l

3.74

968

6099

Anxiety disorders, excluding more controls

3568

17961

1.34

53.36

3.0

2.7

144.33

184.65

ng/l

7.17

3186

16284

Reimbursement for rheumatic diseases

2638

19338

1.40

52.84

3.0

2.8

191.25

195.28

ng/l

0.17

2401

17603

Personality disorders

950

5636

1.74

52.64

2.5

2.7

121.75

137.52

ng/l

0.73

840

5007

Familial hypercholesterolemia

879

5163

1.81

52.62

3.3

2.8

259.18

227.70

ng/l

0.86

823

4705

Sensorineural hearing loss

3833

20691

1.33

52.62

3.2

2.8

196.66

226.63

ng/l

3.93

3555

18879

Acute upper respiratory infections of multiple and unspecified sites

3194

17970

1.36

52.60

3.6

2.7

202.55

195.90

ng/l

0.34

2876

16245

Other specified congenital malformation syndromes affecting multiple systems

111

230

5.66

52.51

3.6

5.2

154.39

166.30

ng/l

0.13

104

206

Maze procedure for atrial fibrillation

101

12.19

52.46

2.7

3.6

317.74

273.26

ng/l

0.27

Fracture of rib(s), sternum and thoracic spine

1513

10104

1.56

52.43

3.5

3.0

239.25

224.97

ng/l

0.37

1381

9176

Other specified/unspecified systemic involvement of connective tissue

325

1336

2.67

52.29

3.4

2.9

150.20

180.37

ng/l

0.76

307

1203

Implicit fungal Sepsis

237

842

3.25

52.02

5.7

2.8

270.43

193.58

ng/l

1.59

225

768

Other peripheral vascular diseases

428

1983

2.34

52.02

3.3

2.9

188.02

178.27

ng/l

0.19

391

1778

Autoimmune diseases related-to ILD

3790

25772

1.32

51.95

3.0

2.8

195.46

198.21

ng/l

0.14

3417

23336

Dental pulpitis 4

5239

21676

1.28

51.83

2.8

2.9

197.12

209.86

ng/l

1.11

4707

19710

Dental pulpitis 1

5238

21680

1.28

51.74

2.8

2.9

197.24

209.69

ng/l

1.07

4707

19712

Enterocolitis due to Clostridium difficile

633

3400

2.01

51.51

4.8

3.0

344.42

245.87

ng/l

3.86

586

3089

Diseases of pulp and periapical tissues, including avohilmo

5230

21656

1.27

51.42

2.8

2.9

197.35

209.68

ng/l

1.06

4701

19692

Azathioprine

639

3412

1.96

51.27

5.7

2.6

219.45

164.45

ng/l

2.41

593

3072

Substance abuse, excluding more controls

2444

15542

1.41

51.16

2.9

2.8

239.86

204.92

ng/l

1.47

2192

14156

Post-traumatic stress disorder

263

969

2.84

51.08

2.7

2.5

92.54

116.46

ng/l

0.52

235

851

Dental caries 1, only avohilmo

4222

16788

1.31

51.07

2.9

3.0

214.67

229.27

ng/l

1.11

3806

15350

Acute sinusitis

2060

13570

1.45

51.00

3.1

2.6

159.06

173.14

ng/l

0.84

1837

12245

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

4067

18666

1.31

50.83

2.7

2.9

184.57

192.15

ng/l

0.50

3681

16913

Malignant neoplasm, wide definition for exclusion

4067

18667

1.31

50.82

2.7

2.9

184.57

192.14

ng/l

0.50

3681

16914

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

4065

18666

1.31

50.64

2.7

2.9

184.73

192.22

ng/l

0.49

3678

16914

Disorders of adult personality and behaviour

981

5931

1.70

50.56

2.5

2.7

117.92

137.59

ng/l

1.05

863

5265

Selective serotonin reuptake inhibitors

4805

20010

1.28

50.42

2.8

2.9

170.25

216.43

ng/l

10.90

4314

18220

Diabetic nephropathy, excluding more controls

778

3704

1.87

50.38

4.2

3.0

495.67

202.74

ng/l

20.29

730

3346

Neuromuscular dysfunction of bladder

513

2583

2.15

50.34

3.1

3.0

162.38

205.87

ng/l

2.25

459

2345

Varicose veins

3147

17998

1.35

50.12

3.1

2.8

210.35

218.43

ng/l

0.43

2870

16463

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

944

5661

1.71

50.03

2.9

2.6

130.97

155.50

ng/l

1.15

831

5063

Somatoform disorder

710

3957

1.88

49.85

3.0

2.7

127.89

166.19

ng/l

2.29

631

3573

Preparation and fitting of bite rail to mouth

554

2851

2.04

49.75

2.7

124.63

143.85

ng/l

0.47

499

2559

Abnormalities of gait and mobility

681

3793

1.93

49.57

2.8

3.0

288.00

225.51

ng/l

1.53

616

3473

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

2253

15959

1.42

49.36

2.9

2.8

161.19

195.44

ng/l

2.14

2025

14569

Viral and other specified intestinal infections

756

4178

1.82

49.32

5.1

2.7

179.39

177.98

ng/l

0.03

673

3647

Benign neoplasm of other and ill-defined parts of digestive system

915

5530

1.75

49.19

3.3

2.9

205.50

203.40

ng/l

0.05

825

5073

Specific personality disorders

816

4737

1.78

49.02

2.5

2.6

122.98

136.44

ng/l

0.50

727

4207

Cervical disc disorders

1707

11803

1.49

48.93

2.9

2.8

131.59

214.60

ng/l

20.66

1575

10770

Disorders of skin appendages

1886

13245

1.46

48.91

3.1

2.7

175.22

177.91

ng/l

0.09

1699

11929

Injuries to the shoulder and upper arm

3874

25385

1.30

48.79

2.9

205.97

205.04

ng/l

0.04

3496

23079

Amputation of toe

456

2244

2.25

48.68

4.3

3.0

496.75

236.03

ng/l

10.81

424

2060

Presence of other functional implants

2739

14439

1.38

48.39

3.2

2.4

236.64

194.24

ng/l

4.51

2521

13119

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

2106

13302

1.44

48.22

2.9

3.0

194.53

221.70

ng/l

1.88

1945

12166

Dental caries 2 and operation codes, only avohilmo

1774

15669

0.69

47.70

2.5

2.9

133.92

166.36

ng/l

5.30

1575

14149

Fungal Sepsis

248

944

3.00

47.69

5.5

2.7

271.12

191.71

ng/l

1.77

234

859

Dentofacial anomalies [including malocclusion]

1018

6243

1.66

47.53

3.3

2.6

141.47

154.37

ng/l

0.44

916

5636

Disorders of lacrimal system

1901

13484

1.45

47.52

3.2

2.8

172.51

200.12

ng/l

2.26

1728

12323

Spondylolisthesis/Spondylolysis

869

5210

1.75

47.50

3.0

2.7

142.64

194.67

ng/l

5.25

791

4743

Poisoning by drugs, medicaments and biological substances

876

5239

1.73

47.33

3.1

2.7

154.74

153.77

ng/l

0.03

790

4656

Misadventures to patients during surgical and medical care

696

3935

1.87

47.33

3.5

2.8

236.60

198.47

ng/l

1.47

646

3573

Any event in cancer register

4173

19460

1.29

47.26

2.7

2.9

187.00

191.01

ng/l

0.22

3765

17652

Later onset COPD

1710

9365

1.50

47.07

3.9

3.1

339.04

270.32

ng/l

3.77

1607

8597

Other disorders of lacrimal gland

1537

10505

1.51

47.05

3.2

2.8

159.30

192.47

ng/l

2.79

1391

9573

Fibromyalgia

360

1609

2.37

46.91

2.9

2.7

86.97

142.68

ng/l

2.80

327

1444

Extracorporeal dialysis

358

1623

2.44

46.74

6.1

2.9

858.27

204.88

ng/l

20.26

345

1486

Mood disorders, excluding more controls

4234

20343

1.29

46.41

2.8

154.20

194.49

ng/l

7.48

3778

18502

Irritable bowel syndrome

1128

7227

1.61

46.33

2.8

2.6

140.87

175.48

ng/l

2.52

1016

6559

Myocardial infarction, with ST-elevation

1038

6589

1.67

46.10

4.1

3.1

383.08

256.25

ng/l

5.39

963

6016

Malignant neoplasm

4126

19285

1.29

46.07

2.7

2.9

186.37

194.93

ng/l

0.57

3741

17504

Open wound of lower leg

715

4103

1.84

46.06

3.5

3.0

269.89

204.32

ng/l

3.30

639

3676

Dermatitis

2710

20431

1.36

45.78

3.2

2.9

201.29

201.71

ng/l

0.01

2456

18628

Hallux valgus (acquired)

1572

7775

1.51

45.61

2.8

2.7

185.72

194.10

ng/l

0.22

1441

7121

Other and unspecified polyneuropathies, also in other diseases

1011

6392

1.67

45.52

3.4

3.0

247.91

225.52

ng/l

0.68

924

5854

Hyperkalaemia

342

1539

2.46

45.52

5.7

2.9

581.83

235.74

ng/l

11.03

318

1402

Paralytic ileus and intestinal obstruction

1279

8489

1.57

45.42

3.1

2.8

214.36

227.56

ng/l

0.50

1173

7748

Sequelae of injuries, of poisoning and of other consequences of external causes

1025

6471

1.64

45.24

2.8

147.87

173.94

ng/l

1.90

928

5827

Hernia of abdominal wall

2130

15537

1.41

45.23

3.4

2.9

230.79

208.21

ng/l

1.20

1937

14177

Exclusion endpoint for clefts

118

289

4.65

45.19

3.5

4.8

151.28

166.83

ng/l

0.19

111

259

Insulin, fast-acting or short human

1714

12038

1.47

45.08

4.0

2.9

283.46

208.60

ng/l

6.53

1592

10873

Embolic stroke with flimmer

194

669

3.36

44.97

3.9

2.5

386.74

213.44

ng/l

3.65

179

601

Iron deficiency anaemia secondary to blood loss (chronic)

863

5266

1.73

44.73

5.2

2.9

353.83

222.60

ng/l

8.74

792

4799

Other degenerative diseases of the nervous system

1329

6707

1.55

44.45

3.2

2.6

211.41

243.27

ng/l

1.99

1211

6184

Depression or dysthymia

3294

14154

1.33

44.32

2.8

169.48

206.70

ng/l

4.51

2958

12894

Vascular disorders of the intestines

427

2121

2.21

44.16

4.5

2.9

418.63

252.49

ng/l

5.40

396

1937

Poisoning by medicine

781

4616

1.75

44.16

3.1

2.8

149.92

151.77

ng/l

0.05

705

4103

Polyneuropathies and other disorders of the peripheral nervous system

1122

7312

1.61

44.09

3.5

3.0

245.42

224.79

ng/l

0.67

1027

6688

Other disorders of eyelid

2253

16097

1.39

44.04

3.1

2.9

202.73

229.74

ng/l

1.93

2048

14791

Symptoms and signs concerning food and fluid intake

496

2572

2.04

43.97

3.3

2.7

228.75

193.73

ng/l

0.92

456

2349

Diseases of the ear and mastoid process

5334

21936

1.25

43.79

3.0

2.8

172.14

205.94

ng/l

6.47

4820

19784

Other reaction to severe stress, and adjustment disorders

1251

8293

1.54

43.46

3.4

2.6

147.31

149.65

ng/l

0.08

1117

7412

Other disorders of the musculoskeletal system and connective tissue

740

4370

1.79

43.41

3.2

2.9

167.72

201.10

ng/l

1.75

686

3974

Phlebitis and thrombophlebitis (not including DVT)

1074

6936

1.61

43.41

2.9

2.8

186.45

196.52

ng/l

0.34

986

6297

Viral pneumonia (known virus, not influenza)

170

556

3.59

43.39

5.5

3.5

248.97

217.26

ng/l

0.36

156

507

Postprocedural musculoskeletal disorders, not elsewhere classified

411

2031

2.22

43.16

3.8

3.0

192.22

208.60

ng/l

0.35

385

1850

Fracture of lumbar spine and pelvis

1145

7519

1.59

43.14

3.6

3.0

262.05

237.70

ng/l

0.96

1040

6830

Emphysema

423

2109

2.19

43.07

3.9

2.9

223.49

253.16

ng/l

0.61

391

1925

Injuries to the hip and thigh

2334

15929

1.38

42.59

3.3

3.0

289.64

233.63

ng/l

4.91

2116

14515

Anxiety (asthma-related co-morbidities)

2145

12349

1.39

42.57

2.8

2.6

134.33

156.10

ng/l

1.58

1890

11091

Benign neoplasm of other and ill-defined parts of digestive system

915

5740

1.68

42.53

3.3

2.9

205.50

201.05

ng/l

0.11

825

5246

Superficial injury of head

1039

6690

1.61

42.23

3.2

3.0

247.19

209.21

ng/l

1.61

954

6028

Congenital malformations of trachea and bronchus

198

6.03

42.11

4.9

3.2

159.20

227.01

ng/l

0.88

178

Pain in thoracic spine

642

3654

1.83

42.04

3.3

2.7

138.14

187.06

ng/l

3.86

595

3289

Need for immunization against other single viral diseases

138

405

3.99

41.63

3.6

3.0

548.95

179.03

ng/l

2.60

132

365

Viral hepatitis, IBD co-morbidity

185

632

3.07

41.42

2.9

2.2

179.59

137.77

ng/l

0.55

165

556

Chronic ulcer of skin, not elsewhere classified

407

2034

2.19

41.35

4.2

3.0

390.44

232.22

ng/l

3.14

367

1855

Osteoporosis with pathological fracture (FG)

409

2051

2.19

41.33

4.5

2.9

224.72

231.20

ng/l

0.11

383

1876

Osteoporosis

1370

8990

1.52

41.25

3.8

2.9

223.25

226.70

ng/l

0.10

1278

8212

Cystitis

3778

18263

1.28

41.10

2.9

2.8

210.36

208.42

ng/l

0.08

3447

16630

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

1422

9828

1.49

40.98

3.6

2.8

207.47

177.03

ng/l

1.54

1278

8920

Other anxiety disorders

1519

9363

1.47

40.76

2.8

2.6

133.84

153.80

ng/l

1.16

1329

8365

Neurotic, stress-related and somatoform disorders

3609

20253

1.29

40.63

3.0

2.7

142.78

176.42

ng/l

5.28

3210

18297

Anxiety disorders

3669

20570

1.28

40.59

3.0

2.7

144.34

177.61

ng/l

5.20

3265

18596

Abnormal findings on diagnostic imaging of other body structures

632

3641

1.84

40.55

3.5

2.8

166.18

190.84

ng/l

0.98

588

3307

Memory loss

568

3200

1.93

40.37

2.3

3.1

236.89

251.11

ng/l

0.25

521

2917

Fracture of lower leg, including ankle

2404

18074

1.35

40.30

2.9

209.69

192.78

ng/l

1.01

2190

16401

Complications of internal orthopaedic prosthetic devices, implants and grafts

1188

7995

1.55

40.22

3.2

2.9

226.88

217.03

ng/l

0.34

1102

7326

Symptoms and signs involving speech and voice

1505

10568

1.47

40.10

3.4

2.8

173.35

203.53

ng/l

2.41

1380

9662

Cervicobrachial syndrome

921

5831

1.63

40.04

2.8

2.7

113.58

189.63

ng/l

12.20

821

5272

Polycystic ovarian syndrome, consortium definition

2684

12276

1.34

40.03

2.8

2.6

134.30

171.47

ng/l

7.07

2446

11093

Cellulitis

966

6203

1.62

39.88

3.7

2.8

258.15

189.36

ng/l

3.54

861

5608

Haemorrhage, not elsewhere classified

242

994

2.74

39.80

3.9

2.9

367.95

231.08

ng/l

3.18

219

915

Gonarthrosis, primary, with knee surgery

2839

17930

1.33

39.77

2.9

187.86

232.54

ng/l

7.55

2598

16470

Missing teeth due to accident, extraction or parodontitis

580

3279

1.88

39.65

4.2

2.8

218.53

197.58

ng/l

0.42

547

2996

Disorder of lipoprotein metabolism, unspecified

709

4246

1.77

39.60

2.8

2.7

283.77

218.81

ng/l

2.38

662

3862

Heartburn

484

2581

1.98

39.57

3.3

2.7

173.14

185.10

ng/l

0.28

444

2346

Other metabolic disorders

516

2800

1.93

39.55

4.0

2.5

181.38

153.39

ng/l

0.63

471

2524

Schizophrenia or delusion, excluding more controls

1165

7711

1.54

39.53

2.8

147.48

179.55

ng/l

1.78

1039

6913

Temporomandibular joint disorders

576

3222

1.85

39.50

2.8

2.5

121.19

168.96

ng/l

2.03

519

2944

Kidney transplant status

262

1111

2.57

39.45

4.2

3.2

573.00

165.39

ng/l

11.81

251

1008

Fall on same level involving ice and snow

2478

18856

1.34

39.38

2.8

2.9

196.25

195.05

ng/l

0.04

2259

17154

Disorders of other endocrine glands

1877

13488

1.40

39.13

3.4

2.9

222.99

197.71

ng/l

1.30

1708

12225

Dental pulpitis 4, only avohilmo

5206

22343

1.23

38.72

2.7

2.9

186.24

210.26

ng/l

3.22

4673

20335

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

147

461

3.47

38.68

3.4

3.9

135.19

148.65

ng/l

0.21

133

408

Delirium, not induced by alcohol and other psychoactive substances

656

3882

1.80

38.63

3.7

3.1

362.61

270.64

ng/l

2.69

604

3526

Other other unspecified disorders of the circulatory system

242

1012

2.70

38.46

4.7

3.0

273.84

217.56

ng/l

1.00

220

935

Unknown and unspecified causes of morbidity

344

1643

2.22

38.32

3.3

2.7

212.49

192.89

ng/l

0.39

309

1482

2212

15707

1.37

38.19

3.4

3.0

246.44

244.75

ng/l

0.06

2044

14440

Voice disturbances

1188

8058

1.53

38.05

3.0

2.8

155.96

189.23

ng/l

2.63

1082

7373

All anxiety disorders

2156

12932

1.36

37.75

2.8

2.6

134.54

157.18

ng/l

1.68

1898

11582

Asthma and opportunity respiratory infection

292

1340

2.43

37.46

3.6

2.9

221.56

209.98

ng/l

0.13

265

1218

Phobic anxiety disorders

392

1964

2.06

37.43

2.9

2.6

128.79

117.08

ng/l

0.29

349

1719

Ventral hernia

1145

7763

1.53

36.95

3.6

2.9

228.52

209.03

ng/l

0.62

1044

7091

TMD related operations

619

3617

1.78

36.88

2.8

2.7

121.25

148.11

ng/l

0.87

555

3252

Sequelae of other external causes

286

1301

2.39

36.69

4.3

2.8

242.32

203.24

ng/l

0.80

265

1173

Coagulation defects, purpura and other haemorrhagic conditions

847

5395

1.63

36.36

3.5

3.0

285.26

197.55

ng/l

5.24

772

4898

Skin changes due to chronic exposure to nonionizing radiation

2109

15075

1.37

36.35

3.4

3.0

250.34

247.40

ng/l

0.11

1947

13867

Congenital malformations of the respiratory system

118

342

4.04

36.34

4.6

3.8

143.94

200.72

ng/l

1.10

108

314

Primary_lymphoid and hematopoietic malignant neoplasms

1189

8171

1.51

35.96

3.3

3.2

253.02

235.77

ng/l

0.63

1097

7492

Speech and linguistic disorders, excluding more controls

266

1096

2.38

35.75

5.1

3.4

186.48

185.10

ng/l

0.02

247

965

Other complications of surgical and medical care, not elsewhere classified

445

2390

1.97

35.75

3.5

2.9

240.15

185.19

ng/l

0.86

409

2152

Migraine without aura

530

2972

1.83

35.73

2.6

2.5

82.94

130.68

ng/l

2.79

457

2671

Intestinal stricture

1499

10757

1.44

35.64

3.1

3.0

223.92

227.69

ng/l

0.11

1371

9796

Extreme obesity with alveolar hypoventilation

231

976

2.62

35.54

4.5

3.0

191.85

200.59

ng/l

0.13

216

888

Filling of root of tooth

168

605

3.09

35.47

4.2

3.0

211.97

167.14

ng/l

0.65

157

550

Seropositive rheumatoid arthritis

1172

8033

1.50

35.07

3.1

2.7

210.39

199.31

ng/l

0.41

1088

7335

Other hammer toe(s) (acquired)

882

5363

1.61

35.05

3.0

2.7

210.15

206.82

ng/l

0.08

825

4941

Bronchiectasis

443

2410

1.98

34.99

3.6

2.9

211.60

221.16

ng/l

0.16

406

2199

Ascites

396

2075

2.06

34.96

4.5

2.7

414.13

200.98

ng/l

6.80

373

1890

DVT of lower extremities

951

6285

1.58

34.96

3.0

2.9

218.74

219.08

ng/l

0.01

864

5726

Dental pulpitis 1, only avohilmo

5176

22442

1.22

34.80

2.7

3.0

184.88

210.35

ng/l

3.55

4642

20429

Epilepsy

1309

9151

1.46

34.78

3.0

2.9

165.94

231.36

ng/l

9.99

1193

8328

Non-selective monoamine reuptake inhibitors

1776

12720

1.39

34.73

3.0

2.8

158.05

216.09

ng/l

7.19

1598

11647

Superficial injury of lower leg

988

6563

1.55

34.68

3.2

2.9

221.00

184.13

ng/l

1.50

893

5897

Actinic keratosis

2055

14793

1.37

34.64

3.4

3.0

253.21

248.46

ng/l

0.18

1896

13618

Rheumatism, unspecified

626

3746

1.75

34.59

2.9

2.6

139.16

176.30

ng/l

1.41

560

3414

Transport accidents

1796

11731

1.38

34.57

2.9

2.8

178.00

176.99

ng/l

0.03

1639

10660

Other infectious diseases

423

2276

1.99

34.33

4.0

3.0

287.75

233.81

ng/l

1.25

387

2071

Emotionally unstable personality disorder

352

1757

2.07

34.10

2.3

2.6

86.08

106.42

ng/l

0.94

316

1540

Right bundle-branch block

176

662

2.90

33.93

3.7

1.9

265.54

93.36

ng/l

4.18

156

580

Other diseases of blood and blood-forming organs, wide

988

6616

1.55

33.90

3.3

2.9

231.63

193.22

ng/l

1.83

899

6022

Benign neoplasm: Stomach

511

2930

1.86

33.78

3.6

3.0

209.30

204.24

ng/l

0.09

457

2687

Substance abuse

2444

18092

1.31

33.73

2.9

239.86

204.23

ng/l

1.52

2192

16387

Thyrotoxicosis

1067

7260

1.52

33.57

3.9

2.8

258.38

182.17

ng/l

2.78

971

6593

Mental and behavioural disorders due to psychoactive substance use

2509

18411

1.31

33.53

2.9

242.26

203.63

ng/l

1.76

2253

16681

Acute upper respiratory infections

4717

24488

1.22

33.44

3.3

2.8

192.81

206.36

ng/l

1.16

4255

22241

Fibrosis and cirrhosis of liver

394

2105

2.02

32.90

4.0

2.9

267.92

202.55

ng/l

1.93

366

1921

Paracetamol of NSAID medication

795

2480

1.65

32.79

3.0

3.1

216.69

264.69

ng/l

1.94

707

2269

Other blood glucose lowering drugs, excl. Insulins

878

5797

1.59

32.70

3.2

2.8

220.53

216.65

ng/l

0.09

806

5311

Injuries to the elbow and forearm

2890

20719

1.28

32.65

2.9

2.8

213.48

190.42

ng/l

1.30

2621

18768

Diabetic retinopathy, excluding more controls

1196

4642

1.51

32.62

3.8

2.9

310.91

191.69

ng/l

9.27

1111

4182

Degeneration of macula and posterior pole

2468

15888

1.32

32.53

3.3

3.0

254.26

238.70

ng/l

0.77

2261

14600

Coxarthrosis, primary

2974

20616

1.28

32.38

3.1

2.9

208.17

230.09

ng/l

2.06

2729

18914

Preparatory care for dialysis

246

1116

2.44

32.33

2.7

3.0

928.75

194.83

ng/l

12.01

238

1017

Family history of certain disabilities and chronic diseases leading to disablement

165

610

2.87

32.32

2.6

2.1

98.35

95.18

ng/l

0.05

147

540

Other and unspecified coagulation defects

218

931

2.52

32.14

3.1

2.9

234.14

170.32

ng/l

0.91

194

844

Myalgia

879

5790

1.56

32.06

2.8

2.7

161.35

180.16

ng/l

0.46

781

5246

Disorders of psychological development

337

1562

2.06

32.03

4.7

3.5

166.21

161.36

ng/l

0.08

308

1354

Viral infections characterized by skin and mucous membrane lesions

1715

12750

1.38

31.97

3.4

2.9

198.05

192.69

ng/l

0.13

1550

11555

Injuries to unspecified part of trunk, limb or body region

461

2602

1.87

31.74

3.4

2.9

298.18

205.53

ng/l

2.27

417

2356

Primary_lymphoid and hematopoietic malignant neoplasms

1189

8375

1.47

31.70

3.3

3.0

253.02

223.95

ng/l

1.37

1097

7659

Mood [affective] disorders

4381

23853

1.22

31.64

2.8

152.45

195.75

ng/l

8.80

3899

21649

Mycoses

1129

7866

1.48

31.48

3.8

2.8

216.40

197.29

ng/l

0.76

1032

7143

Other disorders of eye and adnexa

571

3419

1.74

31.45

3.1

2.9

187.55

182.12

ng/l

0.08

523

3086

Other viral diseases, not elsewhere classified

701

4399

1.64

31.36

4.1

2.9

193.27

178.63

ng/l

0.39

633

3941

Other and unspecified nonorganic psychotic disorders

640

3931

1.67

31.33

2.7

143.64

143.21

ng/l

0.01

552

3457

Other viral diseases

1006

6817

1.51

31.30

4.1

2.9

181.51

165.71

ng/l

0.61

897

6073

Pruritus

491

2830

1.82

31.30

3.2

2.9

226.03

194.67

ng/l

0.73

454

2574

Mood disorders

4391

23910

1.22

31.22

2.8

152.23

196.06

ng/l

9.04

3909

21695

Migraine with aura and triptan purchases

437

2415

1.86

31.21

2.5

2.7

69.73

127.15

ng/l

9.35

371

2154

Depression

3946

22303

1.23

31.20

2.9

2.8

150.67

188.60

ng/l

6.20

3510

20216

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

944

6340

1.52

31.05

2.9

2.7

130.97

148.72

ng/l

0.74

831

5661

Cardiomyopathy in other diseases

8.34

30.91

6.5

2.0

493.19

132.69

ng/l

2.74

Glomerular diseases

836

5519

1.58

30.86

3.7

3.0

480.14

206.42

ng/l

16.86

779

5011

Benign neoplasm: Stomach

511

3012

1.81

30.71

3.6

2.9

209.30

206.81

ng/l

0.04

457

2747

Alcohol use disorder, Swedish definition

2377

17247

1.30

30.63

3.0

2.9

238.08

208.61

ng/l

1.49

2141

15650

Thyrotoxicosis, other and/or unspecified

825

5427

1.57

30.60

4.2

2.7

243.77

178.96

ng/l

2.59

755

4935

Volume depletion

467

2678

1.85

30.60

4.2

2.8

377.05

246.37

ng/l

4.56

427

2420

Other and unspecified dermatitis

2137

16507

1.32

30.54

3.1

2.8

203.03

196.12

ng/l

0.28

1929

15030

Osteomyelitis

345

1809

2.06

30.50

4.1

2.9

393.91

223.95

ng/l

5.63

321

1650

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

735

4740

1.63

30.49

3.1

3.0

221.56

216.26

ng/l

0.12

687

4345

Other disorders of veins

1659

12375

1.37

30.44

2.9

2.7

225.85

189.60

ng/l

2.68

1486

11288

Stomatitis and related lesions

351

1838

2.01

30.33

3.5

2.8

168.95

186.70

ng/l

0.37

313

1658

Flat foot [pes planus] (acquired)

410

2262

1.91

30.23

3.2

2.7

186.91

177.12

ng/l

0.07

375

2056

Other and unspecified effects of external causes

976

6653

1.50

30.05

3.0

2.9

157.17

170.31

ng/l

0.51

863

5961

Other diseases of liver

753

4884

1.60

29.98

3.1

2.8

225.25

176.22

ng/l

2.18

688

4426

SLE (Finngen)

174

694

2.73

29.92

4.0

2.8

202.99

174.06

ng/l

0.34

161

629

Glomerular disorders in diseases classified elsewhere

563

3426

1.73

29.71

3.6

2.9

534.64

207.44

ng/l

17.81

526

3110

Postprocedural endocrine and metabolic disorders, not elsewhere classified

448

2545

1.83

29.65

3.8

2.6

182.00

154.23

ng/l

0.56

406

2300

Abnormal findings on antenatal screening of mother

186

756

2.54

29.62

1.8

2.4

36.82

64.37

ng/l

2.51

168

667

Persons encountering health services for specific procedures, not carried out

305

1534

2.09

29.60

2.1

2.5

280.89

165.48

ng/l

2.66

273

1366

Speech and linguistic disorders

272

1248

2.17

29.58

5.2

3.5

185.31

175.22

ng/l

0.16

253

1087

Diseases of inner ear

2476

19198

1.29

29.22

3.1

2.9

175.16

211.07

ng/l

4.25

2292

17543

Bipolar affective disorders

617

3823

1.66

29.19

2.7

116.09

145.31

ng/l

1.26

535

3427

Other or unspecified ileus, impaction or obstruction

875

5901

1.54

29.07

3.1

2.9

230.98

228.99

ng/l

0.04

802

5388

Other coagulation defects

321

1660

2.05

29.05

3.6

2.9

281.29

196.57

ng/l

1.93

288

1504

Childhood asthma (age<16), excluding more controls

238

843

2.28

28.96

2.8

1.6

58.99

49.10

ng/l

0.38

187

696

Opening and dilatation of root channel of tooth

257

1224

2.22

28.96

3.6

2.8

226.89

149.55

ng/l

1.32

232

1093

Other disorders of kidney and ureter

631

3979

1.67

28.95

3.4

3.0

341.43

208.60

ng/l

6.59

587

3638

Oter anti-inflammatory and antirheumatic agents, non-steroids

1261

4965

1.45

28.91

2.9

3.3

245.65

311.52

ng/l

4.03

1134

4583

ILD medications: pirfenidone

276

4.36

28.85

4.7

2.9

141.19

192.05

ng/l

0.93

255

2469

17932

1.29

28.83

3.0

2.9

241.00

209.64

ng/l

1.69

2231

16249

Other and unspecified injuries of head

304

1554

2.09

28.71

4.0

2.9

199.23

207.23

ng/l

0.13

281

1402

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

824

5407

1.54

28.62

4.4

2.7

189.59

150.93

ng/l

1.31

737

4828

Gastric ulcer

908

6200

1.52

28.58

3.7

2.9

294.39

239.33

ng/l

2.26

838

5670

Sequelae of injuries of upper limb

416

2348

1.86

28.49

2.9

2.8

109.50

169.18

ng/l

6.08

387

2108

Gastroduodenal ulcer

1310

9521

1.42

28.49

3.7

3.0

292.48

251.66

ng/l

1.78

1190

8695

Systemic lupus erythematosus, unspecified

150

571

2.88

28.46

3.8

2.9

216.63

166.03

ng/l

0.61

140

523

Polyarthrosis

926

6076

1.51

28.45

3.1

2.7

212.97

206.21

ng/l

0.09

859

5591

Other and unspecified local infections of skin and subcutaneous tissue

434

2493

1.84

28.19

3.5

2.9

258.69

188.57

ng/l

2.19

390

2258

Traumatic subdural haemorrhage

640

3996

1.65

28.18

3.4

2.7

290.32

288.34

ng/l

0.03

582

3679

Other skin changes

805

5384

1.56

28.18

3.5

2.9

203.21

213.36

ng/l

0.32

757

4935

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

436

2523

1.85

28.10

4.4

3.0

299.32

234.74

ng/l

1.80

407

2307

Abnormal involuntary movements

593

3706

1.67

27.91

3.6

2.9

176.02

199.76

ng/l

0.85

534

3377

Systemic lupus erythematosus

174

718

2.63

27.90

4.0

2.7

202.99

175.98

ng/l

0.31

161

651

2569

18351

1.27

27.86

3.0

2.9

239.12

207.60

ng/l

1.78

2315

16628

Trochanteric bursitis

609

3834

1.66

27.74

2.8

2.7

163.70

195.05

ng/l

1.25

552

3490

Cirrhosis of liver, NAS

278

1404

2.17

27.72

4.4

3.0

284.37

222.73

ng/l

1.32

260

1289

Lung cancer and mesothelioma

869

5030

1.53

27.71

3.0

2.4

224.99

209.93

ng/l

0.45

809

4621

Disorders of tooth development and eruption

177

710

2.55

27.63

8.2

2.8

220.76

133.06

ng/l

1.53

165

614

Mental and behavioural disorders due to alcohol, excluding acute intoxication

1868

14356

1.33

27.58

3.0

2.9

232.49

204.14

ng/l

1.09

1682

13019

Other congenital malformations

311

1613

2.01

27.45

3.3

3.6

152.94

171.36

ng/l

0.37

283

1439

Agoraphobia

106

336

3.34

27.29

2.6

2.4

103.47

97.74

ng/l

0.08

294

Parodontitis or/and operation codes

2783

13267

1.27

27.28

2.9

2.8

175.99

168.38

ng/l

0.44

2493

12008

Type 1 diabetes, wide definition, subgroup 1

774

5132

1.55

27.24

3.6

2.7

305.51

169.08

ng/l

7.13

716

4589

Pain associated with micturition

524

3196

1.72

27.22

3.2

3.0

155.74

203.23

ng/l

2.99

477

2910

Recurrent or chronic depression

1405

7441

1.39

27.10

2.6

2.7

121.33

160.21

ng/l

4.01

1254

6692

Other disorders of binocular vision

179

4.51

27.09

2.7

2.4

67.55

115.88

ng/l

1.13

154

Behavioural syndromes associated with physiological disturbances and physical factors

1041

7315

1.45

27.07

2.7

2.8

162.74

163.21

ng/l

0.01

906

6558

Pulmonary oedema

135

508

3.09

27.06

5.6

3.1

540.08

253.24

ng/l

4.42

123

467

Organic, including symptomatic, mental disorders

2569

14845

1.28

27.05

3.2

3.0

253.92

247.06

ng/l

0.24

2352

13641

Presbycusis

829

5617

1.54

27.02

3.7

3.1

260.72

296.25

ng/l

1.56

758

5140

Disorders of vestibular function (Vertigo)

2122

16558

1.30

26.96

3.1

2.9

175.12

210.02

ng/l

3.55

1973

15146

Schizophrenia or delusion

1165

8372

1.42

26.90

2.8

147.48

170.61

ng/l

1.09

1039

7479

Abnormal blood-pressure reading, without diagnosis

182

775

2.50

26.90

2.7

2.3

194.41

162.59

ng/l

0.42

152

685

Amyloidosis, other/unspecified

118

414

3.32

26.88

5.4

2.9

471.07

219.80

ng/l

3.26

111

384

Other diseases of lip and oral mucosa

710

4661

1.58

26.86

2.9

2.8

189.85

194.64

ng/l

0.11

651

4253

Dermatitis and eczema

4732

26270

1.19

26.72

3.0

2.9

191.73

201.81

ng/l

0.77

4273

23818

Viral pneumonia (unknown virus, not influenza)

288

1477

2.06

26.70

3.7

2.7

233.91

178.76

ng/l

1.10

262

1338

Elevated blood glucose level

385

2174

1.87

26.63

3.9

2.8

275.09

209.58

ng/l

0.97

353

1977

Panic disorder

431

2489

1.78

26.58

3.0

2.6

125.26

135.61

ng/l

0.17

377

2194

Diseases of the myoneural junction and muscle

578

3643

1.67

26.53

3.0

3.1

231.85

222.87

ng/l

0.16

521

3310

Type 1 diabetes

965

6717

1.47

26.52

3.5

2.8

320.87

186.64

ng/l

8.72

902

6010

Other diseases of arteries and capillaries

439

2579

1.80

26.49

3.1

2.9

271.05

203.56

ng/l

1.92

408

2331

Dislocation, sprain and strain of joints and ligaments of knee

2187

15994

1.29

26.33

2.7

141.02

160.47

ng/l

1.97

1987

14392

Follicular cysts of skin and subcutaneous tissue

767

5137

1.55

26.32

3.1

2.8

199.61

190.58

ng/l

0.18

694

4652

Other embolism and thrombosis

612

3914

1.63

26.25

3.0

2.9

196.45

211.60

ng/l

0.37

549

3559

1621

10957

1.36

26.11

3.5

3.1

272.16

263.12

ng/l

0.27

1483

10077

Basal cell carcinoma

2852

18493

1.26

26.09

3.0

277.50

234.06

ng/l

3.11

2616

16984

Pneumonia due to other infectious organisms, not elsewhere classified

166

694

2.62

26.07

4.1

2.6

184.57

183.09

ng/l

0.02

154

629

Mental and behavioural disorders due to alcohol

2123

16272

1.29

25.97

2.9

238.05

207.43

ng/l

1.37

1915

14742

SLE, ICD10

167

700

2.59

25.95

4.1

2.8

208.18

167.77

ng/l

0.50

155

636

SLE, strict definition

167

700

2.59

25.95

4.1

2.8

208.18

167.77

ng/l

0.50

155

636

Other local infections of skin and subcutaneous tissue

450

2676

1.77

25.81

3.5

2.9

254.26

186.71

ng/l

2.17

403

2421

Disorders of continuity of bone

380

2152

1.85

25.72

2.8

191.60

167.37

ng/l

0.16

340

1935

Alcohol use disorder, ICD-based

1709

13122

1.33

25.68

3.0

2.9

222.12

205.57

ng/l

0.49

1544

11885

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

2437

13353

1.28

25.65

2.9

3.0

242.39

222.30

ng/l

1.18

2234

12249

Open wound of head

2278

17859

1.28

25.62

3.2

3.0

245.72

217.61

ng/l

1.90

2081

16219

Basal cell carcinoma, including avohilmo

2903

18675

1.25

25.56

3.0

276.04

233.62

ng/l

3.06

2665

17145

Benign neoplasm: Small intestine

232

1135

2.25

25.41

3.5

2.9

218.38

217.36

ng/l

0.01

211

1047

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

2375

13077

1.28

25.31

2.9

3.0

249.24

224.14

ng/l

1.40

2171

11997

Glaucoma suspect

1713

13224

1.33

25.30

3.4

2.9

187.37

219.85

ng/l

2.86

1578

12127

Alcohol abuse, main dg, excluding more controls

562

3540

1.64

25.21

3.2

2.8

211.66

184.43

ng/l

0.73

508

3175

Impotence

291

1541

2.04

25.17

4.4

2.9

226.57

229.61

ng/l

0.04

277

1412

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

290

1543

2.06

25.13

3.5

3.1

318.19

236.11

ng/l

1.62

261

1428

Suppurative and necrotic conditions of lower respiratory tract

290

1535

2.04

25.09

3.8

3.0

279.05

228.64

ng/l

0.89

268

1400

Alzheimer disease, excluding more controls

943

4394

1.49

25.05

3.4

2.6

229.76

264.36

ng/l

1.58

866

4061

Fracture of femur

1378

9430

1.38

24.94

3.4

3.1

351.90

260.14

ng/l

5.94

1241

8604

Myocardial infarction, unclassifiable

1262

8330

1.40

24.90

4.5

3.1

438.17

280.69

ng/l

10.91

1157

7602

Pyothorax

233

1151

2.21

24.68

3.6

3.0

270.94

236.43

ng/l

0.48

214

1044

Childhood asthma (age<16)

238

902

2.13

24.63

2.8

2.2

58.99

75.19

ng/l

0.56

187

753

Hyperplasia of prostate

1819

8005

1.33

24.62

3.0

223.01

252.47

ng/l

1.62

1659

7283

Cholecystitis

696

4649

1.56

24.58

3.4

3.0

218.84

247.41

ng/l

0.97

633

4231

Candidiasis

548

3463

1.65

24.55

3.9

2.9

227.27

186.81

ng/l

1.18

497

3136

Kyphosis

278

3.72

24.55

4.2

3.1

169.04

199.81

ng/l

0.39

257

Osteonecrosis due to drugs

313

3.66

24.49

3.9

3.1

195.94

214.56

ng/l

0.17

287

Unspecified mental disorder

1508

11443

1.34

24.46

2.8

130.59

179.41

ng/l

5.99

1327

10281

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

2390

13187

1.27

24.43

2.9

3.0

247.74

223.46

ng/l

1.34

2187

12099

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

442

2674

1.76

24.39

3.7

3.2

316.79

237.59

ng/l

2.17

401

2465

Schizophrenia, schizotypal and delusional disorders

1157

8449

1.40

24.30

2.8

146.45

170.41

ng/l

1.15

1032

7551

Pneumocystosis

110

394

3.27

24.28

3.7

2.8

186.01

200.50

ng/l

0.15

101

364

Nonorganic sleeping disorders, excluding more controls

612

3960

1.59

24.26

2.7

2.8

174.68

174.47

ng/l

0.00

528

3566

Benign neoplasm: Small intestine

232

1156

2.21

24.22

3.5

3.2

218.38

222.63

ng/l

0.05

211

1059

Deviated nasal septum

1392

10475

1.36

24.17

2.7

3.0

166.97

207.94

ng/l

1.60

1241

9571

Substance use, excluding alcohol

671

4438

1.55

24.10

2.8

205.20

160.73

ng/l

0.60

587

3944

Cytomegalovirus infection, IBD co-morbidity

119

445

2.98

23.65

6.9

3.4

265.64

164.08

ng/l

1.50

111

400

Ptosis of eyelid

538

3438

1.65

23.55

2.8

3.0

180.46

214.27

ng/l

1.22

474

3144

Other specified and unspecified personality disorders

309

1684

1.91

23.50

2.7

157.72

137.73

ng/l

0.33

277

1498

Immunodeficiencies

212

1022

2.22

23.49

3.9

2.8

179.49

174.96

ng/l

0.05

191

928

Glaucoma

2714

19522

1.24

23.47

3.2

3.0

214.14

234.38

ng/l

1.52

2498

17890

Dementia in Alzheimer disease

465

6302

0.61

23.41

3.5

3.3

263.52

313.14

ng/l

1.59

417

5777

Dissection of aorta

194

915

2.34

23.35

3.9

3.0

258.60

219.85

ng/l

0.65

186

831

Seborrhoeic keratosis

1051

7653

1.42

23.28

3.1

2.8

193.28

204.25

ng/l

0.41

964

7017

Problems related to lifestyle

379

2205

1.78

23.18

3.1

2.8

196.59

158.53

ng/l

0.90

339

1974

Cytomegaloviral disease

119

450

2.93

23.09

6.9

3.4

265.64

166.90

ng/l

1.43

111

404

Chronic periodontitis, complicated

438

2674

1.73

23.01

4.1

2.9

319.41

188.76

ng/l

4.35

411

2430

Malignant neoplasm of small intestine, excluding all cancers (controls excluding all cancers)

180

830

2.41

23.01

3.4

3.1

132.44

215.28

ng/l

4.22

167

767

Other enthesopathies

1156

8523

1.39

22.99

2.8

2.7

153.76

184.97

ng/l

1.83

1039

7738

Sulfasalazine

1117

8191

1.39

22.99

2.8

2.5

187.52

180.86

ng/l

0.22

1013

7420

Coxibs

1363

5402

1.37

22.96

3.1

3.3

226.14

296.24

ng/l

5.14

1211

4952

Fall on and from stairs and steps

1069

7804

1.41

22.95

2.8

2.9

207.19

197.57

ng/l

0.25

964

7066

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

2588

14389

1.25

22.95

2.9

3.0

238.93

218.00

ng/l

1.29

2362

13171

Molar incisor enamel hypoplasia, with caries

5.67

22.91

12.4

3.5

219.33

158.08

ng/l

0.38

Carbimazole or st.post thyroidectomy, condition for graves disease

783

5409

1.49

22.91

4.1

2.7

225.21

166.39

ng/l

2.05

706

4904

Cervicalgia

845

5924

1.47

22.86

3.0

2.7

160.94

207.37

ng/l

3.25

764

5381

Amyloidosis

130

522

2.81

22.74

5.2

3.0

460.17

227.74

ng/l

3.24

120

483

Diabetic nephropathy

782

5376

1.50

22.73

4.3

3.4

496.12

240.73

ng/l

16.09

734

4896

Disorders of ocular muscles, binocular movement, accommodation and refraction

1679

12955

1.31

22.62

3.1

2.8

155.59

178.45

ng/l

1.68

1514

11687

Unspecified visual impairment (binocular)

335

3.32

22.61

3.8

2.9

296.52

216.08

ng/l

0.68

306

Malignant neoplasm of skin

3090

19349

1.22

22.54

3.0

279.04

228.61

ng/l

4.28

2826

17751

Neuroendocrine tumor and carcinoma of small intestine

339

3.37

22.47

3.4

3.1

113.83

209.35

ng/l

3.32

308

Lack of expected normal physiological development

156

4.00

22.28

7.7

5.0

166.52

185.86

ng/l

0.12

133

Decubitus ulcer and pressure area

318

1802

1.90

22.27

4.8

3.1

395.42

253.12

ng/l

2.57

283

1649

Kela-code for severe mental illness

1367

10378

1.34

22.24

2.8

126.79

180.53

ng/l

6.95

1204

9327

Fracture of shoulder and upper arm

1528

11796

1.32

22.18

3.2

3.0

233.61

208.68

ng/l

1.18

1384

10693

Mental and behavioural disorders due to opioids

125

488

2.70

22.13

2.7

2.9

117.39

132.33

ng/l

0.19

107

413

Lesion of ulnar nerve

575

3770

1.58

21.95

3.5

2.8

190.44

189.25

ng/l

0.02

523

3433

Benign neoplasm of other and unspecified endocrine glands

544

3530

1.61

21.94

3.1

2.9

203.96

184.53

ng/l

0.49

505

3225

Excessive, frequent and irregular menstruation

1426

5988

1.35

21.93

2.8

2.7

137.48

194.83

ng/l

6.69

1300

5436

Other and unspecified visual disturbances

407

2464

1.73

21.93

3.1

2.8

178.78

191.96

ng/l

0.27

367

2238

Carcinoid syndrome

229

3.99

21.90

4.0

2.9

97.00

188.30

ng/l

3.01

204

Other/unspecified cytomegaloviral diseases

102

367

3.11

21.87

7.3

3.7

256.14

158.80

ng/l

1.48

332

Vascular diseases of the intestine

216

1086

2.17

21.87

4.4

3.0

477.15

229.89

ng/l

4.93

201

988

Disorders of the thyroid gland

4126

22975

1.19

21.81

3.3

2.8

202.92

207.50

ng/l

0.23

3751

20888

Other diseases of stomach and duodenum

320

1823

1.87

21.77

3.4

2.9

214.71

202.37

ng/l

0.21

281

1662

Adverse effects, not elsewhere classified

680

4612

1.51

21.75

2.9

152.22

166.94

ng/l

0.47

604

4161

Other shoulder lesions

357

2085

1.78

21.69

2.7

2.8

167.23

172.89

ng/l

0.07

324

1888

Lichen simplex chronicus and prurigo

299

1669

1.90

21.68

2.9

2.8

225.22

195.61

ng/l

0.42

272

1513

Injury of unspecified body region

336

1939

1.83

21.65

3.7

2.9

309.78

210.35

ng/l

2.18

309

1753

Inguinal hernia

2686

14874

1.24

21.56

3.1

3.0

243.44

216.31

ng/l

1.79

2447

13468

Exposure to other specified factors

2852

22172

1.22

21.53

2.7

2.9

190.69

183.69

ng/l

0.37

2537

20098

Protozoal diseases

148

645

2.53

21.47

3.7

3.0

202.53

199.90

ng/l

0.03

135

582

Chronic pancreatitis

547

3574

1.60

21.46

2.9

224.11

199.77

ng/l

0.46

502

3252

Impingement syndrome of shoulder

1011

7392

1.40

21.44

3.0

2.7

147.29

188.99

ng/l

3.39

911

6747

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

354

2085

1.79

21.29

3.4

3.0

259.73

208.27

ng/l

1.24

327

1894

Abnormal results of function studies

361

2134

1.77

21.24

4.0

2.8

254.85

184.78

ng/l

1.67

331

1932

Recurring oral aphthae, including avohilmo

555

3640

1.58

21.22

3.4

3.0

221.76

188.42

ng/l

0.60

496

3312

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

652

4435

1.53

21.18

3.7

2.9

267.25

214.37

ng/l

2.17

606

4039

Other inflammation of eyelid

544

3556

1.59

21.17

2.9

161.11

193.39

ng/l

1.71

493

3235

Neuroendocrine tumor and carcinoma of small intestine, excluding all cancers (controls excluding all cancers)

352

3.24

21.04

3.4

3.2

113.83

205.43

ng/l

3.21

325

Benign paroxysmal vertigo

1277

9720

1.35

20.98

3.2

2.9

155.35

206.09

ng/l

6.79

1179

8880

Retinal detachments and breaks

1638

12885

1.30

20.93

3.0

2.9

219.31

217.01

ng/l

0.07

1511

11802

Immunodeficiency with predominantly antibody defects

119

472

2.74

20.84

3.9

2.7

192.70

164.26

ng/l

0.24

102

426

Specific development disorders of speech and language

198

929

2.14

20.80

5.3

3.8

194.43

204.33

ng/l

0.14

188

816

Benign neoplasm: Adrenal gland

340

2001

1.80

20.66

3.1

3.0

234.92

184.81

ng/l

1.17

322

1837

Mental and behavioural disorders due to sedatives or hypnotics

251

1340

1.96

20.60

2.3

2.7

145.57

166.85

ng/l

0.33

214

1189

Suicide or other Intentional self-harm

815

5774

1.44

20.57

3.0

2.7

139.94

155.03

ng/l

0.51

720

5156

Arterial embolism and thrombosis

312

1797

1.85

20.50

4.8

3.0

351.88

244.01

ng/l

2.99

294

1634

Dialysis

189

923

2.20

20.45

4.7

3.1

864.06

168.79

ng/l

9.80

177

834

Glucosamine medication

2482

16314

1.24

20.40

2.9

3.0

213.65

226.15

ng/l

0.72

2270

14994

Ovarian cyst

1327

5804

1.34

20.39

2.6

2.7

145.58

190.24

ng/l

3.36

1204

5279

Acidosis

112

441

2.84

20.29

3.2

2.9

413.70

198.94

ng/l

2.10

103

405

Other interventions on the root canals of the tooth

308

3.18

20.29

4.2

3.0

251.75

144.41

ng/l

0.96

274

Other aneurysm

283

1593

1.90

20.21

3.8

3.0

308.41

220.85

ng/l

2.04

265

1465

Disorders of sclera, cornea, iris and ciliary body

2169

17648

1.25

20.14

3.1

2.9

182.00

195.75

ng/l

0.77

1968

16020

Embolic stroke

279

1568

1.91

20.12

3.7

3.2

369.98

281.09

ng/l

1.23

260

1431

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

823

5903

1.45

20.11

2.7

3.0

159.68

218.44

ng/l

4.95

757

5411

Noninfective enteritis and colitis

1817

14481

1.27

20.10

3.1

2.9

223.53

195.36

ng/l

1.39

1636

13108

Bronchitis, not specified as acute or chronic

376

2278

1.72

20.10

3.8

2.8

200.18

216.07

ng/l

0.27

330

2059

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

492

3166

1.59

20.03

2.8

2.7

124.44

136.52

ng/l

0.38

438

2805

Diseases of male genital organs

2331

9569

1.25

19.95

3.1

3.0

194.37

231.18

ng/l

3.27

2092

8586

Follow-up examination after treatment for malignant neoplasms

460

2937

1.63

19.91

3.0

2.6

236.30

225.74

ng/l

0.14

429

2713

Umbilical hernia

1090

8170

1.37

19.75

3.2

2.9

243.59

196.00

ng/l

2.20

990

7436

Ocular pain

304

1746

1.82

19.74

3.4

2.8

134.26

176.13

ng/l

1.62

276

1567

Other necrotizing vasculopathies (FG)

293

1676

1.86

19.70

3.4

2.8

215.01

212.58

ng/l

0.03

267

1537

Disorders resulting from impaired renal tubular function

180

879

2.22

19.70

3.3

578.13

208.83

ng/l

7.76

171

801

Erectile dysfunction

443

2835

1.66

19.66

8.3

3.0

303.88

237.36

ng/l

1.39

414

2614

Other malignant neoplasms of skin (=non-melanoma skin cancer)

2742

18057

1.22

19.66

3.1

3.0

286.15

233.15

ng/l

4.05

2517

16586

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

2076

13130

1.26

19.66

3.0

220.07

224.45

ng/l

0.17

1895

12030

Cerebral palsy and other paralytic syndromes

471

3032

1.61

19.62

3.4

3.0

200.68

207.66

ng/l

0.13

409

2741

Sleep disorders

732

5137

1.46

19.60

2.7

2.9

170.72

170.96

ng/l

0.00

638

4626

Rheumatoid arthritis, including avohilmo

1670

13263

1.29

19.56

2.9

196.68

201.64

ng/l

0.20

1526

12100

Other overlap syndromes

100

378

2.94

19.54

2.8

2.9

78.28

185.69

ng/l

6.02

344

Diplopia

561

3760

1.55

19.52

3.4

2.9

178.30

204.17

ng/l

0.77

505

3413

Benign neoplasm of other and unspecified endocrine glands

544

3627

1.56

19.44

3.1

2.9

203.96

184.84

ng/l

0.48

505

3302

Hypotension due to drugs

100

385

3.03

19.41

4.6

3.2

275.65

261.45

ng/l

0.10

354

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

244

1316

1.94

19.41

3.3

2.8

188.09

186.47

ng/l

0.02

218

1176

Fracture of forearm

2210

16928

1.24

19.36

2.9

2.8

204.47

188.23

ng/l

0.78

2015

15341

Striking against or struck by other objects

1131

8526

1.35

19.35

3.3

2.8

176.03

175.28

ng/l

0.02

995

7635

Other problems related to primary support group, including family circumstances

321

1824

1.76

19.29

5.6

3.1

200.46

134.49

ng/l

1.24

290

1613

Urticaria and erythema

1288

9904

1.32

19.18

3.3

2.8

171.39

172.74

ng/l

0.04

1143

8951

Drug-induced thyroiditis

9.94

19.15

4.7

2.5

274.78

105.73

ng/l

2.10

Malignant neoplasm of small intestine

130

569

2.57

18.99

3.5

3.1

127.09

212.89

ng/l

3.84

120

524

Cervicocranial syndrome

423

2674

1.64

18.98

2.8

2.7

143.96

194.56

ng/l

2.33

382

2403

Zoster [herpes zoster]

805

5807

1.43

18.95

3.6

3.0

247.36

219.74

ng/l

0.42

728

5294

Artificial joint re-operation

360

2212

1.74

18.92

2.9

3.1

202.28

212.49

ng/l

0.19

333

2023

Acute pancreatitis

846

6146

1.42

18.91

3.1

2.9

240.53

216.82

ng/l

0.79

780

5574

Nonalcoholic fatty liver disease

344

2071

1.73

18.85

2.5

2.8

161.02

156.14

ng/l

0.08

309

1869

Fall involving bed

186

943

2.18

18.77

4.0

3.2

310.91

270.02

ng/l

0.29

168

869

Weight loss

435

2788

1.63

18.77

3.3

3.0

242.07

215.86

ng/l

0.54

402

2534

Hepatic failure, not elsewhere classified

183

918

2.16

18.62

3.6

3.0

343.46

218.18

ng/l

1.75

170

843

Acute posthaemorrhagic anaemia

193

988

2.11

18.58

4.1

3.0

388.57

227.96

ng/l

2.91

184

903

KRA_PSY_EATING, excluding more controls

166

785

2.15

18.53

2.3

2.6

58.50

88.17

ng/l

1.73

135

690

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

554

2371

1.53

18.52

2.2

55.39

70.83

ng/l

1.26

483

2076

Combinations of oral blood glucose lowering drugs

1229

9473

1.33

18.47

3.3

2.8

200.62

203.63

ng/l

0.09

1130

8688

Exclusions for E4_PCOS_BROAD

616

4239

1.49

18.43

3.4

3.0

140.79

178.86

ng/l

2.28

553

3819

Neuralgia and neuritis, unspecified

220

1173

1.98

18.40

2.8

2.9

162.36

185.30

ng/l

0.37

202

1053

Other dialysis

150

701

2.33

18.39

3.5

3.4

798.24

195.15

ng/l

7.74

141

636

Acute bronchiolitis

169

726

2.16

18.38

6.1

4.0

237.64

180.51

ng/l

0.74

157

632

Postmenopausal osteoporosis with pathological fracture

334

2034

1.77

18.38

4.4

3.1

236.74

231.21

ng/l

0.08

312

1847

Asthma mixed form (mode), excluding more controls

187

937

2.08

18.37

3.9

1.9

111.95

114.46

ng/l

0.06

166

838

Cluster headache, strict

130

566

2.43

18.37

2.0

2.7

85.01

153.01

ng/l

2.87

114

511

Retinal vascular occlusion

619

4301

1.51

18.36

3.3

3.0

269.06

235.25

ng/l

0.92

584

3941

Type 1 diabetes, wide definition

792

5694

1.42

18.34

3.6

2.8

318.19

180.38

ng/l

7.22

734

5094

Benign neoplasm: Other and unspecified parts of small intestine

104

418

2.83

18.34

3.5

3.1

191.67

201.70

ng/l

0.11

388

Ulcer of oesophagus

361

2232

1.71

18.31

4.1

2.8

236.20

220.76

ng/l

0.29

336

2052

Dermatopolymyositis (FG)

296

3.15

18.20

4.4

3.1

186.00

199.82

ng/l

0.13

280

Pneumonia derived septicemia

164

795

2.22

18.17

4.7

2.9

337.06

211.99

ng/l

1.91

148

732

Benign neoplasm: Adrenal gland

340

2078

1.73

18.02

3.1

2.9

234.92

196.54

ng/l

0.79

322

1901

Somnolence, stupor and coma

200

1043

2.04

17.95

4.0

3.0

236.48

242.46

ng/l

0.07

184

944

Sequelae of injuries of lower limb

365

2260

1.68

17.93

2.5

2.8

176.10

173.89

ng/l

0.04

322

2028

Event of undetermined intent

225

1215

1.94

17.91

2.7

2.9

153.10

174.65

ng/l

0.44

200

1095

Fracture at wrist and hand level

1255

9712

1.31

17.82

3.1

2.8

167.78

177.83

ng/l

0.40

1142

8737

Vascular dementia (mixed)

117

508

2.66

17.76

4.6

3.2

299.51

330.78

ng/l

0.27

112

465

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

203

1058

1.98

17.76

3.1

2.8

111.89

141.22

ng/l

0.60

174

915

Hyperkinetic disorders, excluding more controls

187

915

2.03

17.76

2.7

2.6

78.99

105.31

ng/l

0.65

152

781

Osteonecrosis

271

1566

1.84

17.67

3.5

2.8

172.35

186.66

ng/l

0.30

243

1419

Other obstetric conditions, not elsewhere classified

571

2487

1.51

17.66

2.2

55.20

71.10

ng/l

1.38

496

2182

Menorrhagia

1339

5724

1.31

17.60

2.7

147.88

200.85

ng/l

5.05

1228

5215

Anankastic personality disorder

130

577

2.37

17.56

2.5

2.6

74.01

133.91

ng/l

2.20

119

516

Other diseases of hard tissues of teeth

2505

15562

1.21

17.54

3.2

2.7

167.88

186.28

ng/l

1.48

2258

14172

Schizoaffective disorder

257

1453

1.84

17.53

2.6

2.9

117.51

145.05

ng/l

0.67

227

1291

Other disorders of adrenal gland

191

989

2.05

17.51

5.0

3.2

112.83

189.26

ng/l

3.87

176

899

Retinal vascular disorders

624

4381

1.49

17.49

3.4

3.0

268.00

236.86

ng/l

0.83

589

4017

Fentanyl

463

3054

1.57

17.39

3.7

2.8

223.84

255.81

ng/l

0.89

431

2767

Injuries to the ankle and foot

2416

18329

1.21

17.36

2.9

2.8

177.42

171.59

ng/l

0.29

2158

16508

Recurring oral aphthae

206

1099

1.99

17.35

4.0

2.9

164.42

197.47

ng/l

0.52

181

1007

Acetic acid derivatives and related substances

1337

5387

1.31

17.31

2.8

3.3

228.79

297.03

ng/l

4.20

1187

4939

Pneumothorax

322

1958

1.73

17.28

3.7

2.8

298.54

227.01

ng/l

0.50

296

1793

Pyogenic arthritis

302

1804

1.76

17.26

3.7

2.9

351.81

212.23

ng/l

1.13

276

1654

Benign neoplasm: Other and unspecified parts of small intestine

104

431

2.74

17.24

3.5

3.3

191.67

201.61

ng/l

0.10

399

Radiculopathy

726

5227

1.43

17.19

3.2

2.8

168.79

232.17

ng/l

6.11

665

4768

Supplementary factors related to causes of morbidity and mortality classified elsewhere

1153

8882

1.32

17.15

3.5

2.9

196.31

190.57

ng/l

0.18

1071

8005

Abnormal weight loss

403

2596

1.63

17.13

3.3

3.0

238.05

217.02

ng/l

0.40

370

2367

Hypothyroidism, strict autoimmune

3079

17312

1.19

17.09

3.1

2.7

188.12

205.56

ng/l

1.60

2803

15718

Inflammatory disease of uterus

404

2581

1.60

17.09

2.3

2.6

86.69

134.61

ng/l

3.80

364

2323

Social phobias

203

1070

1.95

17.06

2.3

2.5

101.57

115.88

ng/l

0.31

175

930

Amputation of foot

151

736

2.28

17.01

4.4

3.1

542.95

241.02

ng/l

5.60

142

673

Assault

378

2380

1.63

17.01

2.6

2.8

131.56

135.71

ng/l

0.08

342

2070

Cluster headache, wide

139

644

2.27

16.97

2.2

2.6

92.85

163.93

ng/l

3.23

121

578

Intestinal adhesions without obstruction

383

2443

1.64

16.93

2.9

2.8

197.59

210.30

ng/l

0.24

352

2233

Other diseases of oesophagus

454

3007

1.57

16.90

3.5

2.9

207.81

227.80

ng/l

0.48

419

2745

Drug-induced adrenocortical insufficiency

342

2.88

16.90

6.5

3.2

99.57

172.18

ng/l

2.13

312

Dermatopolymyositis

314

2.99

16.88

4.3

3.2

186.00

177.69

ng/l

0.08

291

Nonorganic sleeping disorders

612

4277

1.46

16.84

2.7

2.9

174.68

166.41

ng/l

0.16

528

3835

Pure hyperglyceridaemia

116

506

2.51

16.80

3.5

2.8

245.35

190.61

ng/l

0.51

103

459

Polymyalgia rheumatica

671

4810

1.45

16.78

3.3

3.1

226.66

235.16

ng/l

0.22

611

4398

Need for other prophylactic measures

236

1328

1.88

16.73

3.1

2.9

187.30

192.99

ng/l

0.08

204

1202

Panniculitis affecting regions of neck and back

168

845

2.11

16.72

2.6

2.8

155.11

202.25

ng/l

1.01

151

762

Hypertensive Renal Disease

171

868

2.10

16.70

3.2

2.5

676.85

238.04

ng/l

3.66

159

780

1136

8336

1.33

16.68

3.6

3.1

264.93

261.25

ng/l

0.08

1051

7628

Mental retardation, excluding more controls

138

631

2.26

16.63

2.7

3.6

168.61

181.04

ng/l

0.09

130

567

Other extrapyramidal and movement disorders in other diseases

964

7299

1.36

16.60

3.0

2.9

190.71

206.11

ng/l

0.63

884

6660

In situ neoplasms

1480

11269

1.28

16.57

2.9

3.0

250.51

216.70

ng/l

2.01

1334

10325

Fracture of foot, except ankle

824

6076

1.38

16.55

3.0

2.8

173.90

166.01

ng/l

0.22

745

5449

Blepharochalasis

1322

10443

1.30

16.54

3.0

2.8

184.66

209.54

ng/l

1.33

1198

9603

Adrenocortical insufficiency

160

797

2.15

16.50

5.6

2.9

96.86

182.24

ng/l

5.99

148

723

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

379

2175

1.61

16.46

3.8

3.1

94.51

114.19

ng/l

0.71

319

1836

Other disorders of gingiva or/and edentulous alveolar ridge

217

1196

1.92

16.46

4.9

3.0

217.95

203.48

ng/l

0.16

199

1081

Other noninfective gastroenteritis and colitis

967

7325

1.35

16.26

3.4

3.0

247.22

201.42

ng/l

1.59

870

6627

Embedded teeth, including avohilmo

224

1239

1.85

16.22

3.3

2.8

128.62

126.25

ng/l

0.04

201

1078

Extrapyramidal and movement disorders

1642

13314

1.26

16.22

3.0

200.85

223.88

ng/l

1.51

1486

12184

Alcohol abuse, main dg

562

3903

1.48

16.16

3.2

2.9

211.66

178.05

ng/l

1.00

508

3498

Progressive vascular leukoencephalopathy

217

1223

1.96

16.14

3.0

3.2

315.69

272.78

ng/l

0.85

204

1112

Gingival hyperplasia

146

710

2.20

16.04

6.1

3.1

231.14

190.96

ng/l

0.38

133

636

Hypothyroidism, other/unspecified

3744

21422

1.16

16.04

3.1

2.8

189.12

206.75

ng/l

1.73

3397

19480

Reactive arthropathies

341

2137

1.65

15.97

2.7

2.9

163.61

181.30

ng/l

0.38

308

1938

Lesion of lateral popliteal nerve

218

1217

1.89

15.93

2.7

2.8

160.50

209.82

ng/l

1.20

195

1123

Postprocedural disorders of digestive system, not elsewhere classified

163

831

2.12

15.92

3.0

3.3

231.92

221.25

ng/l

0.10

144

766

Fibroblastic disorders

1018

7805

1.33

15.90

3.1

2.9

224.42

235.44

ng/l

0.18

943

7155

Scoliosis

295

1782

1.71

15.89

3.1

2.9

148.58

194.83

ng/l

2.08

273

1593

Disorders of muscles

392

2543

1.59

15.84

3.2

2.9

188.33

196.52

ng/l

0.15

355

2295

Other disorders of skin and subcutaneous tissue, not elsewhere classified

613

4355

1.45

15.81

4.1

2.9

320.93

205.84

ng/l

3.43

552

3956

Other sleep disorders

415

2727

1.57

15.79

3.0

2.7

182.80

206.24

ng/l

0.36

365

2481

Disorders of vitreous body and globe

2149

17489

1.22

15.77

3.0

2.9

196.88

202.43

ng/l

0.21

1976

16052

Personal history of other diseases and conditions

283

1682

1.71

15.71

4.9

2.3

206.15

112.58

ng/l

3.01

257

1491

Other and unspecified tonsillitis

909

5782

1.35

15.71

2.9

2.6

130.32

136.82

ng/l

0.18

792

5101

Other hearing loss

1351

10580

1.28

15.70

3.5

3.0

230.00

266.68

ng/l

2.58

1248

9659

Open wound of ankle and foot

386

2502

1.60

15.68

3.2

2.9

238.56

193.67

ng/l

1.25

347

2252

Dental caries 2, only avohilmo

1889

18071

0.82

15.66

2.5

2.8

133.96

162.21

ng/l

4.23

1681

16278

Other female pelvic inflammatory diseases

586

4128

1.46

15.63

2.7

142.37

155.63

ng/l

0.34

533

3749

Suggestive for eosinophilic asthma

379

2454

1.61

15.61

3.3

2.8

141.73

198.51

ng/l

3.76

334

2227

Disorders of speech understanding and production

154

753

2.11

15.58

5.6

3.7

206.17

219.08

ng/l

0.17

145

668

Benign neoplasm: Sigmoid colon

805

6003

1.38

15.54

3.0

221.58

221.07

ng/l

0.01

733

5508

Female genital prolapse

1203

5397

1.31

15.50

2.5

2.8

136.32

209.34

ng/l

8.80

1106

4927

Occupational exposure to risk-factors

164

846

2.09

15.50

4.7

2.8

179.31

196.40

ng/l

0.18

156

764

Other disorders of binocular movement

378

2.63

15.49

3.0

142.01

152.26

ng/l

0.09

333

Thyroiditis, ILD-related definition

401

2625

1.57

15.47

2.8

175.39

159.48

ng/l

0.39

365

2377

Symptoms and signs involving emotional state

110

482

2.42

15.44

3.3

3.4

221.10

174.22

ng/l

0.50

435

Other localized connective tissue disorders

100

425

2.58

15.41

4.2

2.9

307.96

181.34

ng/l

0.45

388

Malignant neoplasm of oral cavity, excluding all cancers (controls excluding all cancers)

225

1286

1.87

15.38

2.3

3.0

272.52

208.68

ng/l

0.64

207

1184

Anaemia in chronic diseases classified elsewhere

135

654

2.27

15.36

6.6

3.5

447.09

199.56

ng/l

4.69

127

598

Other inflammatory liver diseases

274

1648

1.74

15.32

3.5

2.7

253.98

188.86

ng/l

0.80

237

1484

Colectomy operation

765

5680

1.39

15.23

3.4

2.9

219.65

219.53

ng/l

0.00

693

5199

Malignant neoplasm of gum, excluding all cancers (controls excluding all cancers)

255

3.22

15.19

2.2

3.5

165.97

247.28

ng/l

0.80

239

Inflammatory diseases of female pelvic organs

2028

12664

1.22

15.14

2.6

135.48

160.10

ng/l

2.18

1827

11484

Seropositive rheumatoid arthritis, wide

1171

9210

1.30

15.12

3.1

2.8

210.23

198.34

ng/l

0.46

1087

8398

Acute pancreatitis (for exclusion)

846

6373

1.36

15.10

3.1

2.9

240.53

216.17

ng/l

0.83

780

5794

Other and unspecified myopathies

393

2592

1.59

15.09

3.0

265.22

228.94

ng/l

0.62

357

2366

Insomnia

510

3521

1.48

15.07

2.8

2.9

164.87

166.21

ng/l

0.03

441

3155

Viral warts

349

2230

1.62

15.05

3.2

2.8

158.32

169.35

ng/l

0.22

323

2007

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

1026

7953

1.33

15.02

2.8

3.1

162.64

221.47

ng/l

4.56

944

7322

Pneumonia due to Streptococcus pneumoniae

177

942

1.98

14.98

3.7

2.6

238.73

188.50

ng/l

0.75

158

852

Urticaria

983

7547

1.32

14.95

3.5

2.8

167.13

164.90

ng/l

0.06

871

6813

Intussusception

104

455

2.48

14.94

2.7

2.6

106.74

165.78

ng/l

1.24

422

Hydronephrosis

477

3275

1.51

14.86

3.2

2.7

249.54

191.65

ng/l

2.25

439

2965

Melanocytic naevi

1005

7753

1.32

14.83

3.1

2.8

164.48

185.94

ng/l

1.21

935

7049

Other/unspecified seropositive rheumatoid arthritis

1155

9092

1.30

14.82

3.1

2.8

210.94

197.33

ng/l

0.54

1071

8289

Astigmatism

223

1275

1.82

14.79

3.7

3.3

158.04

186.22

ng/l

0.59

205

1150

Hypothyreosis and Thyroxine purchase for inclusion criteria

3864

22287

1.15

14.79

3.1

2.8

187.81

208.22

ng/l

2.25

3504

20278

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1276

8842

1.28

14.76

2.3

2.4

128.54

122.23

ng/l

0.25

1136

8001

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

1135

8921

1.30

14.75

3.0

2.8

209.22

196.28

ng/l

0.50

1051

8132

Other secondary gonarthrosis

236

1382

1.80

14.73

4.0

2.9

172.25

207.72

ng/l

1.00

221

1258

Other enthesopathy of foot (+metatarsalgia)

372

2426

1.58

14.68

2.9

2.7

123.10

171.39

ng/l

2.66

338

2195

Cyst of kidney

329

2106

1.65

14.61

3.1

3.0

213.90

212.63

ng/l

0.02

305

1934

Fracture of skull and facial bones

783

5849

1.37

14.59

3.2

2.9

220.22

188.94

ng/l

0.95

712

5248

Traumatic subarachnoid haemorrhage

172

919

2.00

14.58

2.8

2.6

254.75

239.70

ng/l

0.16

154

841

D07AA Corticosteroids, weak (group I)

499

3452

1.48

14.50

2.8

3.2

171.85

181.72

ng/l

0.21

445

3087

Lung diseases due to external agents

650

4741

1.42

14.49

3.9

3.1

268.85

260.80

ng/l

0.15

595

4340

Disorders of vitreous body

2070

16989

1.21

14.47

2.9

2.8

195.45

200.91

ng/l

0.20

1901

15602

Superficial injury of abdomen, lower back and pelvis

549

3878

1.45

14.46

3.2

2.9

228.84

192.58

ng/l

1.07

495

3472

Pneumococcal septicemia

153

789

2.07

14.41

4.7

3.0

309.62

220.80

ng/l

1.23

139

724

Chromosomal abnormalities, not elsewhere classified

277

2.84

14.41

3.1

4.9

116.57

179.22

ng/l

0.99

245

Superficial injury of hip and thigh

634

4602

1.42

14.41

3.5

3.1

264.94

237.03

ng/l

0.69

578

4161

Unspecified misadventure during surgical and medical care

239

1415

1.78

14.37

3.6

2.9

233.89

216.56

ng/l

0.24

218

1293

Lesion of plantar nerve

269

1643

1.72

14.30

2.6

2.8

156.66

183.01

ng/l

0.56

251

1496

Overexertion and strenuous or repetitive movements

365

2388

1.58

14.25

2.6

2.9

150.90

171.82

ng/l

0.53

316

2143

Other disorders of white blood cells

238

1412

1.77

14.14

3.8

3.0

266.50

221.45

ng/l

0.69

214

1291

L01XE Protein kinase inhibitors

269

1654

1.72

14.13

3.0

167.64

197.26

ng/l

0.88

246

1516

Polymyositis

170

3.58

14.13

4.8

3.5

189.17

191.32

ng/l

0.02

159

Disorders of refraction and accommodation

840

6338

1.34

14.11

3.0

2.9

141.99

159.61

ng/l

0.83

766

5675

Hidradenitis suppurativa

115

533

2.26

14.07

2.9

2.7

143.53

118.40

ng/l

0.28

101

468

Mixed and other personality disorders

232

1359

1.76

14.00

2.4

2.8

122.40

125.19

ng/l

0.04

196

1191

Benign neoplasm: Duodenum

139

708

2.15

13.89

3.8

3.1

230.09

224.91

ng/l

0.04

127

650

Muscular dystrophy

167

3.59

13.87

3.2

2.7

157.05

216.06

ng/l

0.46

149

Cauda equina syndrome

253

2.99

13.83

4.0

2.9

182.96

163.27

ng/l

0.14

232

Metatarsalgia

347

2261

1.59

13.81

3.0

2.8

126.47

174.03

ng/l

2.36

316

2049

Congenital malformations and deformations of the musculoskeletal system

252

1507

1.71

13.79

2.9

3.5

140.98

165.56

ng/l

0.47

230

1331

Disorders of mineral metabolism

312

1989

1.63

13.78

3.6

2.7

247.44

186.01

ng/l

0.92

275

1799

Papulosquamous disorders

1550

12700

1.24

13.77

2.9

2.8

191.34

191.62

ng/l

0.01

1402

11539

Diseases of peritoneum

435

2981

1.51

13.77

3.5

2.9

337.94

215.51

ng/l

3.85

402

2705

Benign neoplasm: Duodenum

139

711

2.14

13.73

3.8

3.2

230.09

204.49

ng/l

0.24

127

660

Tooth eruption problems

296

1831

1.63

13.69

3.6

3.0

123.96

125.38

ng/l

0.03

264

1575

Other necrotizing vasculopathies

332

2160

1.61

13.68

3.4

3.0

233.94

215.72

ng/l

0.28

305

1975

Other bursopathies

540

3850

1.44

13.68

3.0

2.8

184.65

207.23

ng/l

0.67

500

3516

Other disorders involving the immune mechanism, not elsewhere classified

127

623

2.17

13.66

3.8

2.9

379.83

173.10

ng/l

2.36

114

560

Assault by bodily force

209

1197

1.80

13.64

2.7

143.13

126.45

ng/l

0.25

189

1046

Other and unspecified immunodeficiencies with predominantly antibody defects

193

3.24

13.63

4.4

2.8

240.82

162.24

ng/l

0.39

179

Fissure and fistula of anal and rectal regions

922

7119

1.32

13.62

2.6

2.7

197.15

187.25

ng/l

0.24

823

6461

Other benign neoplasms of skin

1522

12226

1.24

13.62

3.0

209.84

214.29

ng/l

0.10

1378

11174

Autoimmune hyperthyroidism

220

1287

1.78

13.52

3.0

2.7

199.85

159.58

ng/l

0.91

199

1159

Type of accident

1053

8288

1.29

13.40

3.5

2.9

189.66

190.87

ng/l

0.04

982

7469

139

718

2.12

13.40

3.8

3.1

268.44

241.77

ng/l

0.17

129

659

Sicca syndrome [Sjögren]

344

2259

1.58

13.38

3.1

2.8

172.87

177.87

ng/l

0.07

307

2053

Reactive arthropathies, FINNGEN

256

1565

1.69

13.34

2.6

2.7

160.49

173.73

ng/l

0.23

230

1417

Other fall from one level to another

798

6058

1.34

13.32

2.9

3.0

169.47

191.59

ng/l

0.93

707

5440

Infective dermatitis

461

3211

1.48

13.31

3.4

2.9

214.33

197.10

ng/l

0.25

420

2935

Family history of malignant neoplasm

299

1895

1.62

13.28

2.3

2.2

163.29

111.88

ng/l

0.40

261

1708

Chondrocostal junction syndrome [Tietze]

155

826

1.99

13.20

3.4

2.8

153.80

196.80

ng/l

1.18

138

751

Amenorrhoea

163

873

1.91

13.17

2.9

2.8

100.57

135.56

ng/l

1.31

143

781

Ectropion of eyelid

224

1343

1.79

13.16

3.7

3.2

280.10

285.67

ng/l

0.04

212

1227

Secondary and unspecified malignant neoplasm of lymph nodes

374

2516

1.55

13.13

3.4

3.0

286.35

204.35

ng/l

2.33

351

2294

Other noninflammatory disorders of uterus, except cervix

940

4965

1.32

13.10

2.9

2.8

159.56

217.81

ng/l

6.46

853

4551

Other follicular disorders

233

1396

1.73

13.09

3.2

2.7

205.78

157.34

ng/l

0.70

210

1242

Haemolytic anaemias

157

845

1.98

13.07

4.5

3.0

346.53

204.88

ng/l

2.48

143

777

Irregular menses

1297

8461

1.26

13.07

2.4

2.5

98.24

138.35

ng/l

7.79

1158

7600

Enthesopathies of lower limb, excluding foot

761

5758

1.35

13.01

2.8

2.7

130.80

188.61

ng/l

7.82

686

5224

Cramp and spasm

180

1009

1.87

12.99

2.7

2.9

154.26

187.22

ng/l

0.60

156

922

Purpura and other haemorrhagic conditions

527

3779

1.44

12.95

3.4

3.0

300.61

205.64

ng/l

3.94

483

3441

Mental retardation, wide definition

151

799

1.98

12.95

2.7

3.9

162.95

186.33

ng/l

0.19

141

713

Chronic myringitis

4.71

12.93

2.5

54.90

166.09

ng/l

2.53

Persistent mood disorders

717

5394

1.36

12.82

2.9

2.8

153.56

185.52

ng/l

1.43

648

4879

Abnormal findings in nipple discharge synovial fluid wound secretions

292

2.73

12.82

2.6

3.2

270.86

162.59

ng/l

0.67

262

Charcot foot

310

2.66

12.76

3.7

2.3

412.31

129.72

ng/l

3.77

282

Vitreous haemorrhage

427

2964

1.49

12.73

3.2

2.9

356.27

212.17

ng/l

3.37

396

2692

Disorders of conjunctiva

3078

22458

1.16

12.73

3.0

2.8

174.40

184.97

ng/l

0.71

2731

20371

Ill-defined and unknown causes of mortality

123

2336

0.50

12.67

3.7

3.1

506.60

284.31

ng/l

2.63

113

2144

Non-allergic asthma

368

2479

1.54

12.67

3.4

3.2

181.69

199.64

ng/l

0.32

348

2257

Other prurigo

237

2.97

12.63

3.2

3.1

305.55

185.48

ng/l

0.70

214

Otitis media, unspecified

307

1817

1.59

12.61

4.4

3.0

127.09

161.75

ng/l

1.08

280

1607

Other specified and unspecified disorders of eye and adnexa

168

933

1.90

12.60

2.6

2.9

325.82

201.04

ng/l

0.96

152

847

Mental retardation

138

715

2.02

12.59

2.7

4.0

168.61

185.14

ng/l

0.12

130

634

Noninfectious colitis NAS

514

3686

1.43

12.57

3.4

2.9

271.90

198.91

ng/l

1.72

460

3343

Abdominal aortic aneurysm (AAA)

511

3643

1.44

12.54

3.1

3.2

352.71

280.03

ng/l

2.01

474

3349

Unspecified lump in breast

578

4230

1.40

12.50

2.6

2.8

181.11

167.26

ng/l

0.38

520

3856

Pre-eclampsia or poor fetal growth

722

5426

1.34

12.49

2.4

133.30

111.67

ng/l

0.85

636

4877

Kela reimbursement Agammaglobulinemia (D80-84)

130

3.69

12.46

5.5

2.4

207.39

113.45

ng/l

0.39

115

Pregnancy hypertension

1088

7787

1.27

12.46

2.4

125.20

118.74

ng/l

0.24

967

7014

Vascular dementia

459

3137

1.47

12.45

4.0

3.3

367.39

339.57

ng/l

0.49

427

2848

Meralgia paraesthetica

143

758

2.00

12.43

3.7

2.8

163.68

190.99

ng/l

0.49

133

690

Faecal incontinence

382

2609

1.52

12.38

2.6

146.80

197.16

ng/l

2.67

347

2362

Haemorrhoids and perianal venous thrombosis

1244

10077

1.26

12.38

3.1

2.8

211.75

222.66

ng/l

0.36

1131

9218

Injuries to the neck

747

5682

1.34

12.32

2.6

2.8

184.39

176.53

ng/l

0.09

664

5093

Cluster headache, strict, including avohilmo

154

834

1.92

12.28

2.0

2.9

93.82

138.60

ng/l

1.23

132

743

Lichen planus

533

3871

1.42

12.27

2.8

2.9

172.96

189.63

ng/l

0.47

493

3537

Diseases of salivary glands

708

5353

1.35

12.27

2.8

171.53

184.72

ng/l

0.31

621

4890

Parkinson's disease, strict definition, excluding more controls

560

4019

1.41

12.23

3.1

2.6

221.47

260.08

ng/l

1.35

507

3715

Non-follicular lymphoma, hilmo, excluding all cancers

425

2975

1.49

12.22

3.2

3.1

278.55

224.32

ng/l

1.30

394

2753

Other arterial embolism and thrombosis

145

780

1.99

12.21

4.0

3.1

368.90

225.14

ng/l

2.45

135

705

Pre-eclampsia or eclampsia

573

4191

1.39

12.17

2.5

143.13

123.07

ng/l

0.59

507

3794

Acute laryngitis and tracheitis

294

1860

1.58

12.15

3.6

2.8

141.41

144.17

ng/l

0.04

262

1623

Other disorders starting during childhood or adolecense, excluding more controls

426

2.25

12.14

7.5

4.1

132.91

152.22

ng/l

0.25

364

Other and unspecified mood [affective] disorders

184

1052

1.79

12.11

3.1

2.8

172.56

132.89

ng/l

0.46

149

930

Other disorders of glucose regulation and pancreatic internal secretion

328

2179

1.56

12.08

3.7

3.0

396.31

224.86

ng/l

1.57

304

1968

Arthropathies in other diseases classified elsewhere

152

830

1.93

12.04

3.1

2.8

290.61

199.66

ng/l

1.52

134

759

Diabetic retinopathy

1532

8002

1.24

12.04

3.9

3.3

315.96

237.13

ng/l

5.54

1421

7281

Use of pramipexole

935

7373

1.30

12.03

3.2

2.9

242.38

209.22

ng/l

0.72

849

6740

Biological medication for rheuma

448

3152

1.45

12.03

2.5

2.8

119.65

139.83

ng/l

0.82

399

2808

Keratitis

1301

10620

1.24

12.01

3.2

2.8

187.52

190.74

ng/l

0.09

1170

9590

Thyrotoxicosis with toxic multinodular goitre

272

1747

1.64

11.94

3.2

2.9

259.55

212.22

ng/l

0.72

240

1601

Asthma mixed form (mode)

187

1082

1.79

11.94

3.9

2.5

111.95

204.94

ng/l

5.53

166

970

Visual field defects

365

2491

1.52

11.93

3.6

2.9

272.30

215.22

ng/l

1.33

329

2275

Cerebral cysts

199

1176

1.76

11.89

3.4

2.8

184.96

189.79

ng/l

0.06

176

1065

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

115

574

2.13

11.86

3.5

2.8

392.94

171.44

ng/l

2.30

104

512

Parkinson's disease, excluding more controls

590

4262

1.39

11.86

3.1

2.6

221.37

259.12

ng/l

1.36

534

3936

Other and unspecified vascular occlusions

463

3317

1.45

11.81

3.4

3.0

264.38

237.81

ng/l

0.52

433

3025

Wet age-related macular degeneration

903

6997

1.31

11.80

3.4

3.2

270.23

264.97

ng/l

0.13

824

6407

Nummular dermatitis

338

2276

1.54

11.78

3.4

2.9

173.76

203.55

ng/l

0.92

321

2077

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

593

4413

1.39

11.78

3.1

3.0

264.73

219.46

ng/l

1.44

553

4045

134

2429

0.53

11.75

2.5

3.0

355.29

254.30

ng/l

1.22

121

2224

Thyrotoxicosis with diffuse goitre

478

3423

1.43

11.74

3.3

2.7

218.20

166.43

ng/l

0.71

429

3098

Benign neoplasm: Sigmoid colon

805

6260

1.32

11.68

3.0

2.9

221.58

217.28

ng/l

0.10

733

5739

Tubulo-interstitial nephritis, not specified as acute or chronic

295

1932

1.59

11.68

3.4

2.8

263.63

209.64

ng/l

0.98

271

1733

Other specified/unspecified dorsopathies

150

824

1.92

11.64

2.5

2.8

164.54

214.08

ng/l

0.78

133

736

Internal derangement of knee

1376

11299

1.23

11.60

2.6

2.8

195.84

192.93

ng/l

0.08

1246

10281

Glomerulonephritis

392

2724

1.49

11.57

3.9

3.0

403.98

203.27

ng/l

4.57

365

2478

Special screening examination for neoplasms

185

1084

1.79

11.51

2.6

265.63

215.05

ng/l

0.61

169

1001

Other and unspecified disorders of white blood cells

175

1013

1.82

11.50

2.8

2.9

258.01

214.41

ng/l

0.53

154

931

Malignant neoplasm of oral cavity

165

944

1.87

11.45

2.1

3.0

286.16

221.20

ng/l

0.46

152

867

Chronic viral hepatitis

151

830

1.88

11.45

2.8

2.7

165.50

136.07

ng/l

0.34

135

711

Other (seronegative) rheumatoid arthritis, wide

796

6192

1.32

11.41

3.2

2.9

214.80

196.12

ng/l

0.63

721

5634

Acute gastritis

327

2203

1.54

11.37

4.2

2.9

232.33

217.00

ng/l

0.26

306

2014

Coxarthrosis, primary, with hip surgery

2181

17796

1.18

11.33

3.0

210.85

234.80

ng/l

1.97

2010

16343

Ganglion

697

5314

1.33

11.33

2.4

2.7

126.10

172.94

ng/l

4.02

640

4804

Disorders of parathyroid gland

930

7293

1.29

11.30

3.2

2.9

279.05

221.02

ng/l

2.29

849

6647

Localized swelling, mass and lump of skin and subcutaneous tissue

1199

9776

1.25

11.30

3.0

2.9

197.98

202.67

ng/l

0.14

1088

8882

Other and unspecified injuries of lower leg

238

1491

1.65

11.28

3.5

2.7

228.44

184.97

ng/l

0.62

215

1325

Hypothyroidism, strict autoimmune, 3 medication purchases required

3425

20643

1.14

11.27

3.0

2.8

186.40

205.14

ng/l

1.98

3118

18775

Hypertrophic scar

172

990

1.80

11.26

3.1

2.8

175.83

159.01

ng/l

0.23

149

889

Superficial injury of thorax

568

4219

1.38

11.24

3.2

2.9

232.99

209.94

ng/l

0.44

516

3809

Other viral hepatitis

182

1063

1.77

11.24

2.8

2.9

171.20

139.94

ng/l

0.40

162

930

Other diseases of pancreas

317

2132

1.55

11.21

3.1

2.9

234.85

207.47

ng/l

0.43

293

1939

Dissociative [conversion] disorders

112

562

2.07

11.17

2.5

2.8

90.33

165.97

ng/l

2.84

502

Acute pharyngitis

382

2626

1.47

11.14

2.9

2.7

145.47

135.39

ng/l

0.19

329

2302

Rheumatic fever incl heart disease

164

944

1.85

11.08

3.4

3.1

294.89

249.21

ng/l

0.56

150

857

Melanocytic naevi

1005

8051

1.27

11.08

3.1

2.8

164.48

177.99

ng/l

0.64

935

7291

Myopia

345

2348

1.50

11.07

2.8

2.9

135.22

152.46

ng/l

0.42

314

2077

Other symptoms and signs involving the urinary system

425

3025

1.45

11.06

2.8

2.9

225.51

213.80

ng/l

0.20

385

2781

Acute nasopharyngitis (common cold)

382

2639

1.47

11.04

2.6

2.7

126.40

144.23

ng/l

0.61

353

2319

Lichen simplex chronicus

144

796

1.91

11.03

2.7

2.8

152.29

186.03

ng/l

0.49

130

728

Dependence on enabling machines and devices, not elsewhere classified

217

2.87

11.02

7.7

2.6

539.29

163.96

ng/l

2.07

198

Mixed hyperlipidaemia

177

1041

1.79

10.99

3.2

2.7

369.40

203.62

ng/l

1.91

161

943

Pre-eclampsia

512

3742

1.39

10.97

2.5

134.23

121.27

ng/l

0.32

452

3396

Olecranon bursitis

259

1676

1.61

10.93

2.9

3.0

256.88

209.90

ng/l

0.78

236

1524

Redundant prepuce, phimosis and paraphimosis

718

5503

1.32

10.92

3.2

2.9

165.12

216.86

ng/l

3.49

646

4915

Lyme disease

591

7807

0.74

10.89

2.1

2.8

156.42

180.23

ng/l

1.28

534

7126

Primary coxarthrosis, bilateral

1325

10982

1.23

10.88

3.2

3.0

212.62

233.71

ng/l

1.07

1216

10083

Other/unspecified rheumatoid arthritis

555

4140

1.38

10.88

3.5

3.0

239.88

215.23

ng/l

0.63

506

3769

Other epidermal thickening

183

1089

1.77

10.88

3.9

2.9

251.06

203.71

ng/l

0.53

171

997

Other/unspecified reactive arthropathies

236

1493

1.64

10.85

2.6

2.8

143.31

184.60

ng/l

1.26

211

1346

Arterial embolism and thrombosis of lower extremity artery

176

1042

1.79

10.79

5.5

3.0

347.87

243.66

ng/l

1.94

167

943

Tinnitus

901

7162

1.28

10.78

2.6

2.7

132.79

189.71

ng/l

7.39

829

6499

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

209

2.88

10.75

4.5

2.8

200.48

184.83

ng/l

0.11

184

Other and unspecified urticaria

623

4714

1.35

10.75

3.5

2.8

169.62

166.03

ng/l

0.08

556

4263

Secondary parkinsonism, excluding more controls

118

619

2.03

10.70

3.7

2.8

168.47

248.03

ng/l

2.01

105

557

Hyperhidrosis

450

2.18

10.69

2.5

2.7

94.76

148.90

ng/l

2.01

401

Oesophageal varices

180

1074

1.77

10.69

3.5

3.0

205.89

212.79

ng/l

0.10

164

975

Disorders of calcium metabolism

238

1518

1.63

10.66

3.8

2.7

262.58

185.97

ng/l

0.91

215

1386

Other injuries of lower limb, level unspecified

144

3.34

10.65

2.6

3.2

202.97

175.56

ng/l

0.17

133

Benign neoplasm: Transverse colon

439

3172

1.44

10.64

3.2

3.1

239.97

212.23

ng/l

0.69

403

2926

Cluster headache, wide,, including avohilmo

163

940

1.80

10.63

2.1

2.8

100.21

145.41

ng/l

1.34

139

837

Methotrexate

538

3997

1.38

10.61

2.6

2.5

170.78

174.20

ng/l

0.08

492

3646

Other and/or unspecified nontoxic goitre

339

2336

1.50

10.57

2.9

2.8

158.35

184.51

ng/l

1.08

308

2120

Complications following infusion, transfusion and therapeutic injection

308

2.50

10.55

5.8

3.0

246.62

195.97

ng/l

0.44

279

Other and unspecified primary disorders of muscles

140

3.38

10.52

3.3

3.5

138.89

186.36

ng/l

0.33

127

Disorders of oesophagus in diseases classified elsewhere

100

500

2.16

10.51

3.1

2.9

290.87

216.17

ng/l

0.54

466

Ovarian dysfunction

151

850

1.81

10.49

2.6

2.5

76.88

96.27

ng/l

0.73

135

748

Other eating disorders

101

498

2.08

10.46

2.3

3.2

60.79

103.51

ng/l

1.75

440

Anxious personality disorder

239

2.64

10.45

2.2

2.4

101.27

123.17

ng/l

0.26

209

Other benign neoplasms of connective and other soft tissue

369

2585

1.47

10.44

2.7

2.9

153.10

191.73

ng/l

1.52

338

2359

Golimumab

488

2.11

10.44

2.0

2.5

63.52

121.59

ng/l

2.15

434

severe traumatic brain injury, does not include concussion

964

7760

1.27

10.44

3.2

3.1

272.61

246.47

ng/l

0.88

864

7082

Other spirochaetal diseases

602

7884

0.75

10.43

2.1

2.8

157.52

179.96

ng/l

1.18

541

7197

Disorders of breast

1621

12683

1.20

10.38

2.4

2.7

152.83

162.56

ng/l

0.50

1438

11562

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

320

2189

1.52

10.36

3.1

3.0

243.58

256.70

ng/l

0.20

296

1987

Eating disorder

166

962

1.75

10.35

2.3

2.9

58.50

100.12

ng/l

2.84

135

818

Other and unspecified diseases of blood and blood-forming organs

114

599

2.04

10.35

3.2

2.9

232.31

207.11

ng/l

0.26

104

551

Prurigo nodularis

116

614

2.03

10.33

2.8

3.0

335.00

214.03

ng/l

0.99

104

570

Other abnormalities of plasma proteins

365

2.38

10.28

4.9

3.2

266.63

216.33

ng/l

0.46

331

Migraine without aura and triptan purchases

356

2470

1.46

10.28

2.5

2.6

52.18

116.72

ng/l

16.45

308

2198

Other ill-defined and unspecified causes of mortality

112

2047

0.52

10.27

3.7

3.1

523.86

287.14

ng/l

2.49

102

1875

Pain and other conditions associated with female genital organs and menstrual cycle

494

3475

1.38

10.27

2.3

2.6

107.61

143.75

ng/l

1.90

423

3128

Gestational [pregnancy-induced] hypertension

596

4492

1.34

10.26

2.4

109.31

113.22

ng/l

0.11

531

4044

Specific development disorders of scholastic skills

443

2.13

10.26

4.3

3.2

153.21

118.79

ng/l

0.28

360

Brachial plexus disorders

264

1731

1.56

10.23

2.5

2.7

73.38

136.82

ng/l

5.72

235

1558

Eating disorders

238

1519

1.59

10.23

2.4

3.0

140.90

143.10

ng/l

0.02

199

1335

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

485

3574

1.39

10.18

2.9

132.79

176.26

ng/l

2.90

436

3260

Cholangitis (primary sclerosing, PSC)

255

1672

1.59

10.18

2.9

219.23

228.50

ng/l

0.13

240

1513

Malignant neoplasm of other and unspecified parts of tongue

341

2.42

10.15

1.8

2.8

241.24

196.31

ng/l

0.27

307

Hypoglycaemia, other or unspecified

256

1678

1.58

10.13

3.8

3.1

442.54

227.78

ng/l

1.54

238

1527

Hydrocele

511

3803

1.38

10.12

3.1

268.31

278.82

ng/l

0.12

478

3461

Otitis externa

771

6058

1.30

10.12

3.1

2.8

177.10

181.53

ng/l

0.10

681

5483

L02BX Other hormone antagonists and related agents

270

1809

1.58

10.11

3.1

3.0

229.91

248.18

ng/l

0.22

254

1660

Non-follicular lymphoma

425

3084

1.43

10.06

3.2

3.0

278.55

217.77

ng/l

1.58

394

2828

Other misadventures during surgical and medical care

473

2.16

10.06

3.4

3.0

159.45

190.14

ng/l

0.58

431

Lichen planus, including avohilmo

721

5635

1.31

10.04

2.6

2.8

185.19

187.00

ng/l

0.03

661

5133

Other symptoms and signs involving general sensations and perceptions

159

931

1.79

10.04

3.3

3.4

189.22

253.43

ng/l

1.57

145

850

5-aminosalicylic acid

665

5125

1.32

10.03

2.9

2.5

185.06

164.89

ng/l

0.54

589

4612

Cardiomyopathy due to drugs and other external agents

6.68

10.02

3.9

2.5

453.11

166.00

ng/l

1.09

Vitamin B12 deficiency anaemia

496

3687

1.39

10.01

3.3

2.9

285.49

241.13

ng/l

0.87

453

3350

Multiple myeloma

132

741

1.92

9.93

4.0

3.1

259.01

254.81

ng/l

0.03

119

681

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

132

741

1.92

9.93

4.0

3.1

259.01

254.81

ng/l

0.03

119

681

Orchitis and epididymitis

373

2646

1.45

9.91

3.7

3.0

224.94

246.74

ng/l

0.33

333

2403

Vitamin deficiency

189

1164

1.69

9.83

3.4

3.0

271.82

219.19

ng/l

0.43

168

1060

Vitamin deficiency, wide

189

1164

1.69

9.83

3.4

3.0

271.82

219.19

ng/l

0.43

168

1060

Hypertrophic disorders of skin

181

1098

1.70

9.83

3.1

2.8

170.55

160.67

ng/l

0.13

157

982

Alcohol dependence

1031

8404

1.25

9.82

2.9

3.0

208.45

209.81

ng/l

0.03

930

7615

Tumor necrosis factor alpha inhibitors

388

2766

1.43

9.78

2.3

2.8

110.99

139.73

ng/l

1.29

340

2454

Injuries to the wrist and hand

3877

25240

1.12

9.77

3.0

2.8

180.02

190.93

ng/l

0.63

3487

22899

Excessive vomiting in pregnancy

192

1180

1.66

9.76

1.9

2.7

68.63

106.70

ng/l

3.09

166

1055

Vascular syndromes of brain in cerebrovascular disorders

232

1513

1.62

9.75

3.4

3.1

232.31

271.02

ng/l

0.68

213

1383

Benign lipomatous neoplasm

1133

9336

1.23

9.74

2.9

185.93

199.41

ng/l

0.48

1017

8524

Other abnormal uterine and vaginal bleeding

886

5047

1.27

9.71

3.1

2.8

187.11

215.67

ng/l

1.11

805

4619

Generalized anxiety disorder

354

2483

1.45

9.68

2.5

2.6

78.81

130.99

ng/l

4.80

299

2188

Acquired haemolytic anaemia

113

607

2.00

9.67

3.9

3.0

397.13

208.53

ng/l

2.67

105

555

Viral hepatitis

215

1367

1.62

9.62

2.8

172.41

155.40

ng/l

0.22

192

1205

Nail disorders

282

1906

1.52

9.62

3.3

2.9

237.86

182.93

ng/l

0.84

261

1718

Delayed milestone in childhood

235

2.53

9.61

10.3

7.0

196.91

231.70

ng/l

0.22

214

Rheumatic valve diseases

120

658

1.95

9.61

3.6

3.1

327.63

268.90

ng/l

0.54

110

597

Chronic hepatitis, not elsewhere classified

130

727

1.88

9.61

2.7

2.9

153.12

165.05

ng/l

0.18

121

659

Iridocyclitis

840

6714

1.27

9.61

3.4

2.9

188.70

187.17

ng/l

0.03

777

6078

Malignant neoplasm of other and unspecified parts of tongue, excluding all cancers (controls excluding all cancers)

108

574

2.03

9.60

1.9

3.2

244.69

221.63

ng/l

0.17

534

Manic episode

105

547

2.01

9.57

2.8

2.9

149.17

165.50

ng/l

0.14

484

Trigger finger

507

3796

1.36

9.57

3.3

2.8

185.82

187.04

ng/l

0.02

464

3459

Superficial injury of ankle and foot

335

2337

1.46

9.55

2.8

2.9

140.24

155.69

ng/l

0.42

296

2090

Atypical facial pain

189

1172

1.68

9.55

2.8

3.0

105.12

185.87

ng/l

3.13

168

1048

Right hemicolectomy

280

1906

1.54

9.53

3.8

3.1

242.33

245.87

ng/l

0.04

252

1740

Carcinoma in situ of skin of trunk

163

986

1.78

9.52

2.9

3.1

332.97

265.34

ng/l

0.78

152

915

Myotonic disorders

137

3.22

9.51

1.8

3.3

132.91

118.92

ng/l

0.11

123

Background retinopathy and retinal vascular changes

102

533

2.06

9.50

3.9

3.1

379.29

227.50

ng/l

1.31

495

Schizophrenia

509

3812

1.36

9.49

2.9

2.8

121.65

156.48

ng/l

1.72

450

3389

Pleural plaque

476

3558

1.39

9.45

3.7

3.0

203.45

262.60

ng/l

3.32

446

3286

Postprocedural disorders of nervous system

185

1138

1.67

9.43

2.3

2.6

91.10

131.84

ng/l

0.86

162

1014

Other secondary coxarthrosis

144

838

1.81

9.38

3.1

2.9

173.65

196.18

ng/l

0.35

130

764

Other diseases of blood and blood-forming organs

274

1860

1.53

9.32

3.1

3.0

241.83

201.49

ng/l

0.90

250

1693

Thyroiditis

241

1588

1.57

9.31

2.9

2.8

141.90

174.73

ng/l

0.97

222

1433

Dipeptidyl peptidase 4 (DPP-4) inhibitors

515

3896

1.36

9.31

3.3

2.7

253.62

207.74

ng/l

1.40

473

3590

Barrett oesophagus

211

1358

1.63

9.31

3.5

2.8

182.49

200.40

ng/l

0.36

199

1249

Dislocation, sprain and strain of joints and ligaments of thorax

123

684

1.89

9.26

2.6

2.8

147.98

201.60

ng/l

1.34

113

624

Diffuse large B-cell lymphoma, helper endpoint

206

1326

1.64

9.17

4.1

3.1

276.20

222.43

ng/l

0.95

195

1229

Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)

206

1326

1.64

9.17

4.1

3.1

276.20

222.43

ng/l

0.95

195

1229

Other/unspecified enthesopathies of lower limb, excluding foot

232

1520

1.57

9.16

3.1

2.7

132.45

179.23

ng/l

1.96

205

1357

Etanercept

190

1189

1.65

9.15

2.5

2.8

122.85

155.29

ng/l

0.94

168

1062

Acute peritonitis

262

1770

1.54

9.14

3.8

3.0

447.81

228.33

ng/l

5.15

244

1618

Other postsurgical states

224

1460

1.59

9.14

5.8

2.4

174.36

157.91

ng/l

0.29

208

1306

Mild mental retardation

432

2.11

9.13

2.6

3.6

102.32

170.54

ng/l

1.43

390

Pedestrian injured in transport accident

257

1727

1.54

9.10

2.9

232.50

194.15

ng/l

0.67

234

1568

Crohn's disease NAS

205

1308

1.61

9.10

2.7

2.8

168.97

178.07

ng/l

0.11

181

1171

Lichen ruber planus, wide definition including periferal and oral lichen planus

814

6534

1.27

9.09

2.6

2.8

173.85

183.36

ng/l

0.23

739

5953

Pneumonitis due to solids and liquids

357

2563

1.44

9.01

3.8

3.1

282.71

275.05

ng/l

0.10

321

2342

Drug-induced osteoporosis

261

2.53

9.01

4.7

3.4

257.74

187.05

ng/l

0.32

236

Nonhereditary hypogammaglobulinemia

175

2.86

9.01

4.1

2.2

165.57

128.82

ng/l

0.24

157

Complications of labour and delivery

1407

9303

0.84

8.99

2.4

2.5

112.69

134.98

ng/l

2.16

1279

8434

Attention to artificial openings

166

1016

1.72

8.99

3.9

2.9

257.69

215.73

ng/l

0.51

151

935

Other and unspecified abdominal hernia

182

1142

1.68

8.96

4.2

3.0

231.68

212.01

ng/l

0.19

165

1052

Seronegative rheumatoid arthritis

446

3313

1.38

8.96

3.1

2.7

189.11

194.91

ng/l

0.12

403

3030

Carcinoma in situ of skin of trunk

163

1003

1.75

8.95

2.9

3.1

332.97

253.70

ng/l

1.00

152

920

Exclusions for E4_PCOS_CONSORTIUM

2526

13925

1.15

8.93

2.7

2.8

166.93

172.49

ng/l

0.25

2258

12581

Benign neoplasm: Parathyroid gland

263

2.53

8.93

3.3

3.0

241.47

220.06

ng/l

0.12

242

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

485

3651

1.36

8.92

2.9

2.8

132.79

176.66

ng/l

3.00

436

3311

Perforation of tympanic membrane

371

2679

1.42

8.92

3.1

2.9

173.54

199.14

ng/l

0.65

335

2421

Conjunctivitis

2623

20211

1.14

8.92

2.9

2.8

162.44

176.59

ng/l

1.01

2316

18293

Other and unspecified erythematous conditions

130

746

1.84

8.91

2.2

3.0

180.47

195.57

ng/l

0.17

121

688

Other benign neoplasms of connective and other soft tissue

369

2663

1.42

8.91

2.7

2.9

153.10

183.72

ng/l

1.10

338

2412

Diffuse large B-cell lymphoma

206

1336

1.63

8.89

4.1

2.9

276.20

221.66

ng/l

0.97

195

1227

Benign neoplasm: Caecum

437

3253

1.39

8.89

3.2

3.1

239.88

209.27

ng/l

0.70

400

3009

Arthropod-borne viral fevers and viral haemorrhagic fevers

363

2615

1.43

8.88

2.8

2.9

152.51

186.25

ng/l

0.99

331

2372

Benign neoplasm: Oesophagus

269

2.49

8.87

3.0

3.2

197.51

207.67

ng/l

0.08

241

Other specified/unspecified bacterial intestinal infections

259

1756

1.53

8.87

2.6

3.0

214.19

199.12

ng/l

0.19

234

1604

Psychotic depression

200

1276

1.61

8.87

3.1

2.9

122.30

173.53

ng/l

1.64

180

1137

Hyperparathyroidism

806

6411

1.27

8.86

3.0

2.9

290.31

226.64

ng/l

2.18

732

5828

Benign neoplasm: Kidney

152

915

1.76

8.86

3.0

3.1

152.19

205.06

ng/l

0.99

140

846

Alzheimer’s disease, wide definition, excluding more controls

750

4046

1.29

8.86

3.1

2.7

228.85

269.85

ng/l

1.96

682

3743

Other strabismus

681

5341

1.29

8.85

3.1

3.0

155.83

169.03

ng/l

0.36

604

4790

Benign neoplasm: Rectum, anus and anal canal

826

6668

1.27

8.85

2.7

3.0

246.93

220.17

ng/l

0.83

752

6126

Neuroendocrine tumor and carcinoma of pancreas

117

3.42

8.84

3.7

3.6

136.79

242.65

ng/l

1.06

105

Biomechanical lesions, not elsewhere classified

196

1254

1.63

8.83

2.3

2.9

146.51

206.06

ng/l

2.03

180

1140

Benign neoplasm of eye and adnexa

394

2885

1.41

8.80

3.4

3.1

199.34

200.65

ng/l

0.02

360

2642

Dental caries 2

2043

18403

0.87

8.77

2.6

2.8

143.44

163.07

ng/l

2.09

1825

16588

Seborrhoeic dermatitis

361

2605

1.43

8.74

4.0

2.8

191.73

201.80

ng/l

0.13

329

2374

In situ neoplasms

1480

12625

1.19

8.74

2.9

250.51

217.60

ng/l

1.95

1334

11552

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

117

637

1.85

8.73

6.7

3.9

141.31

138.68

ng/l

0.03

105

543

Obsessive-compulsive disorder

140

816

1.75

8.72

2.7

2.6

99.99

128.36

ng/l

0.40

126

705

Dislocation, sprain and strain of joints and ligaments at neck level

420

3095

1.38

8.72

2.3

2.7

103.69

152.87

ng/l

5.55

371

2752

Benign neoplasm: Kidney

152

919

1.75

8.71

3.0

152.19

214.79

ng/l

1.26

140

842

Other general symptoms and signs

153

908

1.72

8.69

3.5

3.1

223.03

186.65

ng/l

0.47

133

827

Hyperkinetic disorders

189

1174

1.61

8.68

2.7

3.3

79.76

100.55

ng/l

0.53

153

1004

conjunctival haemorrhage

313

2214

1.47

8.66

3.8

2.9

248.47

214.09

ng/l

0.58

285

2031

Other noninflammatory disorders of vulva and perineum

289

2004

1.48

8.63

2.9

2.8

156.92

189.68

ng/l

0.78

253

1824

Other bursitis of elbow

187

2.82

8.62

4.2

3.6

179.59

196.31

ng/l

0.14

166

Agranulocytosis

405

2985

1.39

8.62

3.1

2.9

202.93

184.68

ng/l

0.32

365

2728

Oxicams

1096

5142

1.23

8.61

3.0

3.3

198.53

304.70

ng/l

11.79

990

4738

Other maltreatment syndromes

475

2.01

8.60

1.9

2.6

97.59

118.90

ng/l

0.33

418

Vasomotor and allergic rhinitis

1143

9383

1.21

8.59

2.6

2.8

128.02

167.06

ng/l

3.88

1002

8481

Respiratory conditions due to other external agents

100

539

2.00

8.58

4.7

3.1

288.60

226.49

ng/l

0.49

499

Viral haemorrhagic fevers, not elsewhere classified/unspecified

297

2080

1.47

8.56

2.6

2.9

151.82

183.93

ng/l

0.75

273

1892

Ulcerative colitis

834

6747

1.25

8.54

3.1

2.8

210.80

181.56

ng/l

0.91

750

6070

Other disorders of bladder

502

3831

1.35

8.52

2.9

3.0

191.59

226.25

ng/l

1.15

463

3502

Allergic conjunctivitis

1839

15694

1.16

8.52

2.5

2.7

158.33

162.38

ng/l

0.16

1604

14149

Carcinoma in situ of skin of other and unspecified parts of face

388

2864

1.41

8.51

2.9

3.2

340.10

260.74

ng/l

1.86

353

2631

Temporomandibular joint disorders, including avohilmo

1170

9768

1.21

8.48

2.6

99.32

148.50

ng/l

6.23

1045

8767

Budesonide

426

3165

1.37

8.47

3.0

2.5

154.24

167.94

ng/l

0.32

379

2864

Injury of muscle and tendon at lower leg level

533

4100

1.33

8.40

2.8

2.9

157.29

184.45

ng/l

1.49

494

3693

Benign neoplasm of middle ear and respiratory system

314

2231

1.45

8.40

3.0

3.1

291.69

219.41

ng/l

0.48

289

2035

Focal brain injury

244

1649

1.52

8.39

2.8

2.6

236.79

236.31

ng/l

0.00

215

1511

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

168

1048

1.67

8.37

2.8

2.9

133.74

188.14

ng/l

1.53

161

954

Other/unspecified disorders of vestibular function

170

1068

1.67

8.37

3.1

3.0

217.88

234.08

ng/l

0.10

159

977

Congenital malformations of the urinary system

190

1218

1.61

8.36

2.8

3.3

377.47

187.10

ng/l

4.03

180

1096

Other disorders of penis

366

2669

1.41

8.35

3.8

3.1

165.95

227.65

ng/l

3.12

333

2419

Benign neoplasm: Transverse colon

439

3305

1.37

8.33

3.2

3.0

239.97

214.53

ng/l

0.62

403

3036

Localized scleroderma [morphea]

295

2.33

8.32

4.5

2.9

140.29

164.96

ng/l

0.24

270

Carcinoma in situ of skin of ear and external auricular canal

421

2.16

8.32

3.1

3.3

350.69

311.66

ng/l

0.26

392

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

168

1050

1.67

8.31

2.8

2.7

133.74

189.41

ng/l

1.59

161

953

Adhesive capsulitis of shoulder

636

5012

1.29

8.31

3.0

2.8

169.39

197.72

ng/l

1.16

581

4566

Other benign neoplasms of skin

1522

13068

1.18

8.29

3.0

2.9

209.84

212.48

ng/l

0.06

1378

11933

Ulcerative colitis, NAS

453

3409

1.35

8.29

3.5

2.9

202.18

176.62

ng/l

0.49

408

3061

Leisure time condition

633

4986

1.29

8.29

3.6

2.9

178.70

199.66

ng/l

0.87

583

4491

Spondylopathies (FG)

422

3140

1.37

8.28

2.6

2.7

147.24

159.96

ng/l

0.32

381

2837

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1760

14988

1.16

8.27

2.5

2.7

157.96

162.29

ng/l

0.17

1533

13519

Other congenital malformations of the digestive system

146

874

1.72

8.26

3.5

3.8

208.50

196.60

ng/l

0.13

132

794

Vasculitis limited to skin, not elsewhere classified

115

654

1.87

8.23

3.7

3.1

239.60

218.28

ng/l

0.23

105

603

Hepatocellular carcinoma, excluding all cancers (controls excluding all cancers)

139

837

1.77

8.21

2.7

3.2

224.99

275.64

ng/l

0.84

128

781

Certain zoonotic bacterial diseases

411

2.11

8.20

3.8

3.0

247.37

196.70

ng/l

0.53

375

Benign neoplasm: Skin of upper limb, including shoulder

425

2.08

8.17

2.3

2.9

171.26

184.50

ng/l

0.10

385

Other mental disorders due to brain damage and dysfunction and to physical disease

504

3878

1.34

8.16

3.2

201.57

248.91

ng/l

1.39

465

3521

Other disorders of pigmentation

176

1122

1.64

8.09

3.3

3.0

149.78

199.81

ng/l

1.82

162

1033

Chronic lymphocytic leukaemia, helper endpoint

140

849

1.76

8.07

2.6

3.1

234.19

244.74

ng/l

0.11

124

788

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)

140

849

1.76

8.07

2.6

3.1

234.19

244.74

ng/l

0.11

124

788

Postmenopausal bleeding

1118

5113

1.22

8.07

2.7

2.8

173.06

215.19

ng/l

3.00

990

4681

Carcinoma in situ of skin of ear and external auricular canal

426

2.13

8.06

3.1

3.2

350.69

273.67

ng/l

0.64

385

Dental caries 2 and operation codes

1998

18112

0.87

8.06

2.7

2.8

141.52

162.30

ng/l

2.34

1783

16317

Crushed, pushed or stepped on by crowd or human stampede

187

1201

1.59

8.05

3.0

159.56

162.60

ng/l

0.04

163

1063

Conjunctivitis (acute, non atopic)

897

7337

1.23

8.02

3.6

2.9

162.51

175.43

ng/l

0.50

812

6626

Palmar fascial fibromatosis [Dupuytren]

679

5425

1.28

8.01

3.2

3.0

269.48

259.87

ng/l

0.10

632

4979

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

423

3181

1.37

7.98

2.5

3.1

284.12

227.37

ng/l

0.97

381

2920

Somnolence

210

2.54

7.98

3.3

3.0

163.14

166.77

ng/l

0.03

186

Diseases of external ear

1260

10687

1.19

7.97

3.2

2.9

208.48

204.74

ng/l

0.09

1127

9715

Alzheimer’s disease (Late onset), excluding more controls

717

3826

1.28

7.95

3.2

2.7

242.55

274.62

ng/l

1.04

657

3539

Tobacco use

168

1060

1.64

7.95

2.6

2.8

204.13

160.34

ng/l

0.60

157

961

Disturbance of activity and attention

171

1061

1.61

7.93

2.7

3.1

82.25

97.69

ng/l

0.33

138

906

Single delivery by forceps and vacuum extractor

120

1246

0.58

7.89

2.1

2.4

36.69

94.20

ng/l

8.74

103

1080

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

577

4539

1.31

7.89

3.6

3.4

319.77

276.01

ng/l

1.11

528

4179

Carcinoma in situ of skin of scalp and neck

130

783

1.80

7.88

2.9

3.3

298.12

287.93

ng/l

0.07

120

734

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

299

2129

1.44

7.87

3.4

3.0

173.99

181.49

ng/l

0.12

271

1929

Hypermetropia

232

1575

1.51

7.83

3.3

3.2

155.83

187.24

ng/l

0.93

216

1420

Abnormal spermatozoa

301

4151

0.70

7.79

3.5

3.0

243.29

237.85

ng/l

0.03

284

3803

Other disorders of bone

640

5083

1.28

7.78

3.0

2.8

158.33

166.05

ng/l

0.22

572

4570

Sulfonylureas

1749

12158

1.16

7.77

3.8

2.9

321.73

251.01

ng/l

6.23

1604

11180

Melanocytic naevi of upper limb, including shoulder

453

2.00

7.76

3.1

2.9

204.58

192.52

ng/l

0.10

408

Car occupant injured in other and unspecified transport accidents

568

4446

1.30

7.75

2.9

2.8

152.75

175.27

ng/l

0.90

511

3977

Anti-inflammatory and antirheumatic products, non-steroids

1310

5565

1.19

7.71

3.0

3.4

215.89

292.22

ng/l

7.05

1182

5098

Other superficial mycoses

364

2.11

7.67

4.1

3.0

183.90

175.85

ng/l

0.08

321

Other diseases of spinal cord

119

696

1.79

7.67

3.3

2.8

158.10

204.62

ng/l

0.80

109

633

Adult respiratory distress syndrome

307

2.26

7.64

4.1

2.9

284.12

200.23

ng/l

0.44

276

Cushing syndrome

209

2.53

7.64

2.3

2.6

214.27

163.25

ng/l

0.51

188

Benign neoplasm: Parathyroid gland

282

2.35

7.64

3.3

3.5

241.47

222.87

ng/l

0.10

262

Car occupant injured in noncollision transport accident

115

664

1.80

7.63

2.7

2.9

188.30

171.35

ng/l

0.13

106

600

Melanocytic naevi of trunk

379

2817

1.37

7.62

3.4

2.9

182.79

184.70

ng/l

0.04

349

2565

Oral leukoplakia and related diseases, including avohilmo

341

2501

1.40

7.61

2.5

2.9

229.02

189.49

ng/l

0.79

310

2275

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

526

1.90

7.61

2.4

3.0

90.13

169.33

ng/l

3.51

470

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

196

2.55

7.61

2.1

2.8

184.59

140.02

ng/l

0.23

179

Anterior Iridocyclitis

731

5916

1.26

7.60

3.4

2.9

190.00

188.02

ng/l

0.04

675

5345

Focal epilepsy

770

6264

1.25

7.60

3.0

3.1

172.94

210.85

ng/l

2.41

698

5672

Any dementia, excluding more controls

1734

10487

1.17

7.60

3.4

3.1

269.60

269.09

ng/l

0.01

1589

9658

Dermatitis due to substances taken internally

191

1256

1.57

7.56

3.8

2.7

181.71

196.46

ng/l

0.20

173

1145

Malignant neoplasm of tongue, excluding all cancers (controls excluding all cancers)

121

717

1.79

7.56

1.9

3.1

254.00

214.05

ng/l

0.33

112

663

Total colectomy

147

912

1.67

7.52

4.0

2.9

176.14

184.42

ng/l

0.09

127

828

Total colectomy operation

147

912

1.67

7.52

4.0

2.9

176.14

184.42

ng/l

0.09

127

828

Inflammatory diseases of prostate (prostatitis)

519

4047

1.31

7.52

3.2

3.0

152.35

244.79

ng/l

8.79

482

3682

Other erythematous conditions

138

845

1.71

7.51

2.4

3.0

175.01

194.65

ng/l

0.25

129

776

Open wound of forearm

323

2350

1.41

7.48

3.5

2.9

234.86

208.36

ng/l

0.35

287

2132

Otitis externa, unspecified

348

2561

1.39

7.47

3.5

2.9

179.74

177.09

ng/l

0.03

310

2307

Status post-ami

355

2146

1.39

7.45

4.7

2.6

415.37

243.87

ng/l

4.99

330

1948

Benign neoplasm of eye and adnexa

394

2965

1.37

7.45

3.4

3.0

199.34

204.42

ng/l

0.07

360

2704

Colorectal cancer, excluding all cancers (controls excluding all cancers)

1211

9972

1.19

7.45

2.9

3.1

227.35

238.67

ng/l

0.41

1100

9155

Nasal polyp

728

5906

1.25

7.44

2.8

3.0

141.94

211.23

ng/l

8.93

660

5384

Malignant neoplasm of digestive organs

1730

14895

1.16

7.43

3.0

3.1

221.48

253.85

ng/l

2.25

1573

13665

Carcinoma in situ of skin of upper limb, including shoulder

121

726

1.80

7.42

3.1

3.2

299.96

258.20

ng/l

0.39

107

665

Diseases of tongue

242

1679

1.49

7.42

2.8

3.0

168.74

204.47

ng/l

0.90

218

1535

Injury of muscle and tendon at shoulder and upper arm level

1418

12224

1.18

7.41

2.8

2.9

159.12

203.43

ng/l

5.11

1286

11175

Spondyloarthritis

648

5186

1.27

7.41

3.1

2.9

194.26

206.40

ng/l

0.33

595

4677

Haemorrhagic disorder due to circulating anticoagulants

333

2.21

7.40

5.4

3.0

452.48

282.51

ng/l

1.73

304

Acute appendicitis, no complications

1859

16264

1.15

7.39

2.8

2.7

160.71

173.57

ng/l

0.70

1653

14679

Unspecified event, undetermined intent

453

1.96

7.38

3.0

2.9

136.71

160.97

ng/l

0.42

407

Intentional self-harm by sharp object

274

2.22

7.33

2.6

86.82

121.95

ng/l

0.58

238

Plantar fascial fibromatosis

325

2374

1.40

7.33

2.5

2.7

117.05

174.13

ng/l

3.23

298

2138

Other disorders starting during childhood or adolescence

539

1.84

7.30

7.5

4.1

132.05

154.07

ng/l

0.31

456

Carcinoma in situ of skin of scalp and neck

130

800

1.76

7.30

2.9

3.2

298.13

257.72

ng/l

0.33

120

739

Benign neoplasm: Caecum

437

3355

1.34

7.28

3.2

3.0

239.88

211.79

ng/l

0.62

400

3083

Maternal care for other conditions predominantly related to pregnancy

385

2837

1.35

7.28

2.1

2.4

81.16

88.54

ng/l

0.22

330

2528

Additional codes for the location of defect, injury or illness

204

1375

1.53

7.26

3.7

3.0

167.77

200.95

ng/l

0.80

189

1247

Delivery

1133

7092

0.84

7.25

2.8

158.83

188.26

ng/l

1.96

1034

6444

Alcohol-induced chronic pancreatitis

238

1654

1.49

7.25

3.2

2.8

240.69

184.08

ng/l

0.94

213

1504

Nonsuppurative otitis media

602

4122

1.28

7.24

3.3

2.9

163.25

169.74

ng/l

0.16

531

3645

Open wound of abdomen, lower back and pelvis

549

1.86

7.24

2.9

3.0

364.14

190.61

ng/l

0.87

490

Benign neoplasm: Choroid

239

1667

1.49

7.24

3.7

3.1

195.53

204.28

ng/l

0.10

217

1534

Benign neoplasm of urinary organs

190

1266

1.56

7.24

3.0

191.47

213.31

ng/l

0.22

174

1163

Propionic acid derivatives

1303

5565

1.19

7.24

3.0

3.4

208.31

292.22

ng/l

8.38

1176

5098

Salpingitis and oophoritis

562

4439

1.29

7.22

2.7

2.6

149.54

150.21

ng/l

0.01

520

4026

Benign neoplasm of middle ear and respiratory system

314

2294

1.41

7.21

3.0

2.9

291.69

208.64

ng/l

0.58

289

2089

Endometriosis

1149

5764

1.20

7.18

2.6

2.7

117.22

192.15

ng/l

13.50

1046

5245

Lateral epicondylitis

415

3152

1.34

7.18

2.6

2.7

129.11

156.36

ng/l

0.78

373

2849

Cholera

167

1083

1.61

7.17

2.1

2.7

202.01

187.28

ng/l

0.20

152

983

Inflammatory bowel disease

1049

8838

1.20

7.15

3.0

2.8

197.55

178.28

ng/l

0.65

941

7946

Ulcerative proctitis

187

1238

1.55

7.15

2.9

2.7

225.13

166.12

ng/l

0.65

165

1115

Other disorders of nervous system

247

1734

1.47

7.15

3.8

2.7

148.43

199.99

ng/l

1.82

235

1582

Benign lipomatous neoplasm

1133

9623

1.19

7.15

2.9

2.8

185.93

195.81

ng/l

0.33

1017

8745

Multiple myeloma, excluding all cancers (controls excluding all cancers)

215

1477

1.52

7.15

3.9

3.0

293.13

240.31

ng/l

0.77

195

1368

Other and unspecified rosacea

289

2083

1.42

7.13

3.1

2.8

166.45

178.76

ng/l

0.23

260

1887

Polyarthritis, unspecified

140

871

1.67

7.13

3.6

2.9

276.63

190.58

ng/l

0.90

125

796

Benign neoplasm: Oesophagus

296

2.24

7.12

3.0

3.3

197.51

213.62

ng/l

0.13

274

Carcinoma in situ of skin of upper limb, including shoulder

121

735

1.78

7.11

3.1

299.96

256.52

ng/l

0.42

107

674

Fitting and adjustment of other devices

1419

11408

1.17

7.11

3.2

2.7

223.82

223.91

ng/l

0.00

1258

10453

Other bursitis of hip

476

1.94

7.10

3.1

3.2

167.94

217.03

ng/l

0.83

435

Malignant neoplasm of retroperitoneum and peritoneum

169

2.72

7.07

2.1

3.3

105.67

229.61

ng/l

2.50

155

Other diseases of jaws

232

1609

1.48

7.07

3.3

2.7

232.37

181.39

ng/l

0.57

202

1451

Acute generalized exanthematous pustulosis

162

1046

1.61

7.05

3.8

2.9

164.59

205.80

ng/l

0.74

147

956

Benign neoplasm: Rectum

712

5810

1.25

7.03

2.7

3.0

247.20

217.48

ng/l

0.84

652

5337

Contact with sharp object, undetermined intent

369

2.04

7.02

2.0

2.9

136.02

162.67

ng/l

0.38

327

Other neurotic disorders

192

1288

1.54

7.02

2.9

2.8

213.55

210.75

ng/l

0.02

173

1170

Neuroendocrine tumor and carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

134

2.96

7.01

3.7

3.4

136.79

232.61

ng/l

1.02

125

Other specified and unspecified retinal disorders

147

933

1.65

7.01

3.1

3.0

231.62

220.34

ng/l

0.14

127

862

Pulmonary eosinophilia, not elsewhere classified

305

2.21

6.99

3.2

3.1

239.39

207.09

ng/l

0.19

280

L02BB Anti-androgens

425

3273

1.34

6.98

3.0

3.1

242.19

281.87

ng/l

1.09

399

3030

Carcinoma in situ of skin

361

2719

1.38

6.98

3.2

267.38

235.68

ng/l

0.56

335

2506

Parodontitis, operation under 40 years and operation codes

136

836

1.65

6.97

3.2

2.5

111.10

75.89

ng/l

0.58

116

690

Small fibre neuropathy

114

680

1.77

6.96

3.9

3.0

209.66

190.61

ng/l

0.17

103

619

Corns and callosities

263

1877

1.45

6.95

3.1

2.9

214.56

192.52

ng/l

0.37

240

1696

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

828

6867

1.23

6.95

3.1

3.2

220.65

244.61

ng/l

0.94

754

6297

Emotional disorders starting during childhood or adolecense, excluding more controls

372

1.98

6.94

3.2

3.0

69.84

106.20

ng/l

0.67

321

Unspecified abortion

132

811

1.67

6.93

2.5

2.9

65.29

100.69

ng/l

2.03

118

723

Erosion of teeth, including avohilmo

615

4761

1.26

6.91

2.7

2.6

155.40

153.36

ng/l

0.05

546

4303

Mental disorders, not otherwise specified

208

1415

1.50

6.90

2.6

3.0

147.87

139.83

ng/l

0.10

180

1253

Benign neoplasm: Ascending colon

533

4226

1.29

6.88

3.5

3.0

269.57

212.18

ng/l

1.71

486

3894

Lymphoid leukaemia

235

1651

1.48

6.87

2.7

3.3

248.26

234.93

ng/l

0.18

208

1530

Superficial injury of wrist and hand

563

4471

1.28

6.87

3.2

2.8

155.85

164.05

ng/l

0.21

481

3989

Nephrotic syndrome

120

727

1.73

6.84

4.6

3.3

619.90

198.09

ng/l

2.73

111

664

Chronic lymphocytic leukaemia

140

888

1.67

6.83

2.6

3.1

234.19

235.24

ng/l

0.01

124

820

Parodontitis, under 40 years and operation codes

135

833

1.64

6.82

3.2

2.5

111.19

76.00

ng/l

0.57

115

689

Parodontitis, under 40 years, or operation codes

143

895

1.62

6.82

3.1

2.6

108.95

75.67

ng/l

0.56

119

740

Haemorrhage in early pregnancy

678

5363

1.25

6.81

2.4

2.5

103.42

123.14

ng/l

0.79

612

4835

Lesion of radial nerve

141

890

1.65

6.80

3.2

2.9

195.31

210.90

ng/l

0.16

127

820

Injury of nerves at lower leg level

158

2.65

6.78

2.6

2.2

125.21

167.46

ng/l

0.54

137

Anomalies of pupillary function

353

2.05

6.78

2.7

2.8

98.81

159.12

ng/l

1.55

318

Normotensive glaucoma

387

2958

1.35

6.76

3.4

3.0

214.11

227.98

ng/l

0.37

357

2720

Bursitis of shoulder

556

1.83

6.75

2.7

2.9

124.50

192.30

ng/l

1.54

506

Acute myeloid leukaemia and myelodysplastic syndromes, excluding all cancers (controls excluding all cancers)

172

1144

1.58

6.74

3.5

3.2

281.40

275.31

ng/l

0.07

153

1063

Haemangioma, any site

280

2028

1.42

6.73

2.7

2.9

157.38

183.19

ng/l

0.54

251

1845

Discitis, unspecified

414

1.99

6.72

5.3

3.1

329.32

236.12

ng/l

0.75

380

Other diseases of peritoneum

176

1172

1.56

6.72

2.9

174.22

201.53

ng/l

0.50

161

1072

Other disorders of conjunctiva

561

4484

1.28

6.71

3.7

2.9

242.15

209.58

ng/l

0.85

510

4103

Ethmoidectomy

416

3196

1.33

6.71

2.9

2.8

115.17

162.72

ng/l

2.94

381

2877

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

840

6978

1.22

6.70

2.9

2.7

156.14

158.26

ng/l

0.05

762

6258

Superficial injury of shoulder and upper arm

381

2895

1.34

6.67

3.0

2.9

208.75

201.75

ng/l

0.11

344

2613

Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)

261

1873

1.43

6.65

3.6

2.9

164.77

171.57

ng/l

0.11

238

1701

Other endocrine disorders

155

963

1.59

6.63

5.0

3.8

219.48

181.25

ng/l

0.32

144

868

Parodontitis, under 40 years

142

894

1.61

6.62

3.1

2.6

109.02

75.67

ng/l

0.55

118

740

Sacrococcygeal disorders, not elsewhere classified

557

1.81

6.62

2.2

2.9

100.71

203.09

ng/l

3.32

492

Myositis

108

643

1.76

6.62

2.8

3.0

147.28

212.79

ng/l

1.50

593

Herpesviral [herpes simplex] infections

376

2855

1.34

6.61

3.7

2.9

166.72

185.97

ng/l

0.42

334

2581

Multiple myeloma and malignant plasma cell neoplasms

210

1460

1.50

6.59

4.0

3.0

287.21

240.75

ng/l

0.66

191

1353

Adalimumab

232

1628

1.45

6.59

2.2

2.8

113.33

138.31

ng/l

0.65

201

1447

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

154

992

1.58

6.59

2.2

2.5

96.31

80.03

ng/l

0.21

134

887

Oral leukoplakia and related diseases

230

1623

1.47

6.59

2.7

3.0

247.75

207.42

ng/l

0.57

210

1484

Amputation of ankle bones

102

601

1.80

6.58

5.6

3.2

539.64

235.90

ng/l

4.83

548

Benign neoplasm: Skin of upper limb, including shoulder

459

1.92

6.58

2.3

3.2

171.26

205.63

ng/l

0.30

425

Benign neoplasm: Rectosigmoid junction

177

1190

1.56

6.57

2.9

3.1

219.15

223.47

ng/l

0.05

164

1097

Early lumbar disc prolapse, operated

211

1452

1.47

6.57

2.5

2.7

76.65

102.16

ng/l

0.72

181

1267

Atrophic disorders of skin

494

3894

1.29

6.57

2.8

158.44

167.84

ng/l

0.29

444

3519

Malignant neoplasm of other and unspecified parts of mouth, excluding all cancers (controls excluding all cancers)

240

2.36

6.56

3.0

3.6

339.10

253.93

ng/l

0.47

223

Other specified/unspecified inflammatory spondylopathies

132

823

1.65

6.56

2.3

2.8

79.52

170.77

ng/l

5.57

123

727

Acute and subacute iridocyclitis

676

5519

1.24

6.55

3.4

2.8

192.34

185.15

ng/l

0.13

622

4990

Carcinoma in situ of skin of other and unspecified parts of face

388

2985

1.35

6.54

2.9

3.1

340.10

257.93

ng/l

1.97

353

2720

Acute and transient psychotic disorders

353

2658

1.35

6.54

2.6

2.8

148.10

161.41

ng/l

0.25

305

2368

Intentional self-harm by unspecified means

136

2.70

6.54

2.4

2.3

121.90

124.67

ng/l

0.02

118

Complications of other internal prosthetic devices, implants and grafts

160

1052

1.59

6.54

2.8

222.89

214.50

ng/l

0.08

140

965

Contusion of other and unspecified parts of foot

128

793

1.66

6.52

2.4

2.9

109.56

156.69

ng/l

1.44

110

705

Multiple myeloma and malignant plasma cell neoplasms

210

1464

1.50

6.50

4.0

3.0

287.21

230.55

ng/l

0.89

191

1345

Acute alcohol intoxication, ICD10

639

5187

1.25

6.50

2.9

227.66

187.74

ng/l

1.27

577

4643

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

218

1516

1.47

6.49

2.2

2.8

111.73

149.27

ng/l

1.59

189

1349

Mandibular prognathia

230

2.28

6.49

2.9

3.1

130.64

147.16

ng/l

0.12

210

Disorder of external ear, unspecified

120

738

1.70

6.48

3.2

2.9

245.98

198.81

ng/l

0.44

110

678

Other/unspecified synovitis and tenosynovitis

392

3004

1.33

6.46

3.0

2.8

272.38

195.10

ng/l

0.65

353

2715

Other and unspecified injuries of abdomen, lower back and pelvis

278

2.17

6.45

6.0

3.0

223.77

185.88

ng/l

0.28

247

Fenamates

616

3343

1.26

6.44

2.5

3.3

176.76

270.98

ng/l

6.73

543

3089

Unspecified/other endometriosis

210

1451

1.47

6.43

2.3

2.7

96.50

165.06

ng/l

2.56

191

1311

Other encephalitis

564

1.80

6.42

2.4

3.0

190.62

207.40

ng/l

0.11

507

Otalgia

248

1774

1.43

6.42

3.1

3.0

139.56

194.37

ng/l

2.03

226

1598

Coeliac disease

398

3059

1.33

6.42

3.4

2.9

148.59

176.48

ng/l

1.34

355

2766

Bruxism

264

2.17

6.40

2.7

2.9

74.56

131.02

ng/l

1.58

240

Colorectal cancer

1018

8668

1.19

6.40

2.9

3.0

227.00

241.58

ng/l

0.52

927

7934

Cerebral palsy

231

2.26

6.40

2.9

2.7

138.52

134.96

ng/l

0.02

206

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

253

1815

1.42

6.39

2.1

2.7

158.19

135.03

ng/l

0.33

223

1641

Giant cell arteritis

186

1272

1.53

6.39

3.4

2.9

245.68

229.77

ng/l

0.18

171

1165

Paralytic ileus

163

1082

1.57

6.38

4.0

2.9

223.51

232.88

ng/l

0.10

149

991

Family history of other conditions

144

2.62

6.35

2.3

1.9

55.14

90.02

ng/l

1.36

131

Abscess of anal and rectal regions

265

1919

1.41

6.35

2.8

2.7

202.35

163.42

ng/l

0.74

235

1731

Inflammatory diseases of the central nervous system

277

2024

1.40

6.33

2.7

2.8

187.21

189.89

ng/l

0.03

247

1820

Strabismus

863

7221

1.21

6.32

3.2

2.9

170.77

180.07

ng/l

0.27

768

6505

Achilles tendinitis

348

2633

1.35

6.31

2.8

2.7

145.61

188.41

ng/l

2.03

320

2376

Haemangioma and lymphangioma, any site

296

2188

1.38

6.29

2.7

2.9

153.48

184.26

ng/l

0.74

267

1997

Other and unspecified intracranial injuries

119

736

1.69

6.29

3.1

2.9

248.75

232.02

ng/l

0.14

110

668

Restless leg syndrome

441

3451

1.31

6.29

2.8

2.9

176.37

196.13

ng/l

0.59

397

3137

Congenital malformations of the musculoskeletal system, not elsewhere classified

188

2.40

6.29

1.9

2.5

90.31

107.11

ng/l

0.21

168

Other and unspecified injuries of thorax

350

2.02

6.28

4.2

3.1

207.65

219.12

ng/l

0.06

318

Injury of intra-abdominal organs

471

1.86

6.27

3.1

169.68

203.50

ng/l

0.41

422

Caught, crushed, jammed or pinched in or between objects

145

937

1.59

6.26

2.9

2.8

142.70

167.03

ng/l

0.40

134

847

Effects of other external causes

448

1.87

6.26

2.4

3.7

100.73

144.39

ng/l

1.13

390

Hypothermia

438

1.91

6.25

3.9

3.2

232.53

246.36

ng/l

0.11

399

Generalized skin eruption due to drugs and medicaments

139

893

1.61

6.24

4.1

3.0

166.39

216.01

ng/l

0.81

127

818

Squamous cell neoplasms and carcinomas of the skin

577

4676

1.27

6.24

3.6

3.1

319.77

269.31

ng/l

1.39

528

4284

Effects of foreign body entering through natural orifice

808

6744

1.21

6.23

3.2

2.9

161.68

186.64

ng/l

0.92

715

6078

Exposure to other and unspecified inanimate mechanical forces

212

1483

1.47

6.22

2.9

207.90

171.43

ng/l

0.53

190

1340

Single spontaneous delivery

1140

7081

0.85

6.22

2.8

156.98

188.41

ng/l

2.20

1044

6433

Secondary uncertain malignant neoplasm

523

4188

1.28

6.21

3.3

3.0

280.42

235.19

ng/l

1.07

487

3825

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

108

651

1.71

6.21

2.2

2.9

124.78

152.14

ng/l

0.68

583

Myeloid leukaemia

113

695

1.71

6.20

3.8

3.1

220.43

239.94

ng/l

0.27

106

649

Encephalitis

101

600

1.75

6.20

2.4

2.9

186.39

204.53

ng/l

0.13

540

Melanocytic naevi of upper limb, including shoulder

489

1.85

6.19

3.1

204.58

184.65

ng/l

0.17

451

Benign neoplasm: Rectum, anus and anal canal

826

6930

1.21

6.19

2.7

2.9

246.93

215.10

ng/l

1.08

752

6353

Primary biliary cholangitis (PBC)

490

1.85

6.17

2.7

2.6

244.01

172.84

ng/l

0.60

447

Use of disulfiram, acamprosate or naltrexone

263

1912

1.41

6.17

2.8

2.7

155.61

144.98

ng/l

0.18

236

1704

Chronic laryngitis and laryngotracheitis

501

3989

1.28

6.16

3.0

2.9

157.21

198.61

ng/l

1.67

455

3644

Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

215

1513

1.46

6.16

3.9

2.9

175.77

163.21

ng/l

0.18

196

1374

Sleep disorders, other/unspecified

509

1.80

6.15

2.2

2.8

151.56

144.37

ng/l

0.06

449

Algoneurodystrophy

562

1.77

6.15

2.5

2.6

76.79

137.05

ng/l

3.11

506

Infection due to other mycobacteria

376

1.98

6.13

3.3

2.9

142.80

203.23

ng/l

1.35

336

Other specified and unspecified disorders of conjunctiva

186

2.44

6.12

5.3

2.9

294.02

181.62

ng/l

0.57

170

Melanocytic naevi of trunk

379

2916

1.32

6.10

3.4

2.9

182.79

181.99

ng/l

0.02

349

2632

Granulomatous disorders of skin and subcutaneous tissue

520

1.80

6.10

3.4

2.7

139.30

165.63

ng/l

0.45

472

Malignant neoplasm of rectosigmoid junction, excluding all cancers (controls excluding all cancers)

136

880

1.63

6.09

2.9

3.1

246.94

256.53

ng/l

0.08

121

820

Trigeminal neuralgia

210

1476

1.46

6.08

3.2

2.9

148.95

200.63

ng/l

1.26

181

1333

Other/unspecified soft tissue disorders related to use, overuse and pressure

573

1.76

6.05

4.0

2.8

146.72

167.81

ng/l

0.37

520

Other disorders of patella

490

3890

1.28

6.05

2.6

2.7

137.59

157.96

ng/l

0.42

441

3516

Cysts of oral region, not elsewhere classified

154

1019

1.56

6.04

3.4

2.9

251.63

190.42

ng/l

0.48

144

920

Femoral hernia, unilateral

113

699

1.70

6.04

3.1

3.0

193.24

211.96

ng/l

0.26

100

647

Inguinal hernia, unilateral

113

699

1.70

6.04

3.1

3.0

193.24

211.96

ng/l

0.26

100

647

Inguinal of femoral hernia, unilateral

113

699

1.70

6.04

3.1

3.0

193.24

211.96

ng/l

0.26

100

647

Myeloid leukaemia

113

700

1.70

6.04

3.8

3.0

220.43

236.73

ng/l

0.22

106

644

Pedal cyclist injured in transport accident

706

5836

1.23

6.04

3.0

2.8

163.65

170.64

ng/l

0.21

656

5234

Allergic urticaria

240

1725

1.42

6.03

4.2

3.0

150.41

179.49

ng/l

0.80

214

1546

Other and unspecified disorders of skin and subcutaneous tissue

110

1751

0.61

6.02

4.9

3.0

207.57

198.06

ng/l

0.10

100

1584

Carcinoma in situ of skin

361

2783

1.34

5.99

3.2

3.1

267.38

237.38

ng/l

0.52

335

2548

Nonspecific lymphadenitis

178

1213

1.50

5.98

2.8

2.9

197.23

146.53

ng/l

0.43

167

1090

Tongue abnormality

234

1685

1.43

5.98

2.8

3.0

164.40

199.04

ng/l

0.86

211

1537

Benign neoplasm: Rectosigmoid junction

177

1215

1.52

5.98

2.9

3.0

219.15

221.69

ng/l

0.03

164

1119

Sub-endpoint used in defining T1D endpoints

1070

9027

1.18

5.96

3.6

3.0

322.47

225.31

ng/l

5.46

993

8082

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

840

7083

1.21

5.95

2.8

3.2

240.91

246.18

ng/l

0.13

764

6497

Post-traumatic wound infection, not elsewhere classified

555

1.77

5.94

3.6

3.0

317.07

193.37

ng/l

1.03

503

Colonic or urogenital fistula

980

8360

1.19

5.94

2.6

2.9

195.37

193.99

ng/l

0.03

879

7578

Radial styloid tenosynovitis [de Quervain]

159

1061

1.54

5.92

3.3

2.8

167.85

153.35

ng/l

0.17

142

943

Chronic iridocyclitis

175

1195

1.51

5.92

3.2

2.9

155.26

199.28

ng/l

1.04

159

1081

Disorders of orbit

145

952

1.57

5.90

2.4

3.0

184.55

167.21

ng/l

0.21

125

873

Malignant neoplasm of endocrine gland

242

1753

1.42

5.90

3.5

2.9

173.68

181.38

ng/l

0.11

220

1589

Malignant neoplasm of tongue

484

1.84

5.89

1.7

3.0

261.44

217.22

ng/l

0.26

438

Noise effects on inner ear

161

1085

1.54

5.88

2.8

191.93

212.91

ng/l

0.26

144

985

Other specified and unspecified disorders of lens

294

2.15

5.85

6.3

2.9

346.71

232.66

ng/l

0.41

274

Use of other anti-dementia drugs

1237

9375

1.17

5.84

3.3

249.62

301.14

ng/l

3.91

1132

8611

Use of memantine

1237

9375

1.17

5.84

3.3

249.62

301.14

ng/l

3.91

1132

8611

Other diseases of gallbladder

182

1259

1.50

5.83

2.7

2.8

215.58

215.57

ng/l

0.00

166

1146

Benign neoplasm: Choroid

239

1738

1.42

5.82

3.7

3.0

195.53

206.39

ng/l

0.12

217

1586

Dementia, including avohilmo

2153

13351

1.13

5.82

3.1

243.65

261.28

ng/l

0.80

1960

12322

Other and unspecified vasculitis limited to skin

591

1.75

5.81

3.9

3.1

258.31

223.62

ng/l

0.35

547

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

991

8446

1.18

5.81

2.7

157.35

149.15

ng/l

0.27

875

7524

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

1001

8567

1.18

5.80

2.8

2.9

206.22

186.31

ng/l

0.37

892

7723

Prepatellar bursitis

168

1144

1.52

5.79

3.4

2.9

218.73

198.21

ng/l

0.25

153

1037

Oesophagitis

209

1484

1.45

5.78

3.1

2.9

200.20

212.24

ng/l

0.13

195

1353

Secondary parkinsonism+Parkinsonism in other disease

122

779

1.64

5.78

3.7

3.1

165.56

248.28

ng/l

2.35

109

714

Wegener granulomatosis

362

1.97

5.77

3.3

106.98

211.18

ng/l

2.94

330

Benign neoplasm of urinary organs

190

1329

1.48

5.77

3.0

191.47

215.80

ng/l

0.25

174

1220

Exposure to other and unspecified animate mechanical forces

431

1.85

5.76

2.9

3.0

210.33

151.91

ng/l

0.38

384

Abnormal findings in secretions and smears from cervix uteri vagina vulva

1260

8596

1.16

5.74

2.6

2.5

144.27

129.28

ng/l

0.72

1136

7743

Status epilepticus

133

864

1.60

5.73

3.8

2.7

182.01

237.09

ng/l

0.92

123

789

Dislocation, sprain and strain of joint and ligaments of hip

147

979

1.56

5.72

2.4

3.1

204.76

228.32

ng/l

0.26

140

895

Polycystic ovarian syndrome

518

1.75

5.71

2.6

78.97

77.37

ng/l

0.03

448

Crohn disease

380

2949

1.31

5.71

2.9

2.8

162.12

163.06

ng/l

0.02

334

2633

Impetigo

116

727

1.64

5.71

3.3

102.63

159.19

ng/l

2.10

105

650

Other specified/unspecified necrotizing vasculopathies

321

2.03

5.71

3.1

3.2

247.64

223.94

ng/l

0.15

289

Benign neoplasm: Cerebral meninges

346

2663

1.33

5.70

2.4

3.0

163.88

191.45

ng/l

1.01

314

2428

Sequelae of intentional self-harm, assault and events of undetermined intent

3.19

5.70

2.5

2.4

63.28

91.33

ng/l

0.54

Vitamin D deficiency

298

2.04

5.69

2.7

2.8

133.50

155.03

ng/l

0.28

271

Monoplegia

321

2.02

5.68

5.7

3.0

255.81

195.50

ng/l

0.32

292

Dermatographic urticaria

178

1226

1.48

5.67

2.9

2.6

130.93

160.57

ng/l

0.57

157

1096

Other disorders of Eustachian tube

600

1.72

5.67

3.0

2.9

147.98

169.60

ng/l

0.21

547

Lymphoid leukaemia

235

1712

1.42

5.67

2.7

3.1

248.26

237.31

ng/l

0.14

208

1568

Papillary adenocarcinoma of thyroid gland

174

1198

1.50

5.66

4.0

2.7

170.49

177.36

ng/l

0.09

160

1086

Generalized epilepsy

119

753

1.62

5.65

2.6

3.0

108.44

160.98

ng/l

1.48

109

673

Thyroiditis, unspecified

300

2.04

5.63

3.0

2.8

147.32

155.23

ng/l

0.07

275

Other and unspecified iridocyclitis

141

931

1.56

5.62

3.1

152.93

178.49

ng/l

0.55

131

840

Type 1 diabetes, wide definition, subgroup 2

490

0.31

5.61

3.8

3.1

832.29

308.89

ng/l

1.35

450

Secondary parkinsonism

118

753

1.65

5.61

3.7

3.1

168.47

252.03

ng/l

2.25

105

688

Delivery, wide proxy

1000

6214

0.85

5.60

2.8

2.9

171.17

196.34

ng/l

1.35

927

5646

Ankylosing spondylitis

279

2081

1.37

5.60

2.6

2.8

148.41

196.58

ng/l

1.54

252

1874

Other specified/unspecified spondylopathies

113

714

1.66

5.60

3.6

2.9

318.47

250.96

ng/l

0.34

103

647

Corneal scars and opacities

104

643

1.69

5.59

4.4

3.0

333.49

197.97

ng/l

0.87

585

False labour

545

2753

1.25

5.58

2.0

2.3

45.75

83.05

ng/l

8.95

472

2430

Monoamine oxidase A inhibitors

417

3290

1.29

5.57

2.5

2.8

150.89

181.41

ng/l

1.00

380

2995

Benign neoplasm of meninges

381

2979

1.31

5.57

2.5

2.9

170.68

193.53

ng/l

0.74

347

2724

Seropositive rheumatoid arthritis, strict definition

551

4490

1.25

5.57

2.7

2.8

212.69

178.88

ng/l

1.00

503

4084

Certain conditions originating in the perinatal period

156

925

1.51

5.56

3.3

4.0

97.48

140.03

ng/l

1.66

139

796

Contusion of toe(s) without damage to nail

378

1.89

5.56

2.6

2.7

141.21

137.09

ng/l

0.03

337

Hypertrophy of breast in women and men

550

4472

1.25

5.55

2.3

2.6

123.85

148.85

ng/l

0.99

488

4059

Mixed conductive and sensorineural hearing loss

493

3976

1.27

5.54

2.9

2.8

182.04

214.41

ng/l

1.18

451

3629

Spondylopathies in diseases classified elsewhere

290

2.08

5.54

2.7

2.9

163.50

225.36

ng/l

0.95

263

Burn and corrosion of trunk

104

643

1.68

5.53

3.2

3.0

161.11

193.66

ng/l

0.47

582

Exposure to other specified electric current

167

2.38

5.53

2.0

4.9

73.41

127.36

ng/l

0.98

142

Benign neoplasm: Ascending colon

533

4341

1.26

5.52

3.5

2.9

269.57

208.47

ng/l

1.91

486

3982

Temporal arteritis

164

1129

1.52

5.52

3.4

2.9

218.21

233.99

ng/l

0.18

149

1037

Other ulcerative colitis

172

1186

1.49

5.50

3.4

2.8

283.06

169.58

ng/l

1.40

159

1062

Crossbite

154

958

1.52

5.50

3.9

3.6

131.53

141.74

ng/l

0.11

135

848

Heterophoria

225

1627

1.41

5.49

3.9

3.1

140.17

174.68

ng/l

0.96

203

1448

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

101

618

1.68

5.49

3.2

2.6

370.27

98.72

ng/l

3.47

542

Generalized epilepsy, mode (most common among epilepsy diagnosis)

535

1.73

5.48

2.4

3.0

92.93

152.22

ng/l

1.82

477

Hypermobility syndrome

111

695

1.63

5.46

1.9

2.5

113.07

97.73

ng/l

0.11

610

Other specified disorders of muscle

108

677

1.66

5.45

3.1

234.22

213.60

ng/l

0.16

103

615

Secondary polycythaemia

532

1.75

5.44

3.5

2.9

296.97

186.86

ng/l

1.57

481

Recurrent dislocation of patella

103

633

1.66

5.44

1.8

2.7

68.00

114.47

ng/l

2.50

560

Rosacea

357

2773

1.31

5.41

3.0

2.8

153.27

176.27

ng/l

0.65

320

2516

Bulimia nervosa (incl. atypical)

308

1.95

5.41

2.9

2.7

61.42

79.59

ng/l

0.51

266

Other and specified injuries of hip and thigh

549

1.74

5.41

3.6

3.3

242.90

252.70

ng/l

0.07

504

!Aliquae complicationes praecoces traumatis

145

973

1.54

5.39

3.8

2.9

303.22

207.99

ng/l

1.11

134

880

Early complications of trauma

145

973

1.54

5.39

3.8

2.9

303.22

207.99

ng/l

1.11

134

880

Hemiplegia

184

1293

1.46

5.38

3.2

2.9

228.03

220.18

ng/l

0.08

158

1175

Colon adenocarcinoma, excluding all cancers (controls excluding all cancers)

503

4084

1.26

5.38

3.2

244.07

239.06

ng/l

0.09

462

3756

Acne

181

1259

1.45

5.37

2.9

2.8

105.33

107.61

ng/l

0.04

153

1072

Haemangioma, any site

280

2108

1.36

5.36

2.7

2.9

157.38

188.94

ng/l

0.71

251

1913

Portal vein thrombosis

335

1.96

5.36

3.0

3.1

220.98

197.01

ng/l

0.16

295

Calcific tendinitis of shoulder

186

1309

1.46

5.36

3.4

2.7

109.19

169.36

ng/l

3.25

173

1180

Focal epilepsy, strict definition

703

5885

1.21

5.36

3.0

3.1

182.18

214.26

ng/l

1.63

637

5334

Campylobacter enteritis

580

1.70

5.33

2.8

2.9

216.20

197.80

ng/l

0.13

526

Other noninfective disorders of lymphatic vessels and lymph nodes

124

808

1.59

5.31

4.3

2.8

209.93

186.96

ng/l

0.26

110

734

Sequelae of injuries of neck and trunk

101

627

1.67

5.30

3.1

2.7

123.59

170.44

ng/l

1.55

564

Insulin, fast-acting (human)

431

3432

1.27

5.28

3.1

2.8

364.81

184.68

ng/l

4.90

399

3033

Atypical mycobacterium lung infection

281

2.06

5.28

3.7

3.0

182.94

187.49

ng/l

0.04

250

Struck by thrown, projected or falling objec

144

968

1.53

5.26

3.0

2.8

122.56

162.47

ng/l

1.43

124

860

Malignant neoplasm of thyroid gland

223

1627

1.41

5.26

3.6

2.9

171.31

182.45

ng/l

0.16

204

1475

Problems related to social environment

100

620

1.67

5.26

4.8

3.0

209.51

227.97

ng/l

0.21

563

Giant cell arteritis with polymyalgia rheumatica

164

1141

1.50

5.25

3.4

3.0

218.21

236.91

ng/l

0.23

149

1049

Paraplegia, diplegia of upper limbs

515

1.75

5.24

2.9

180.13

202.98

ng/l

0.20

474

Lupus erythematosus

553

1.72

5.24

2.6

2.8

237.17

195.90

ng/l

0.29

512

Unspecified nephritic syndrome

531

1.74

5.22

3.3

3.0

302.51

215.44

ng/l

0.79

481

Other specified/unspecified soft tissue disorders

189

1344

1.45

5.22

3.6

2.9

213.65

224.40

ng/l

0.11

171

1212

Benign neoplasm: Descending colon

264

1987

1.37

5.20

3.3

3.1

228.76

215.26

ng/l

0.23

245

1828

Intercostal neuropathy

174

2.37

5.20

4.1

2.8

95.27

209.44

ng/l

3.43

162

Anuria and oliguria

155

2.47

5.20

6.0

4.8

318.93

237.06

ng/l

0.27

141

Injury of other and unspecified intrathoracic organs

234

1726

1.39

5.19

2.7

2.9

252.13

220.01

ng/l

0.35

213

1565

Erythema intertrigo

563

1.71

5.19

3.7

2.9

250.47

221.49

ng/l

0.31

517

Dermatophytosis

477

3862

1.26

5.18

3.4

2.9

213.86

205.69

ng/l

0.17

442

3505

Haemangioma and lymphangioma, any site

296

2258

1.34

5.18

2.7

2.9

153.48

187.77

ng/l

0.87

267

2052

Central retinal artery occlusion

108

692

1.65

5.16

3.3

3.2

269.25

256.56

ng/l

0.12

102

642

FESS (DNB20)

386

3047

1.29

5.16

2.7

2.8

105.84

162.17

ng/l

4.06

353

2738

Scar conditions and fibrosis of skin

123

804

1.58

5.15

3.1

2.8

135.12

157.34

ng/l

0.39

110

722

All dysplastic lesions of the vulva

130

861

1.55

5.13

2.4

2.9

213.57

157.62

ng/l

0.63

115

770

Unspecified jaundice

201

1451

1.43

5.12

3.3

2.9

340.08

234.40

ng/l

1.64

185

1318

Other diseases of biliary tract

341

2664

1.31

5.08

3.0

2.9

252.86

227.10

ng/l

0.42

322

2428

Corneal ulcer

582

4811

1.23

5.08

3.0

2.9

177.50

178.22

ng/l

0.01

526

4341

Other and unspecified glaucoma

307

2370

1.33

5.08

2.8

3.1

251.19

243.82

ng/l

0.12

280

2163

Infections with a predominantly sexual mode of transmission

722

6071

1.20

5.07

2.5

2.6

178.29

131.89

ng/l

1.68

621

5386

Vascular dementia (subcortical)

151

1044

1.52

5.06

3.8

3.3

369.39

319.80

ng/l

0.47

145

953

Malignant neoplasm of retroperitoneum and peritoneum, excluding all cancers (controls excluding all cancers)

439

1.81

5.05

2.1

3.1

108.95

203.97

ng/l

3.30

405

Contact with lifting and transmission devices, not elsewhere classified

385

1.85

5.05

2.4

2.9

170.53

163.60

ng/l

0.05

346

Any dementia

1838

11647

1.13

5.05

3.4

3.1

284.46

269.03

ng/l

0.49

1680

10725

Benign neoplasm of mouth and pharynx

388

3078

1.29

5.04

2.9

3.0

215.29

191.84

ng/l

0.44

343

2813

Chronic drug-induced interstitial lung disorders

4.67

5.04

2.4

2.1

267.43

122.63

ng/l

0.52

Diabetic neuropathy

467

3772

1.26

5.04

3.8

3.5

282.54

252.07

ng/l

0.55

434

3421

Convergent concomitant strabismus

152

1041

1.49

5.03

3.0

2.9

197.73

154.52

ng/l

0.35

131

924

Habit and impulse disorders

207

2.16

5.03

2.1

2.7

71.41

109.27

ng/l

0.80

177

Ehlers-Danlos syndrome

100

2.72

5.01

1.7

2.1

40.32

91.45

ng/l

1.73

Rash and other nonspecific skin eruption

335

2614

1.31

4.97

2.5

3.0

227.72

196.62

ng/l

0.54

302

2365

Malignant neoplasm of colon

636

5330

1.22

4.96

3.2

3.0

221.65

239.84

ng/l

0.54

584

4892

Other peripheral vertigo

343

2689

1.31

4.96

3.1

3.0

136.27

203.24

ng/l

6.02

323

2453

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

231

1714

1.38

4.95

2.7

2.9

194.49

190.85

ng/l

0.05

211

1566

Left hemicolectomy

106

682

1.64

4.95

4.0

3.1

249.09

243.89

ng/l

0.04

629

Alzheimer’s disease (Atypical or mixed), excluding more controls

349

2369

1.31

4.94

3.9

2.8

278.69

320.34

ng/l

0.89

322

2177

Graves disease, strict definition

267

2019

1.34

4.93

3.2

2.8

145.60

152.81

ng/l

0.17

235

1814

Retinal detachment with retinal break

514

4222

1.24

4.92

2.9

215.89

208.59

ng/l

0.14

479

3851

Spontaneous rupture of synovium and tendon

293

2251

1.33

4.92

3.3

2.8

162.50

208.00

ng/l

1.25

269

2048

Dislocation of lens

421

1.82

4.89

2.2

2.9

213.67

282.70

ng/l

0.81

388

Erythema multiforme

471

1.75

4.88

2.6

3.0

165.64

192.56

ng/l

0.29

425

Nail dystrophy

121

2.60

4.87

2.6

77.34

137.28

ng/l

1.35

108

Noninflammatory disorders of female genital tract

1364

6040

1.14

4.86

2.8

2.7

145.27

194.32

ng/l

5.31

1226

5479

Autonomic disorders

488

1.73

4.84

2.5

2.9

167.67

206.28

ng/l

0.27

446

Combined immunodeficiencies

226

2.12

4.83

3.1

2.6

154.42

190.50

ng/l

0.35

206

Other injuries of upper limb, level unspecified

185

2.23

4.83

2.0

2.4

353.49

171.81

ng/l

0.39

162

Benign neoplasm: Cerebral meninges

346

2727

1.30

4.82

2.4

2.9

163.88

196.65

ng/l

1.30

314

2485

Benign neoplasm of meninges

381

3038

1.28

4.81

2.5

3.0

170.68

194.66

ng/l

0.79

347

2770

Unspecified chronic bronchitis

145

998

1.50

4.81

3.8

2.9

173.00

260.59

ng/l

2.01

128

908

Sequelae of injuries of head

170

1204

1.45

4.80

2.7

185.35

185.54

ng/l

0.00

154

1089

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

486

3983

1.25

4.79

2.9

3.2

318.26

233.26

ng/l

1.95

454

3662

Peptic ulcer

214

2.14

4.75

3.2

2.7

277.06

247.34

ng/l

0.11

195

Atopic conjunctivitis

118

778

1.55

4.74

3.0

2.8

157.78

161.66

ng/l

0.04

103

702

Benign neoplasm: Rectum

712

6050

1.20

4.74

2.7

2.9

247.20

211.51

ng/l

1.11

652

5544

Other and unspecified epidermal thickening

607

1.64

4.74

3.6

2.8

194.85

188.62

ng/l

0.06

554

Calculus of kidney and ureter

1171

10310

1.15

4.73

2.9

3.0

192.57

227.08

ng/l

2.02

1066

9409

Congenital iodine-deficiency syndrome/hypothyroidism

120

800

1.56

4.71

3.4

2.9

217.43

221.38

ng/l

0.04

110

731

Other/unspecified enthesopathies, not elsewhere classified

309

2405

1.31

4.70

3.0

2.9

222.99

208.79

ng/l

0.18

272

2177

LSIL lesion of the vulva

529

1.68

4.69

2.3

2.7

202.57

145.16

ng/l

0.50

473

Speech disturbances, not elsewhere classified

339

2676

1.30

4.68

4.4

3.0

226.71

232.46

ng/l

0.09

318

2428

Antenatal screening

256

1908

0.75

4.67

2.2

73.10

77.69

ng/l

0.15

219

1677

Disorders of lacrimal system and orbit in diseases classified elsewhere

469

1.73

4.67

2.7

150.23

160.81

ng/l

0.11

434

IgA nephropathy (IgA glomerulonephritis)

485

1.72

4.66

2.8

506.75

165.42

ng/l

2.70

433

Other congenital malformations of skin

115

758

1.56

4.66

2.9

3.1

129.78

178.24

ng/l

1.27

102

686

Anomalies of dental arch relationship, including avohilmo

464

3390

1.24

4.65

3.3

2.9

125.48

143.42

ng/l

0.45

418

3000

Acute appendicitis

2457

21225

1.10

4.64

2.8

173.54

184.00

ng/l

0.39

2186

19208

Burns and corrosions of external body surface, specified by site

322

2521

1.30

4.64

2.7

2.8

193.77

181.98

ng/l

0.19

289

2261

Crohn's disease of large intestine

143

986

1.48

4.63

2.8

178.40

161.69

ng/l

0.19

128

882

Ménière disease

370

2955

1.28

4.63

3.2

3.0

212.09

210.98

ng/l

0.01

347

2700

Abnormality of white blood cells, not elsewhere classified

156

2.34

4.62

5.1

2.8

243.59

158.59

ng/l

0.61

139

Benign neoplasm: Skin of scalp and neck

556

1.66

4.62

2.8

3.1

233.60

213.75

ng/l

0.13

507

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

148

1033

1.48

4.61

2.9

208.01

205.76

ng/l

0.02

136

944

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

148

1033

1.48

4.61

2.9

208.01

201.33

ng/l

0.07

136

945

Postzoster neuralgia

422

1.79

4.60

3.5

3.1

326.02

254.65

ng/l

0.42

394

Other and unspecified disorders of vitreous body

1578

14095

1.12

4.60

2.8

153.66

193.45

ng/l

4.58

1439

12948

Acute lymphadenitis

165

1170

1.44

4.59

2.9

2.8

201.69

170.32

ng/l

0.33

144

1049

Femoral hernia

177

1277

1.43

4.59

3.8

2.9

188.54

220.56

ng/l

0.70

157

1174

Anorexia (incl.atypical)

132

895

1.50

4.59

2.2

3.1

196.18

165.26

ng/l

0.19

109

800

Injury of nerves and spinal cord at neck level

520

1.69

4.56

2.9

165.31

210.05

ng/l

0.57

475

Colorectal adenocarcinoma

840

7256

1.18

4.56

2.8

3.0

240.91

235.63

ng/l

0.13

764

6666

Psoriatic and enteropathic arthropathies

351

2783

1.28

4.56

3.1

2.7

198.62

162.60

ng/l

0.65

305

2533

Emotional disorders and disorders of social functioning with onset specific to childhood

462

1.69

4.54

3.0

3.3

50.75

119.76

ng/l

2.53

396

Hepatocellular carcinoma

602

1.65

4.54

2.8

3.2

248.18

268.10

ng/l

0.19

548

Chronic mastoiditis

113

752

1.57

4.53

3.6

3.0

205.10

227.63

ng/l

0.25

102

689

Exposure to smoke, fire and flames

520

1.68

4.52

2.9

234.64

201.26

ng/l

0.19

468

Acne vulgaris

133

905

1.49

4.52

2.9

2.7

78.18

87.23

ng/l

0.16

114

759

Alcoholic liver disease

360

2874

1.28

4.51

2.7

2.9

250.82

207.60

ng/l

1.05

334

2612

Herpesviral keratitis and keratoconjunctivitis

152

1070

1.46

4.51

3.8

2.9

153.63

194.34

ng/l

1.02

135

976

Psoriasis

981

8561

1.16

4.51

3.0

2.9

207.03

183.40

ng/l

0.79

882

7749

Intracerebral haemorrhage

527

4381

1.23

4.50

3.6

3.0

263.70

255.39

ng/l

0.16

472

4000

Intestinal malabsorption

145

1011

1.47

4.50

3.6

2.9

261.03

179.04

ng/l

0.93

126

913

Pedal cyclist injured in noncollision transport accidents

332

2621

1.29

4.49

3.0

2.8

176.65

174.30

ng/l

0.04

313

2348

Acute alcohol intoxication

894

7753

1.17

4.48

3.0

2.9

218.74

219.68

ng/l

0.02

812

7021

Ingrowing nail

162

1152

1.44

4.48

3.1

2.8

253.73

182.48

ng/l

1.05

149

1045

Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)

263

2023

1.33

4.48

2.3

3.1

191.09

221.03

ng/l

0.73

233

1857

Amputation of thigh

132

910

1.51

4.48

5.8

3.3

517.84

285.37

ng/l

3.14

123

833

Clear cell adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

183

1338

1.42

4.45

2.9

3.0

282.43

208.61

ng/l

0.78

172

1239

Vasomotor rhinitis (mode)

244

1856

1.34

4.44

2.7

2.9

199.13

185.74

ng/l

0.18

224

1683

Dementia

2010

12624

1.11

4.44

3.1

248.56

262.73

ng/l

0.55

1830

11645

malignant neoplasm of male genital organs

1830

10513

1.12

4.42

2.8

3.2

259.46

266.64

ng/l

0.19

1671

9670

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

275

1.93

4.42

2.4

3.0

118.44

161.47

ng/l

0.54

254

Pseudomembranous colitis

159

2.28

4.40

4.4

2.4

234.95

169.06

ng/l

0.36

141

Polypectomy (DHB20)

242

1843

1.34

4.40

2.5

2.8

126.11

189.68

ng/l

3.73

219

1675

Other and unspecified corneal deformities and disorders

104

682

1.57

4.38

3.3

2.9

192.09

190.00

ng/l

0.01

616

Vulvovaginal ulceration/inflammation in other diseases

125

848

1.50

4.37

2.1

2.9

117.87

127.60

ng/l

0.15

106

761

Metabolic disorder, other/unspecified

3.62

4.37

8.8

2.6

410.87

150.49

ng/l

0.55

Disorders of synovium and tendon in diseases classified elsewhere

495

1.69

4.37

2.8

2.9

107.18

186.81

ng/l

2.60

447

Normal-pressure hydrocephalus

121

1744

0.67

4.34

2.4

3.1

171.72

253.77

ng/l

2.12

106

1596

Alcohol abuse counselling and surveillance

287

0.30

4.34

10.2

2.9

102.78

159.42

ng/l

—

256

Juvenile arthritis (FINNGEN)

640

1.57

4.34

3.0

189.70

150.72

ng/l

0.41

567

Polyarteritis nodosa and related conditions

293

1.90

4.31

3.6

3.3

237.33

190.18

ng/l

0.30

262

Other condition

426

3477

1.24

4.31

3.2

2.9

199.84

185.09

ng/l

0.34

407

3116

Abnormal findings on examination of urine, without diagnosis

155

1105

1.44

4.31

3.2

3.1

263.54

205.08

ng/l

1.11

148

1010

Hypopituitarism

197

1457

1.38

4.29

3.6

3.2

131.07

171.17

ng/l

0.93

168

1311

Hypoparathyroidism

138

966

1.48

4.29

4.6

2.8

172.57

203.09

ng/l

0.73

128

878

Nontoxic multinodular goitre

780

6733

1.17

4.27

2.6

2.8

177.24

195.46

ng/l

0.77

718

6157

Use of rotigotine

252

1.99

4.26

2.2

3.3

147.40

185.27

ng/l

0.40

230

Convalescence

161

1155

1.43

4.26

4.1

2.5

238.76

164.02

ng/l

0.92

142

1041

Maxillary retrognathism

235

1.98

4.26

1.9

3.0

48.82

90.65

ng/l

2.58

210

Open wound of thorax

279

1.91

4.26

2.3

3.0

249.73

184.57

ng/l

0.25

244

Bell's palsy

392

3180

1.25

4.23

3.0

2.9

187.42

199.57

ng/l

0.25

346

2885

Crowding of teeth, including avohilmo

152

883

1.44

4.23

3.2

3.1

116.76

110.02

ng/l

0.08

139

754

Senility

244

1.98

4.22

2.2

3.2

352.33

256.34

ng/l

0.58

224

Other keratitis

331

2634

1.28

4.22

2.8

2.9

216.78

175.22

ng/l

0.64

292

2376

Intracranial and intraspinal abscess and granuloma

253

1.98

4.21

2.4

2.8

255.14

231.13

ng/l

0.15

222

Entropion and trichiasis of eyelid

371

3004

1.26

4.20

3.4

3.0

286.38

260.18

ng/l

0.42

344

2759

Benign neoplasm: Descending colon

264

2055

1.32

4.17

3.3

3.1

228.76

215.60

ng/l

0.23

245

1881

Pyogenic granuloma

340

1.81

4.17

4.2

2.9

177.75

190.51

ng/l

0.09

304

Dependent personality disorder

377

1.76

4.17

2.2

2.9

190.37

163.86

ng/l

0.18

345

Idiopathic urticaria

302

1.85

4.16

2.6

3.0

182.39

149.29

ng/l

0.22

272

Other specified disorders of kidney and ureter

116

789

1.52

4.16

4.2

3.0

297.86

219.75

ng/l

0.92

106

724

Melanocytic naevi of ear and external auricular canal

2.62

4.16

3.5

2.9

178.83

249.26

ng/l

0.47

Kela-code for behavioural disturbances in mental retardation

198

2.11

4.15

2.0

3.4

85.85

188.86

ng/l

2.17

180

Open bite

647

1.56

4.15

4.9

3.3

141.82

120.30

ng/l

0.16

569

Fasciculation

197

2.08

4.13

2.8

2.6

86.00

174.41

ng/l

2.07

174

Achalasia of cardia

441

1.71

4.13

2.9

212.64

228.30

ng/l

0.11

406

Other and unspecified follicular disorders

121

830

1.50

4.12

3.6

2.9

258.16

183.06

ng/l

0.65

111

749

Graves ophthalmopathy, strict

417

1.72

4.11

2.8

2.9

161.59

168.63

ng/l

0.06

387

Other Crohn's disease

181

1331

1.38

4.10

2.3

2.7

162.67

157.39

ng/l

0.06

153

1194

Benign neoplasm of mouth and pharynx

388

3160

1.25

4.09

2.9

215.29

199.08

ng/l

0.28

343

2879

Hyperfunction of pituitary gland

125

862

1.48

4.09

3.0

2.8

144.90

164.44

ng/l

0.28

112

770

Contact with and exposure to communicable diseases

488

5837

0.83

4.09

3.4

2.7

110.41

132.15

ng/l

1.08

441

5131

Pedestrian injured in collision with pedal cycle

107

718

1.54

4.09

2.9

200.97

206.53

ng/l

0.05

654

Marginal zone B-cell lymphoma, excluding all cancers (controls excluding all cancers)

413

1.74

4.08

2.1

3.2

306.00

196.91

ng/l

0.71

385

Correction of physiology of bite - demanding therapy visit

175

1281

1.39

4.08

3.0

2.9

131.38

147.63

ng/l

0.18

153

1150

Synovial cyst of popliteal space [Baker]

264

2057

1.31

4.08

2.9

195.47

217.17

ng/l

0.37

240

1866

Cerebral aneurysm, nonruptured

293

2313

1.29

4.07

2.8

180.12

184.23

ng/l

0.07

268

2103

Viral meningitis

596

1.58

4.06

3.5

2.8

198.34

141.41

ng/l

0.28

527

Mandibular retrognathia

148

1050

1.43

4.05

2.5

2.9

77.10

130.67

ng/l

2.70

135

926

Benign neoplasm: Skin of scalp and neck

576

1.60

4.04

2.8

3.1

233.60

217.08

ng/l

0.11

540

Drug-induced fever

4.01

4.04

4.4

2.3

145.92

152.18

ng/l

0.05

Allergic rhinitis

770

6587

1.17

4.03

2.6

2.8

102.72

146.32

ng/l

4.68

664

5895

Urolithiasis

1259

11258

1.13

4.02

2.9

3.0

198.58

231.95

ng/l

1.87

1147

10280

Mixed disorders of conduct and emotions, excluding more controls

163

2.12

4.01

2.0

3.0

23.46

87.04

ng/l

1.92

136

Pedal cyclist injured in other and unspecified transport accidents

343

2760

1.26

4.00

3.1

2.9

158.19

185.45

ng/l

0.70

315

2479

Assault by sharp object

248

1.92

4.00

2.5

2.7

69.41

112.87

ng/l

1.40

210

Acute suppurative otitis media

560

4401

1.20

3.99

3.2

2.8

173.52

137.30

ng/l

1.08

493

3817

Anoxic brain damage

347

1.80

3.98

5.3

2.9

241.62

252.13

ng/l

0.08

314

Psoriasis vulgaris

626

5339

1.19

3.98

2.9

2.8

222.60

185.94

ng/l

1.03

562

4846

Malignant neoplasm of rectosigmoid junction

424

1.72

3.97

3.0

3.1

284.97

232.16

ng/l

0.34

389

Clear cell adenocarcinoma of kidney

183

1365

1.39

3.97

2.9

3.0

282.43

206.61

ng/l

0.81

172

1256

Other and unspecified mononeuropathies of upper limb

100

666

1.55

3.97

3.6

2.8

162.86

196.39

ng/l

0.38

607

Myelodysplastic syndrome, excluding all cancers (controls excluding all cancers)

131

926

1.48

3.96

3.4

3.2

294.14

277.44

ng/l

0.17

115

863

Immunodeficiency associated with other major defects

3.56

3.96

4.5

2.0

145.79

180.63

ng/l

0.19

Gonococcal infection

593

1.58

3.95

2.4

3.1

265.78

136.58

ng/l

0.64

533

UC patients in KELA-register (code 208), prior to 1994

153

1106

1.42

3.95

2.6

2.8

237.40

190.89

ng/l

0.48

136

1006

Compression of brain

7.10

3.95

2.8

1.8

93.67

297.56

ng/l

—

Foreign body in respiratory tract

162

1181

1.40

3.94

4.2

2.9

133.13

190.82

ng/l

1.54

142

1071

Hypertrophy of breast

434

3581

1.22

3.94

2.0

2.6

74.68

132.13

ng/l

11.20

381

3256

Other and unspecified acne

152

2.18

3.93

3.4

2.7

152.60

96.26

ng/l

0.46

133

Divergent concomitant strabismus

222

1696

1.33

3.93

2.8

2.9

118.57

182.01

ng/l

3.26

197

1522

Other degenerative diseases of the basal ganglia

458

1.70

3.92

2.5

3.2

120.52

215.32

ng/l

3.99

416

Melanocytic naevi of ear and external auricular canal

102

2.54

3.92

3.5

2.8

178.83

214.08

ng/l

0.21

Exophthalmic conditions

223

1.99

3.91

1.8

2.9

205.43

177.98

ng/l

0.16

204

Malignant neoplasm of head and neck

325

2614

1.27

3.91

2.4

3.0

302.95

228.00

ng/l

1.08

293

2397

Graves ophthalmopathy

485

1.64

3.91

2.8

152.09

161.76

ng/l

0.10

449

Parapsoriasis

385

1.73

3.90

2.7

2.8

184.53

165.29

ng/l

0.14

350

Viral agents as the cause of diseases classified to other chapters

424

1.69

3.87

4.3

3.1

278.30

170.20

ng/l

0.68

382

Burns and corrosions

405

3328

1.23

3.87

2.8

2.9

189.60

179.88

ng/l

0.19

357

2979

Varicella [chickenpox]

119

823

1.48

3.86

3.6

2.8

198.22

131.20

ng/l

1.10

107

725

Other disorders of optic disc

202

2.02

3.86

4.2

3.3

138.87

170.25

ng/l

0.19

179

Persistent delusional disorders

263

2064

1.30

3.85

3.1

3.0

197.65

201.46

ng/l

0.05

246

1860

Acquired pure red cell aplasia [erythroblastopenia]

2.65

3.84

2.7

3.3

272.50

176.27

ng/l

0.33

Hyperprolactinaemia

509

1.61

3.83

2.9

2.7

115.58

119.25

ng/l

0.04

453

Recurrent dislocation and subluxation of joint

173

1277

1.38

3.83

2.2

2.8

109.13

139.37

ng/l

1.01

148

1142

Chronic tubulo-interstitial nephritis

132

935

1.45

3.83

2.8

2.7

247.14

205.26

ng/l

0.50

119

839

Benign neoplasm: Skin of eyelid, including canthus

566

4811

1.19

3.82

2.8

2.9

233.42

205.54

ng/l

0.34

518

4405

Onycholysis

103

2.49

3.82

2.8

2.3

290.47

98.80

ng/l

1.03

Thrombocytopenia, unspecified

250

1954

1.31

3.81

3.4

2.9

297.32

209.95

ng/l

2.08

232

1788

Follow-up care involving plastic surgery

742

0.54

3.81

1.9

2.5

101.54

167.75

ng/l

1.65

667

Oral leukoplakia

436

1.68

3.80

2.9

3.0

212.65

214.53

ng/l

0.02

396

Other, unspecified and serous retinal detachments

115

798

1.49

3.79

3.7

3.1

194.88

219.49

ng/l

0.29

106

743

Emotional disorders starting during childhood or adolescence

458

1.62

3.78

3.2

3.3

69.84

113.79

ng/l

0.91

389

Urethral stricture

233

1809

1.32

3.78

3.1

3.0

264.33

235.59

ng/l

0.34

213

1655

Monosomies and deletions from the autosomes, not elsewhere classified

3.79

3.76

6.1

3.1

205.25

150.34

ng/l

0.24

Myeloproliferative diseases

320

2582

1.27

3.76

3.5

3.0

223.96

220.74

ng/l

0.05

296

2351

Acute myeloid leukaemia and myelodysplastic syndromes

517

1.63

3.76

3.2

3.0

301.21

272.70

ng/l

0.25

479

Inflammatory disorders of breast

145

1044

1.41

3.76

2.1

2.9

138.82

140.58

ng/l

0.02

124

938

Unspecific neurodegenerative disorder

1951

12330

1.10

3.75

3.2

254.57

272.30

ng/l

0.84

1775

11365

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

231

1792

1.32

3.74

2.7

2.9

194.49

194.11

ng/l

0.01

211

1635

Autoimmune thyroiditis

298

1.80

3.74

3.2

2.7

103.13

136.22

ng/l

0.55

271

Hypersomnia

240

1.91

3.74

2.2

3.0

116.18

166.32

ng/l

0.68

215

Contact with other and unspecified heat and hot substances

104

2.46

3.74

2.8

2.0

160.44

139.08

ng/l

0.14

Foreign body in ear

344

1.75

3.73

3.3

3.0

142.08

157.21

ng/l

0.19

307

Chronic conjunctivitis

635

1.54

3.72

2.4

3.0

166.16

184.82

ng/l

0.23

582

Mental and behavioural disorders due to cannabinoids

312

1.76

3.71

3.2

3.1

73.11

100.92

ng/l

0.50

261

Alzheimer’s disease (Early onset)

105

1507

0.68

3.67

2.6

3.2

249.97

320.02

ng/l

0.94

1362

Malignant neoplasm of prostate

1797

10361

1.10

3.67

2.8

3.2

262.11

268.31

ng/l

0.15

1643

9538

Chronic Coagulation defects

414

1.67

3.67

2.9

3.0

190.02

146.35

ng/l

0.37

379

Chronic diseases of tonsils and adenoids

2717

15952

1.08

3.66

2.6

2.8

133.82

173.42

ng/l

7.43

2408

14438

Other infective otitis externa

193

1466

1.35

3.63

3.3

2.9

179.53

191.24

ng/l

0.19

168

1329

Certolizumab pegol

213

1.94

3.63

1.8

2.7

41.09

115.67

ng/l

4.55

187

Other benign neoplasm of uterus: Other parts/unspecified

113

1589

0.69

3.62

2.3

3.1

209.52

242.05

ng/l

0.54

106

1443

Alzheimer disease, including avohilmo

1666

10970

1.11

3.62

3.3

3.2

261.82

283.60

ng/l

0.98

1517

10094

Other disorders of cornea

319

2583

1.26

3.60

3.0

2.9

238.77

195.18

ng/l

0.50

290

2348

Use of ropinirole

141

1027

1.42

3.59

3.1

2.9

163.19

207.61

ng/l

1.11

132

940

Oesophageal obstruction

142

1035

1.42

3.58

3.1

2.9

192.53

225.96

ng/l

0.52

133

953

Other benign neoplasm of uterus: Other parts/unspecified

113

1585

0.69

3.58

2.3

3.1

209.52

227.90

ng/l

0.27

106

1438

Benign neoplasm of major salivary glands

349

2857

1.24

3.57

2.6

3.0

237.04

206.16

ng/l

0.59

303

2618

Hydrocephalus

192

2498

0.75

3.57

2.7

2.9

153.29

234.36

ng/l

3.84

174

2276

Bullous disorders

219

1701

1.32

3.57

4.2

2.9

192.95

222.90

ng/l

0.62

201

1556

Deep bite

267

1847

1.28

3.56

3.2

3.0

115.20

146.10

ng/l

1.09

242

1638

Superficial injury of forearm

270

2145

1.28

3.55

2.4

2.9

270.84

181.22

ng/l

0.69

233

1928

Early lumbar disc prolapse operation

217

1675

1.31

3.54

2.5

2.7

76.75

87.96

ng/l

0.27

187

1443

Nontraumatic intracranial haemmorrhage

811

7124

1.15

3.53

3.4

3.0

270.61

241.84

ng/l

0.99

724

6502

Late syphilis

291

1.81

3.51

3.4

3.0

396.43

177.27

ng/l

1.73

258

Postpartum haemorrhage

310

3333

0.80

3.49

2.0

2.3

84.61

90.54

ng/l

0.15

274

2980

Colon adenocarcinoma

503

4280

1.20

3.46

3.2

3.0

244.07

243.78

ng/l

0.00

462

3924

Congenital malformations of eye, ear, face and neck

154

1137

1.38

3.45

3.2

3.6

159.55

172.70

ng/l

0.18

136

1013

Suppurative and unspecified otitis media

922

7226

1.14

3.45

3.4

2.8

169.55

158.31

ng/l

0.35

820

6367

Other juvenile arthritis

538

1.55

3.45

3.1

3.2

196.47

150.81

ng/l

0.40

484

L04AC Interleukin inhibitors

122

868

1.43

3.44

2.5

2.7

155.76

147.44

ng/l

0.09

114

776

Benign neoplasm: Lip

543

1.57

3.44

3.0

122.59

211.95

ng/l

3.70

495

Pyoderma gangrenosum

135

2.21

3.43

2.6

3.1

403.74

177.34

ng/l

0.69

124

Lens-induced iridocyclitis

3.70

3.43

3.7

1.8

717.75

191.70

ng/l

0.40

Suppurative otitis media, unspecified

493

1.58

3.42

4.5

3.0

153.83

191.82

ng/l

0.49

449

Benign neoplasm: Lip

544

1.57

3.42

3.0

122.59

223.77

ng/l

4.18

506

Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease

110

2.39

3.39

3.6

3.4

471.63

193.79

ng/l

1.11

Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions

3.33

3.39

12.5

2.0

207.15

117.73

ng/l

0.48

Perineal laceration during delivery

147

1771

0.73

3.38

1.8

2.3

50.91

80.17

ng/l

2.68

123

1559

Benign neoplasm: Skin of other and unspecified parts of face

396

3302

1.22

3.38

3.0

207.70

219.45

ng/l

0.18

357

3022

Injury of eye and orbit

415

3468

1.21

3.38

2.7

2.9

166.92

174.74

ng/l

0.18

375

3079

Gestational diabetes (for exclusion)

461

3875

0.84

3.38

2.0

2.3

65.60

83.48

ng/l

1.30

402

3418

L01XX Other antineoplastic agents

225

1770

1.31

3.37

3.4

3.0

205.35

225.19

ng/l

0.36

210

1615

Maltreatment syndromes

103

712

1.47

3.37

2.5

2.7

152.00

118.88

ng/l

0.30

620

Undefined dementia

376

4149

0.82

3.37

3.3

351.27

327.40

ng/l

0.18

337

3756

Other vitreous opacities

138

1012

1.40

3.36

3.5

3.0

163.80

210.74

ng/l

0.77

132

931

Duodenal ulcer

441

3720

1.20

3.33

3.7

2.9

303.17

247.55

ng/l

1.10

391

3420

Necrobiosis lipoidica, not elsewhere classified

2.58

3.32

3.7

2.2

168.62

123.44

ng/l

0.18

Other menopausal disorders

687

4551

0.86

3.31

2.0

2.7

98.37

182.60

ng/l

12.99

610

4171

Other and unspecified pemphigus

2.89

3.29

3.1

3.0

128.06

164.52

ng/l

0.28

Bacterial, viral and other infectious agents

237

1873

1.28

3.29

3.6

3.0

243.38

159.78

ng/l

1.59

207

1670

Benign neoplasm of ovary

590

5096

1.17

3.29

2.7

2.8

165.50

172.23

ng/l

0.19

536

4654

Mucosal proctocolitis

348

2868

1.23

3.29

3.0

2.8

175.78

166.99

ng/l

0.13

310

2559

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)

251

2006

1.28

3.29

3.2

203.85

256.73

ng/l

1.74

234

1853

Other bullous disorders

655

1.50

3.28

4.5

3.1

187.05

206.78

ng/l

0.17

602

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

521

1.54

3.28

3.3

3.9

95.94

156.24

ng/l

2.01

458

Endometriosis of pelvic peritoneum

381

3124

1.21

3.27

2.4

2.6

80.14

144.67

ng/l

10.61

344

2841

Malignant neoplasm of other connective and soft tissue, excluding all cancers (controls excluding all cancers)

156

1172

1.37

3.27

2.4

3.1

220.19

214.52

ng/l

0.06

139

1074

Other and unspecified injuries of wrist and hand

100

694

1.47

3.26

2.8

125.05

159.41

ng/l

0.77

630

Dystonia

168

1273

1.35

3.26

2.6

3.0

154.14

187.23

ng/l

0.43

150

1144

Beningn neoplasm: Meninges, unspecified

375

1.67

3.26

2.3

3.2

172.39

219.22

ng/l

0.36

347

Benign neoplasm: Parotid gland

273

2202

1.26

3.26

2.5

3.0

215.72

203.84

ng/l

0.19

238

2018

Malignant neoplasm of renal pelvis, excluding all cancers (controls excluding all cancers)

338

1.73

3.25

4.0

3.5

382.83

244.65

ng/l

0.87

315

Simple and mucopurulent chronic bronchitis

156

1172

1.36

3.23

3.2

211.50

276.06

ng/l

1.02

147

1067

Exclusion endpoint for supernumerary teeth

144

2.08

3.23

2.7

3.0

67.38

109.83

ng/l

1.07

133

Maxillary prognathism

2.77

3.22

2.7

2.5

39.38

94.46

ng/l

1.34

Inflammatory disorders of male genital organs, not elsewhere classified

314

1.73

3.22

2.8

3.0

198.93

225.00

ng/l

0.25

278

Injury of muscle and tendon at ankle and foot level

469

1.58

3.22

2.2

3.0

125.67

149.51

ng/l

0.23

422

Psoriatic arthropathies

301

2452

1.24

3.22

3.1

2.8

198.00

171.90

ng/l

0.38

263

2226

Arthropathy in Crohn disease

152

2.06

3.20

2.6

3.5

90.57

87.03

ng/l

0.05

138

Injury of nerves at wrist and hand level

110

781

1.44

3.20

2.5

2.8

132.67

167.91

ng/l

0.69

705

Viral infections of the central nervous system

214

1679

1.30

3.19

3.0

2.9

188.35

185.36

ng/l

0.02

191

1519

Malnutrition

472

1.59

3.19

5.7

3.9

233.31

239.55

ng/l

0.05

437

Leiomyosarcoma

168

2.05

3.19

1.9

3.4

158.68

170.88

ng/l

0.08

151

Other congenital malformations of nervous system

118

2.20

3.18

1.6

2.9

81.10

121.43

ng/l

0.50

107

Benign leiomyoma with endometriosis

410

4857

0.83

3.17

2.6

2.7

129.84

174.90

ng/l

3.16

381

4440

Injuries involving multiple body regions

108

766

1.44

3.16

3.8

3.0

187.27

206.84

ng/l

0.13

692

Other lesions of median nerve

113

812

1.44

3.16

3.5

2.9

213.42

253.30

ng/l

0.42

101

747

Third [oculomotor] nerve palsy

450

1.60

3.15

3.6

3.0

189.02

224.67

ng/l

0.38

412

Benign neoplasm: Larynx

115

828

1.43

3.15

3.3

3.1

411.95

216.47

ng/l

0.50

104

761

Ankylosing spondylitis, ICD10

261

2100

1.26

3.14

2.7

2.8

147.92

172.48

ng/l

0.56

236

1885

Carcinoma in situ of skin of lower limb, including hip

624

1.52

3.14

2.6

3.2

275.86

249.11

ng/l

0.16

576

Contact with machinery

373

3117

1.22

3.14

2.7

2.9

169.81

194.04

ng/l

0.62

341

2818

Pregnancy, childbirth and the puerperium

956

5608

0.88

3.13

3.0

201.89

216.09

ng/l

0.50

878

5088

Idiopathic thrombocytopenic purpura

103

728

1.46

3.12

3.0

3.4

201.23

204.74

ng/l

0.04

665

Other and unspecified psoriasis

216

1704

1.29

3.12

3.1

2.9

269.84

193.86

ng/l

1.04

189

1547

Anogenital herpesviral [herpes simplex] infection

124

900

1.40

3.12

2.4

2.8

103.95

121.54

ng/l

0.45

109

784

Benign neoplasm: Spinal cord

286

1.75

3.12

3.0

2.7

151.48

158.98

ng/l

0.06

255

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

408

3444

1.21

3.11

3.0

3.1

319.01

226.77

ng/l

1.81

381

3171

Persons encountering health services in circumstances related to reproduction

1647

10226

1.10

3.11

3.2

2.7

119.48

135.89

ng/l

1.19

1484

9105

Postmenopausal atrophic vaginitis

719

4927

0.87

3.09

2.4

2.7

144.05

200.70

ng/l

4.46

646

4520

Pseudopolyposis of colon

3.26

3.08

4.8

2.2

97.03

184.37

ng/l

0.50

Poor fetal growth

181

1391

1.31

3.08

2.2

2.3

112.93

78.08

ng/l

0.60

156

1225

Nontoxic goitre/thyroid nodule

1132

10236

1.12

3.06

2.8

181.00

195.57

ng/l

0.70

1043

9345

Abscess of lung

342

1.68

3.06

3.8

3.0

341.12

199.46

ng/l

0.79

303

Foreign body or object entering through skin

174

1337

1.32

3.05

2.5

2.8

150.60

166.29

ng/l

0.22

158

1206

Alcohol induced polyneuropathy

236

1.84

3.05

4.1

3.0

280.29

181.48

ng/l

0.53

213

Autism spe, excluding more controls

182

1.90

3.04

2.7

2.8

78.11

91.56

ng/l

0.16

153

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

1467

8748

1.10

3.04

2.5

2.7

165.02

165.37

ng/l

0.01

1342

7934

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

1467

8748

1.10

3.04

2.5

2.7

165.02

165.37

ng/l

0.01

1342

7934

Appendectomy

2150

19237

1.08

3.03

2.8

2.7

167.81

173.39

ng/l

0.17

1919

17386

Oral lichen ruber planus wide, hypothyreosis or thyroxin

180

1396

1.32

3.02

2.3

2.9

188.44

186.33

ng/l

0.02

166

1270

Other and unspecified localized connective tissue disorders

2.93

3.01

2.1

1.8

183.07

135.73

ng/l

0.22

Appendicitis, broad definition

2609

22316

1.07

3.00

2.8

175.46

185.28

ng/l

0.38

2320

20211

Polyp of the female genital tract

1060

5538

1.12

3.00

2.5

2.7

160.57

202.27

ng/l

2.83

963

5056

Conductive hearing loss, unspecified

270

2195

1.25

3.00

3.1

2.8

149.22

200.71

ng/l

2.45

245

1986

IBD patients in KELA-register

652

5708

1.15

2.99

2.8

184.59

163.12

ng/l

0.55

582

5108

Other deformities of toe(s)

113

818

1.42

2.99

2.6

2.9

197.62

199.76

ng/l

0.02

105

751

Other acquired deformities of musculoskeletal system and connective tissue

150

1135

1.35

2.98

2.9

124.83

187.40

ng/l

2.57

137

1034

Benign neoplasm of ovary

590

5141

1.16

2.96

2.7

2.8

165.50

174.51

ng/l

0.27

536

4688

Benign neoplasm: Mediastinum

2.63

2.96

2.8

2.4

183.59

177.51

ng/l

0.02

Postpartum haemorrhage due to anatomy

1057

0.67

2.94

3.1

2.1

138.53

55.69

ng/l

0.86

922

Hordeolum and other deep inflammation of eyelid

154

1171

1.34

2.94

3.2

2.9

194.25

179.13

ng/l

0.17

141

1061

Sacroiliitis, not elsewhere classified

691

1.44

2.94

3.0

2.7

167.87

151.48

ng/l

0.15

596

Ulcer of vagina/vulva

456

1.56

2.92

2.9

2.8

105.10

198.45

ng/l

3.04

418

Erythema nodosum

670

1.46

2.92

2.8

215.46

181.33

ng/l

0.27

609

Cystic kidney disease

100

712

1.44

2.92

2.8

3.0

496.99

169.08

ng/l

4.36

646

Alcohol withdrawal state with delirium

234

1881

1.27

2.92

3.1

2.9

254.42

190.90

ng/l

0.92

207

1704

Chronic suppurative otitis media

223

1782

1.27

2.90

4.1

3.1

191.73

214.47

ng/l

0.43

199

1619

Malignant neoplasm of mesothelium and soft tissue

167

1292

1.33

2.90

2.3

2.9

212.67

231.16

ng/l

0.25

146

1187

Deficiency of other B group vitamins

524

1.52

2.89

2.4

3.0

274.01

252.66

ng/l

0.11

478

Asymmetry of jaw

179

1.90

2.88

1.9

2.7

48.71

102.47

ng/l

2.34

160

Diffuse brain injury

107

771

1.42

2.88

2.5

172.21

227.56

ng/l

0.87

702

Use of biperiden

164

1263

1.32

2.88

3.3

2.8

130.63

187.35

ng/l

1.73

143

1151

Injury of muscle and tendon at wrist and hand level

424

3612

1.19

2.86

2.9

195.24

181.48

ng/l

0.10

381

3240

Other disorders of iris and ciliary body

649

1.46

2.86

3.7

3.1

253.20

230.44

ng/l

0.22

598

Malignant neoplasm of liver and intrahepatic bile ducts

133

1000

1.37

2.85

2.8

3.1

230.02

269.08

ng/l

0.60

122

913

Other meningitis

293

1.69

2.85

2.3

3.0

178.33

163.93

ng/l

0.10

259

Pemphigus

132

2.09

2.83

2.8

2.5

143.93

188.65

ng/l

0.40

117

Preterm labour and delivery

614

5374

1.15

2.82

2.5

2.4

120.77

120.19

ng/l

0.01

548

4846

Benign leiomyoma with endometriosis

410

4803

0.84

2.82

2.6

2.8

129.84

178.02

ng/l

3.50

381

4378

Oral lichen ruber planus

543

1.50

2.82

1.9

3.2

106.27

184.22

ng/l

1.18

493

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

1312

7310

1.10

2.80

2.7

3.2

232.71

252.20

ng/l

0.72

1194

6712

Disturbances of smell and taste

127

948

1.37

2.79

2.3

2.9

122.67

184.08

ng/l

2.58

115

855

Postpartum hemorraghe, parous women as controls

310

3268

0.83

2.79

2.0

2.2

84.61

84.56

ng/l

0.00

274

2910

Benign neoplasm: Skin of eyelid, including canthus

566

4946

1.16

2.78

2.8

2.9

233.42

203.72

ng/l

0.37

518

4510

Other and unspecified aplastic anaemias

258

1.75

2.78

3.5

3.0

314.63

181.14

ng/l

0.56

229

Other bursitis, not elsewhere classified

205

1.84

2.77

2.8

3.4

364.06

190.29

ng/l

0.94

180

Focal epilepsy, mode (most common among epilepsy diagnosis)

627

5512

1.15

2.77

3.0

3.1

183.46

212.44

ng/l

1.26

567

4993

Amblyopia ex anopsia

109

794

1.40

2.77

3.2

2.9

168.47

171.42

ng/l

0.03

717

Chorioretinal inflammation

619

1.46

2.77

4.4

2.9

110.75

195.09

ng/l

2.90

568

Wide developmental disorders, excluding more controls

275

1.68

2.77

3.2

3.3

72.89

131.60

ng/l

1.24

235

Intermittent heterotropia

134

1007

1.35

2.76

3.3

129.16

173.35

ng/l

0.85

120

903

Oral leukoplakia, including avohilmo

654

1.45

2.76

2.7

3.0

205.69

196.70

ng/l

0.09

602

Disorders of purine and pyrimidine metabolism

127

2.11

2.75

3.6

3.4

459.44

206.66

ng/l

1.02

114

Juvenile osteochondrosis

494

1.51

2.74

2.8

3.0

110.97

168.21

ng/l

1.34

432

Diseases of appendix

2628

22487

1.07

2.74

2.8

175.16

185.81

ng/l

0.42

2336

20362

Open wound of shoulder and upper arm

351

1.61

2.74

2.6

3.0

194.60

188.20

ng/l

0.05

311

Toxic effects of substances chiefly nonmedicinal as to source

318

2653

1.21

2.73

2.8

2.9

172.19

178.19

ng/l

0.09

282

2376

Persons with potential health hazards related to communicable diseases

910

8107

1.12

2.73

3.3

2.8

214.14

142.82

ng/l

2.61

822

7203

Benign neoplasm: salivary glands, exclude unknown (D119)

304

2531

1.22

2.73

2.5

2.9

211.42

201.97

ng/l

0.16

263

2307

Open wound of wrist and hand

1378

12517

1.10

2.73

2.7

2.9

182.58

186.21

ng/l

0.11

1232

11298

Benign neoplasm of major salivary glands

349

2943

1.20

2.72

2.6

2.9

237.04

210.13

ng/l

0.50

303

2682

Vascular dementia (undefined)

169

1308

1.31

2.72

4.5

3.4

409.93

390.51

ng/l

0.17

153

1185

Injury of muscle and tendon at hip and thigh level

287

2374

1.23

2.72

3.1

2.8

179.94

178.90

ng/l

0.01

259

2146

Crushing injury of wrist and hand

345

1.63

2.72

3.5

2.6

106.98

168.91

ng/l

1.58

310

Other trisomies and partial trisomies of the autosomes, not elsewhere classified

5.33

2.72

2.9

227.14

173.73

ng/l

—

Burn and corrosion of shoulder and upper limb, except wrist and hand

384

1.58

2.70

2.5

2.9

198.93

176.98

ng/l

0.11

340

Ankylosing spondylitis, strict definition

105

763

1.40

2.70

2.3

2.7

98.93

141.57

ng/l

1.20

671

Benign neoplasm: Connective and other soft tissue of head, face and neck

369

1.60

2.70

2.5

3.0

149.59

189.78

ng/l

0.32

335

Carcinoma in situ of vulva

156

1.96

2.69

2.3

3.1

209.46

217.09

ng/l

0.03

143

Chondropathies

445

3826

1.17

2.69

3.1

2.8

163.50

170.16

ng/l

0.16

395

3442

Atopic dermatitis, strict definition with reimbursement

687

5892

1.14

2.68

2.7

2.8

148.12

135.34

ng/l

0.33

608

5236

Diabetes insipidus

163

1.93

2.68

2.4

3.0

92.92

148.05

ng/l

0.90

145

Benign neoplasm: Spinal cord

299

1.67

2.68

3.0

3.1

151.48

159.91

ng/l

0.07

274

Benign neoplasm: Connective and other soft tissue of head, face and neck

370

1.59

2.67

2.5

3.2

149.59

183.91

ng/l

0.27

344

Fitting and adjustment of external prosthetic device

2.75

2.67

4.1

2.0

318.96

207.16

ng/l

0.47

Disorders of iron metabolism

268

1.70

2.67

3.3

3.1

190.72

163.31

ng/l

0.27

240

Monoarthritis, not elsewhere classified

129

972

1.35

2.67

2.7

2.9

243.16

194.03

ng/l

0.42

117

877

LeFortI or BSSRO operation

588

1.45

2.66

1.8

2.8

63.15

130.09

ng/l

4.02

509

Acute hepatitis B

2.50

2.65

2.4

167.63

84.28

ng/l

0.52

Stenosis and insufficiency of lacrimal passages

328

2758

1.21

2.65

3.6

3.0

224.20

213.45

ng/l

0.15

303

2513

Other benign neoplasms of uterus

149

1912

0.76

2.64

2.3

3.1

185.17

223.32

ng/l

0.90

138

1739

Carcinoma in situ of skin of lower limb, including hip

647

1.46

2.64

2.6

3.2

275.86

235.96

ng/l

0.26

593

Primary open-angle glaucoma

1408

12640

1.09

2.63

3.3

3.0

228.04

249.68

ng/l

1.03

1291

11627

Benign neoplasm: Larynx

115

857

1.38

2.61

3.3

3.0

411.95

218.45

ng/l

0.49

104

775

Inflammatory bowel disease, strict (require KELA)

652

5767

1.14

2.61

2.8

184.59

162.78

ng/l

0.56

582

5157

Acute alcohol intoxication ICD-9

126

952

1.36

2.60

3.9

2.9

220.73

212.90

ng/l

0.07

119

868

Tibial collateral bursitis [Pellegrini-Stieda]

209

1.79

2.60

1.8

3.1

129.27

176.38

ng/l

0.53

189

Crohn's disease of small intestine

172

1351

1.29

2.60

2.8

2.7

171.09

161.45

ng/l

0.11

150

1215

Other renal tubulo-interstitial diseases

469

1.51

2.60

2.8

2.6

231.01

168.87

ng/l

0.70

423

Fracture of neck

211

1704

1.26

2.60

3.1

3.0

334.74

224.30

ng/l

0.52

192

1552

Other melanin hyperpigmentation

613

1.45

2.59

4.0

3.0

175.04

216.49

ng/l

0.69

565

6-mercaptopurine

419

1.53

2.59

3.1

2.7

94.07

144.76

ng/l

1.27

366

Mental and behavioural disorders due to tobacco

245

2007

1.24

2.58

2.9

2.8

314.43

172.34

ng/l

0.83

218

1816

Inguinal or femoral hernia, bilateral

408

3505

1.18

2.57

3.0

259.08

226.81

ng/l

0.32

375

3233

Toxic effect of ethanol

101

736

1.40

2.57

2.5

2.7

167.34

164.75

ng/l

0.03

651

Glycogen storage disease

6.19

2.57

2.0

4.8

323.17

88.17

ng/l

—

Assault by unspecified means

301

1.63

2.57

3.7

2.6

136.81

106.22

ng/l

0.39

264

Volvulus

706

1.41

2.56

2.7

2.9

228.31

211.50

ng/l

0.15

648

Smoking dependency

245

2009

1.24

2.56

2.9

2.8

314.43

171.90

ng/l

0.83

218

1815

Frostbite

180

1.85

2.56

3.5

2.8

164.93

177.02

ng/l

0.05

155

Other otitis externa (chronic)

201

1615

1.27

2.56

2.4

2.8

139.41

193.43

ng/l

2.61

185

1468

Leiomyosarcoma, excluding all cancers (controls excluding all cancers)

219

1.78

2.55

2.2

3.9

165.87

243.40

ng/l

0.79

201

Essential (haemorrhagic) thrombocythaemia

138

1061

1.34

2.55

3.1

3.0

172.25

203.93

ng/l

0.86

131

977

Other combined immunodeficiencies

3.84

2.54

3.4

1.7

102.11

113.05

ng/l

—

Burn and corrosion of head and neck

398

1.55

2.54

2.0

2.8

84.73

169.99

ng/l

2.83

355

Oral lichen ruber planus, including avohilmo

181

1439

1.28

2.53

1.8

2.9

97.85

172.62

ng/l

3.17

158

1307

Benign neoplasm: Parotid gland

273

2269

1.22

2.53

2.5

2.9

215.72

203.67

ng/l

0.19

238

2070

Inguinal hernia, bilateral

401

3446

1.18

2.53

3.0

260.25

226.18

ng/l

0.33

368

3177

Other and unspecified mononeuropathies of lower limb

682

1.42

2.53

3.0

2.8

125.45

200.43

ng/l

2.39

629

Abscess of mediastinum

3.13

2.53

7.5

1.9

207.45

222.34

ng/l

0.05

Benign neoplasm: Mediastinum

2.41

2.52

2.8

2.7

183.59

209.77

ng/l

0.10

Lichen sclerosus et atrophicus

325

2746

1.20

2.50

2.8

162.55

176.66

ng/l

0.40

293

2486

Synovial hypertrophy, not elsewhere classified

145

1.93

2.49

2.0

2.8

108.32

116.18

ng/l

0.08

131

Aneurysms, operations, SAH

584

5156

1.14

2.49

2.9

229.85

204.64

ng/l

0.70

522

4710

Urethritis and urethral syndrome

466

1.50

2.48

3.4

3.3

110.89

192.47

ng/l

2.65

422

Macular hole

218

1780

1.25

2.48

3.1

3.0

192.69

208.50

ng/l

0.25

202

1635

Autoimmune polyglandular failure

5.49

2.47

2.3

191.67

143.58

ng/l

—

Injury of nerves at shoulder and upper arm level

205

1.78

2.47

3.3

2.8

194.73

182.22

ng/l

0.07

181

Open wound of hip and thigh

590

1.44

2.47

2.7

3.0

142.90

176.20

ng/l

0.69

516

Other obstetric trauma

644

0.61

2.46

2.0

2.4

73.20

69.02

ng/l

0.07

564

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

125

949

1.34

2.46

2.3

2.9

124.80

179.56

ng/l

1.33

110

851

Paranoid personality disorder

345

1.58

2.46

2.3

2.8

195.09

168.85

ng/l

0.19

306

Medial epicondylitis

104

769

1.38

2.45

2.6

2.8

116.85

159.83

ng/l

1.19

700

Blood alcohol or alcohol intoxication level

409

1.53

2.45

4.9

2.6

199.17

153.53

ng/l

0.50

365

Personal history of malignant neoplasm

104

770

1.38

2.45

2.0

2.3

152.33

155.45

ng/l

0.03

696

Long labour

325

3356

0.84

2.45

1.9

2.4

91.69

96.50

ng/l

0.10

278

3010

Malignant neoplasm of breast, HER-positive

995

10770

0.90

2.44

2.4

2.8

163.63

177.01

ng/l

0.66

906

9871

Other salmonella infections

116

875

1.35

2.43

2.4

2.7

385.01

194.02

ng/l

0.68

108

795

Mixed disorders of conduct and emotions

197

1.75

2.41

2.0

3.5

23.46

110.33

ng/l

2.86

162

Other complications of labour and delivery, not elsewhere classified

1134

0.72

2.41

1.9

2.2

46.75

65.26

ng/l

1.09

991

Degenerative diseases of the nervous system

1568

10955

1.09

2.41

3.4

3.2

264.63

282.46

ng/l

0.69

1436

10061

Benign neoplasm: Skin of other and unspecified parts of face

396

3414

1.18

2.41

3.0

207.70

220.73

ng/l

0.21

357

3110

Primary open-angle glaucoma, strict

1137

10409

1.10

2.40

3.3

3.0

218.36

241.00

ng/l

1.22

1040

9570

Intracranial injury with prolonged coma

5.43

2.40

2.5

6.7

142.83

333.77

ng/l

—

Tooth agenesis EXCLUDE clefts and syndromes

410

1.51

2.39

4.2

3.0

156.17

131.47

ng/l

0.12

359

Pediculosis, acariasis and other infestations

154

1209

1.29

2.38

3.6

2.7

154.26

161.02

ng/l

0.09

139

1093

Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers

153

1205

1.30

2.38

3.4

3.2

328.70

235.54

ng/l

1.20

142

1113

Labour and delivery complicated by fetal stress [distress]

252

2034

0.82

2.38

2.1

2.2

88.22

68.54

ng/l

0.37

222

1801

Malignant neoplasm of thymus

2.64

2.37

3.0

2.4

208.38

102.59

ng/l

1.06

Other and unspecified types of non-Hodgkin lymphoma, hilmo

153

1206

1.30

2.36

3.4

3.1

328.70

229.51

ng/l

1.32

142

1108

Melanocytic naevi, other sites/unspecified

216

1765

1.24

2.36

3.1

2.9

170.95

183.74

ng/l

0.20

204

1610

Tuberculosis, IBD comorbidity

296

2498

1.20

2.36

3.8

3.1

210.58

270.09

ng/l

2.21

274

2278

Contusion of ankle

680

1.39

2.35

3.6

2.9

170.56

161.48

ng/l

0.09

612

Ulcerative enterocolitis

613

1.41

2.35

2.6

2.9

174.85

169.76

ng/l

0.03

551

Episcleritis

132

1018

1.32

2.34

2.8

2.9

141.46

154.11

ng/l

0.15

121

916

Enteropathic arthropathies

422

1.50

2.34

2.9

2.7

167.48

153.89

ng/l

0.08

387

Atopic dermatitis, strict definition

646

5636

1.13

2.34

2.7

2.8

146.06

137.17

ng/l

0.20

570

5008

Schizoid personality disorder

326

1.58

2.32

2.2

2.9

146.79

145.42

ng/l

0.01

286

Failure of sterile precautions during surgical operation

2.63

2.31

3.7

2.3

237.08

200.90

ng/l

0.14

Malignant neoplasm of bronchus and lung

639

6686

0.89

2.31

2.8

3.2

224.86

279.89

ng/l

2.51

589

6131

Syphilis

549

1.44

2.30

2.9

351.59

177.09

ng/l

1.54

488

Injury of heart

3.06

2.30

4.4

2.0

151.30

202.73

ng/l

—

Carcinoma in situ of vulva

165

1.85

2.30

2.3

3.3

209.46

181.48

ng/l

0.13

154

Visual impairment including blindness (binocular or monocular)

240

1992

1.22

2.29

3.7

3.0

289.86

247.79

ng/l

0.55

220

1803

Papilloedema, unspecified

392

1.52

2.28

2.4

3.0

95.52

166.96

ng/l

2.47

354

Failed induction of labour

572

1.41

2.28

2.0

2.4

25.26

76.13

ng/l

7.19

493

Diseases of middle ear and mastoid

1752

13387

1.08

2.27

3.1

2.8

172.94

180.69

ng/l

0.30

1571

12002

Benign neoplasm of bone and articular cartilage

222

1827

1.23

2.27

2.5

2.9

184.39

174.08

ng/l

0.09

199

1654

Myeloproliferative diseases (CML excluded)

279

2353

1.21

2.26

3.3

3.0

229.14

220.84

ng/l

0.12

256

2142

Multifocal fibrosclerosis

159

1.87

2.26

2.7

2.9

177.86

262.85

ng/l

0.63

143

Outcome of delivery

184

1416

0.80

2.26

2.0

2.2

59.88

73.13

ng/l

0.54

148

1248

Other benign neoplasms of uterus

149

1870

0.78

2.25

2.3

3.1

185.17

220.52

ng/l

0.83

138

1690

Beningn neoplasm: Meninges, unspecified

412

1.51

2.24

2.3

3.4

172.39

226.37

ng/l

0.44

379

Dislocations, sprains and strains involving multiple body regions

4.12

2.24

3.3

2.4

69.57

178.16

ng/l

—

Antepartum haemorrhage, not elsewhere classified

134

1040

1.30

2.23

1.9

2.4

42.60

83.66

ng/l

4.83

118

926

Scleritis and episcleritis

156

1238

1.28

2.23

2.7

2.9

139.27

160.36

ng/l

0.32

143

1113

Carcinoma in situ of other and unspecified digestive organs

700

1.39

2.23

3.2

3.1

268.45

224.92

ng/l

0.42

644

Alzheimer disease

1406

9832

1.09

2.23

3.5

3.2

280.03

290.31

ng/l

0.30

1283

9034

Autism

218

1.68

2.21

2.9

77.33

106.15

ng/l

0.40

177

Collagenous colitis

284

2402

1.20

2.21

3.4

2.9

212.22

193.56

ng/l

0.22

254

2175

Mandibular prognathia AND surgery (LeFortI or BSSO or LeFortI AND BSSO), including avohilmo

137

1.88

2.19

2.0

2.9

56.10

99.69

ng/l

1.21

124

Abnormalities of forces of labour

124

1596

0.77

2.19

2.1

2.5

131.80

91.58

ng/l

0.50

107

1435

Macular pucker

593

5298

1.13

2.18

2.7

2.9

230.08

208.86

ng/l

0.52

545

4869

Other abnormal auditory perceptions

190

1.74

2.18

2.8

3.3

67.82

197.77

ng/l

3.82

175

Postpartum hemorraghe, all women as controls

310

3620

0.85

2.17

2.0

2.3

84.61

89.98

ng/l

0.13

274

3222

Mental and behavioural disorders due to use of other stimulants, including caffeine

314

1.55

2.17

2.5

2.6

121.94

95.78

ng/l

0.34

262

All dysplastic lesions of the cervix uteri, vagina or vulva

578

5107

1.13

2.16

2.3

2.4

156.32

116.32

ng/l

1.38

510

4587

Pollen allergy

357

3040

1.17

2.16

2.6

2.9

93.00

123.88

ng/l

1.70

305

2680

Other congenital malformations of circulatory system

506

1.44

2.15

2.0

2.9

177.43

162.72

ng/l

0.12

458

Other and unspecified nail disorders

423

1.48

2.15

4.6

2.9

150.80

159.76

ng/l

0.11

382

Biological medicines for asthma

206

1.70

2.14

3.2

2.7

107.07

132.82

ng/l

0.18

186

Ectopic pregnancy

406

3534

1.16

2.14

2.1

2.5

104.99

121.15

ng/l

0.73

365

3180

Fall on and from ladder

270

2284

1.20

2.13

3.2

2.9

211.87

209.09

ng/l

0.04

247

2087

Carcinoma in situ of other and unspecified digestive organs

706

1.37

2.13

3.2

3.1

268.45

221.58

ng/l

0.47

660

Other disorders of optic [2nd] nerve and visual pathways

189

1545

1.24

2.12

3.4

2.9

203.54

199.60

ng/l

0.04

170

1404

Benign neoplasm: Skin of lower limb, including hip

636

1.39

2.11

4.2

3.0

174.36

201.99

ng/l

0.35

582

Endometriosis ASRM stages 1,2

391

3399

1.16

2.10

2.4

2.5

83.68

123.22

ng/l

4.97

352

3066

Prolapse and hernia of ovary and fallopian tube

186

1510

1.25

2.10

3.4

3.3

242.35

296.94

ng/l

0.44

171

1372

Unspecified dementia

374

3874

0.86

2.10

3.2

3.3

350.40

333.49

ng/l

0.12

335

3508

Meningitis

139

1098

1.29

2.10

2.8

2.9

166.28

192.39

ng/l

0.36

120

999

Melanocytic naevi of other and unspecified parts of face

163

1312

1.26

2.09

2.7

3.0

103.22

181.07

ng/l

5.85

147

1189

Major anomalies of jaw size

466

1.44

2.09

2.8

2.9

110.41

127.07

ng/l

0.29

424

Alcoholic gastritis

352

1.53

2.09

3.2

3.0

219.37

198.32

ng/l

0.12

321

Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)

273

3206

0.84

2.08

2.6

3.0

192.83

200.16

ng/l

0.11

246

2921

Upper arm

3.06

2.08

7.7

1.6

256.72

101.67

ng/l

—

Peritonsillar abscess

532

4723

1.13

2.08

2.5

2.8

145.22

167.47

ng/l

0.80

472

4264

Motor neuron disease (with DMD)

469

1.45

2.07

3.3

2.8

155.01

231.64

ng/l

1.05

428

Scabies

111

853

1.32

2.07

4.0

2.8

166.84

153.44

ng/l

0.14

771

Sclerosis of liver

5.58

2.06

9.6

1.6

207.00

118.45

ng/l

—

Myasthenia gravis

386

1.50

2.06

3.5

3.1

146.18

187.62

ng/l

0.66

351

Burns and corrosions confined to eye and internal organs

501

1.43

2.06

3.1

2.8

123.77

152.97

ng/l

0.46

445

Occlusion and stenosis of arteries, not leading to stroke

378

1.51

2.06

3.9

3.4

276.19

286.06

ng/l

0.04

346

Sequelae of transport accidents

2.25

2.05

3.1

3.0

128.80

138.55

ng/l

0.06

Benign neoplasm of other and unspecified sites

106

813

1.33

2.05

3.2

3.0

122.17

194.39

ng/l

2.79

742

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

179

1466

1.25

2.03

3.4

3.2

208.83

255.52

ng/l

1.11

164

1347

Assault by other and unspecified firearm discharge

3.62

2.03

7.9

1.9

117.43

113.75

ng/l

—

289

1.54

2.02

5.9

6.8

195.00

214.35

ng/l

0.09

263

Chronic suppurative otitis media, including avohilmo

248

2091

1.20

2.02

4.0

3.1

191.83

212.32

ng/l

0.41

218

1892

Crohn disease (strict definition, require KELA)

146

1165

1.27

2.02

2.1

2.8

154.20

155.44

ng/l

0.01

127

1036

Respiratory tuberculosis, confirmed

497

1.43

2.01

3.9

3.1

261.25

237.41

ng/l

0.16

450

Contact with heat and hot substances

143

1140

1.27

2.01

2.8

3.2

228.97

189.22

ng/l

0.51

123

1033

Bicipital tendinitis

144

1151

1.27

2.00

2.7

2.8

175.42

178.67

ng/l

0.03

128

1043

Malignant neoplasm of nasal cavity and middle ear

2.08

2.00

2.9

2.6

113.00

168.93

ng/l

0.72

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

436

3838

1.14

1.99

3.1

2.9

198.02

168.68

ng/l

0.58

390

3425

HSIL lesion of the vulva

356

1.51

1.98

2.5

2.9

210.17

185.84

ng/l

0.13

331

Other disorders of breast

335

2897

1.17

1.98

2.4

2.8

195.22

153.11

ng/l

0.89

299

2629

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)

376

3285

1.16

1.98

2.5

3.1

240.21

227.48

ng/l

0.22

337

3019

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

1285

7151

1.09

1.98

2.7

3.1

243.13

254.81

ng/l

0.33

1168

6582

Right side

139

0.34

1.98

2.2

2.7

46.80

182.93

ng/l

—

123

Alcohol-induced acute pancreatitis

110

854

1.31

1.95

2.9

2.8

275.97

185.93

ng/l

0.95

100

768

Cerebral atherosclerosis

341

1.52

1.95

3.3

3.0

247.52

283.65

ng/l

0.22

313

Traumatic cerebral oedema

2.45

1.95

3.7

3.1

92.67

221.80

ng/l

1.51

Glaucoma secondary to other eye disorders

143

1148

1.27

1.94

2.9

3.2

321.87

238.70

ng/l

0.90

131

1051

Periodontosis

3.43

1.94

3.1

2.7

72.86

273.80

ng/l

—

Other proliferative retinopathy

2.20

1.94

3.1

1.9

456.33

271.25

ng/l

0.27

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

355

3086

1.16

1.94

2.8

2.7

132.24

145.16

ng/l

0.27

322

2771

Other predominantly sexually transmitted diseases, not elsewhere classified

336

2909

1.16

1.93

2.6

126.32

124.93

ng/l

0.03

284

2566

Benign neoplasm: Anus and anal canal

101

778

1.33

1.92

2.8

3.1

284.59

229.99

ng/l

0.54

717

Neovascular glaucoma

142

1141

1.27

1.92

2.9

3.0

321.34

230.93

ng/l

1.00

130

1045

Allergic purpura

620

1.36

1.92

3.2

2.9

230.81

183.84

ng/l

0.54

563

237

1.61

1.91

2.5

2.8

397.25

207.86

ng/l

0.70

207

Use of selegiline

113

1434

0.77

1.91

3.6

3.0

199.52

244.66

ng/l

0.55

101

1315

Foreign body in alimentary tract

166

1356

1.24

1.91

3.0

3.2

188.69

209.51

ng/l

0.27

147

1239

Spirochaetal infections, other/unspecified

189

2274

0.82

1.91

2.1

2.9

165.84

190.23

ng/l

0.46

166

2071

Malignant neoplasm of corpus uteri

231

2724

0.84

1.90

2.6

3.0

204.60

204.75

ng/l

0.00

209

2488

Other drug-induced secondary parkinsonism

207

1.67

1.89

3.7

2.9

170.93

169.13

ng/l

0.01

185

Non-small cell lung cancer, adenocarcinoma, excluding all cancers (controls excluding all cancers)

237

2009

1.20

1.89

2.9

3.1

234.36

241.14

ng/l

0.07

214

1851

Disorders of puberty

144

1.77

1.88

6.3

2.7

201.50

119.95

ng/l

0.37

126

Deficiency of other/unspecified vitamins

3.36

1.87

3.3

1.8

195.00

124.89

ng/l

—

Polyp of middle ear

3.03

1.87

2.5

2.2

96.75

127.08

ng/l

—

Presbyopia

165

1350

1.24

1.86

2.7

173.88

149.64

ng/l

0.28

145

1211

Evidence of alcohol involvement determined by level of intoxication

145

1.77

1.86

3.4

2.2

178.91

142.28

ng/l

0.18

123

269

1.54

1.86

6.1

7.2

203.49

226.49

ng/l

0.10

246

Oligomenorrhoea

562

1.37

1.85

2.7

3.0

121.93

158.91

ng/l

0.66

507

Other obstructive and reflux uropathy

118

930

1.29

1.85

3.0

2.8

288.49

183.60

ng/l

1.19

832

Tuberculosis

255

2178

1.19

1.85

4.1

3.1

234.31

286.15

ng/l

1.41

233

1992

Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers)

363

3182

1.16

1.85

2.5

3.1

243.65

228.92

ng/l

0.25

326

2927

Crohn disease (strict definition, require KELA, min 2 HDR)

142

1143

1.26

1.85

2.1

2.8

150.09

154.50

ng/l

0.05

124

1019

Other and unspecified mononeuropathies, also in other diseases

765

1.32

1.84

2.9

176.55

221.35

ng/l

0.60

708

Benign neoplasm: Other and unspecified parts of mouth

110

862

1.30

1.84

3.0

2.9

205.13

187.85

ng/l

0.22

786

Other acute skin changes due to ultraviolet radiation

116

915

1.29

1.84

4.0

2.9

183.73

210.55

ng/l

0.43

109

841

Retinal haemorrhage

697

1.34

1.84

3.4

3.1

200.59

235.95

ng/l

0.69

648

Congenital malformations of genital organs

179

1467

1.22

1.84

2.9

3.1

168.31

130.07

ng/l

0.51

159

1288

Keratoconus

454

1.42

1.83

2.5

2.9

277.83

145.06

ng/l

0.46

404

Lactose intolerance

539

1.38

1.82

2.3

2.9

169.96

168.07

ng/l

0.02

494

Contact with sharp glass

625

1.35

1.81

3.2

2.9

291.55

143.41

ng/l

0.99

547

Non-Hodgkin lymphoma, all

156

1278

1.25

1.81

3.5

3.1

298.30

259.41

ng/l

0.54

146

1168

Benign neoplasm of other and unspecified sites

106

829

1.31

1.81

3.2

3.1

122.17

202.28

ng/l

3.32

760

Perioral dermatitis

321

1.49

1.81

3.3

2.7

101.13

132.35

ng/l

0.54

293

Calcium deposit in bursa

2.52

1.80

2.9

1.9

117.45

144.82

ng/l

0.21

Schizotypal disorder

354

1.47

1.80

1.9

2.8

223.98

141.50

ng/l

0.45

309

Degenerative macular diseases

499

4473

1.13

1.80

3.3

3.0

247.79

231.01

ng/l

0.37

459

4097

Benign neoplasm: Skin of lower limb, including hip

655

1.34

1.78

4.2

3.0

174.36

181.72

ng/l

0.08

608

Testicular hypofunction

628

1.35

1.78

3.0

2.8

187.25

160.10

ng/l

0.20

553

Pilonidal cyst

191

1592

1.21

1.77

2.4

2.6

161.95

125.13

ng/l

0.58

167

1391

Autism spe

217

1.59

1.75

2.7

3.8

78.11

101.44

ng/l

0.33

179

Disorders of optic nerve and visual pathways

257

2203

1.18

1.75

3.1

2.9

193.55

184.11

ng/l

0.12

234

1992

Malignant neoplasm of urinary organs

378

3338

1.15

1.75

3.1

3.0

336.60

235.42

ng/l

1.82

354

3058

Benign neoplasm: Tongue

666

1.34

1.75

2.7

2.9

261.70

190.26

ng/l

0.43

606

Melanocytic naevi, other sites/unspecified

216

1826

1.20

1.75

3.1

2.9

170.95

184.99

ng/l

0.22

204

1653

Drug-induced myopathy

2.26

1.74

2.8

219.00

155.91

ng/l

0.36

Benign neoplasm: Other and unspecified parts of mouth

110

870

1.29

1.73

3.0

3.2

205.13

188.99

ng/l

0.20

798

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

2.23

1.73

3.3

2.9

92.77

105.11

ng/l

0.11

Other or unspecified common variable immunodeficiency

2.23

1.73

6.2

1.9

71.15

120.02

ng/l

0.86

Melanocytic naevi of other and unspecified parts of face

163

1345

1.23

1.72

2.7

2.8

103.22

181.75

ng/l

6.37

147

1214

Lesion of sciatic nerve

179

1495

1.22

1.71

3.6

3.0

223.54

253.13

ng/l

0.45

162

1369

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

241

2062

1.18

1.71

2.7

2.9

156.87

174.61

ng/l

0.30

206

1874

Muscle strain

632

1.34

1.71

4.3

3.0

160.47

165.51

ng/l

0.06

568

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

293

1.51

1.71

2.6

3.1

108.27

190.63

ng/l

1.99

263

Lesion of femoral nerve

142

1.76

1.71

1.9

2.7

91.06

175.60

ng/l

1.94

130

Polycystic ovarian syndrome, broad definition

145

1179

1.24

1.71

2.3

2.2

64.59

70.89

ng/l

0.21

130

1026

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

993

7718

1.09

1.70

2.9

3.1

229.64

247.62

ng/l

0.62

919

7097

Follicular lymphoma

147

1205

1.24

1.70

2.5

3.1

267.73

200.92

ng/l

0.91

134

1108

Other abnormal products of conception

556

3331

1.12

1.70

2.1

2.3

54.95

87.28

ng/l

6.58

483

2967

Contact with other hot fluids

555

1.36

1.69

2.3

3.4

167.01

175.25

ng/l

0.07

500

Contact with other hot metals

302

1.50

1.69

3.5

2.8

256.59

158.56

ng/l

1.28

270

Respiratory tuberculosis, confirmed and not-confirmed

214

1818

1.20

1.69

3.9

3.1

226.49

272.78

ng/l

1.05

196

1672

Respiratory tuberculosis

214

1818

1.20

1.69

3.9

3.1

226.49

272.78

ng/l

1.05

196

1672

Female infertility, associated with anovulation

754

1.29

1.67

2.0

2.5

50.03

92.25

ng/l

2.20

663

Malignant neoplasm of thymus, excluding all cancers (controls excluding all cancers)

2.02

1.67

2.6

3.0

190.88

117.32

ng/l

0.81

Respiratory tuberculosis, bacteriologically and histologically confirmed

515

1.37

1.67

3.9

3.2

261.25

236.31

ng/l

0.17

468

Subacute thyroiditis

758

1.30

1.67

2.2

2.5

106.16

164.11

ng/l

1.12

675

Benign neoplasm of bone and articular cartilage

222

1890

1.19

1.67

2.5

2.8

184.39

176.26

ng/l

0.07

199

1704

Medicines for HER+ breast cancer

1065

11143

0.93

1.67

2.4

2.8

161.22

176.72

ng/l

0.86

971

10207

Ulcerative colitis (strict definition, require KELA)

450

4022

1.13

1.66

3.1

2.9

204.81

168.49

ng/l

0.76

402

3589

Endometriosis of ovary

458

4087

1.12

1.66

2.6

2.7

118.52

177.11

ng/l

4.92

427

3723

Malignant neoplasm of respiratory system and intrathoracic organs

759

7595

0.91

1.65

2.8

3.1

223.01

273.96

ng/l

2.58

695

6966

Other disorders of male genital organs

106

839

1.28

1.65

3.0

2.9

206.52

216.81

ng/l

0.10

101

752

Hirsutism, drug-induced

3.77

1.64

2.2

1.4

60.20

103.64

ng/l

—

Retinal breaks without detachment

532

4809

1.12

1.64

2.7

2.8

143.40

183.47

ng/l

2.18

481

4398

Superficial injury of neck

295

1.48

1.64

2.3

2.8

210.22

152.89

ng/l

0.39

258

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

152

1.71

1.63

1.5

3.2

127.42

177.77

ng/l

0.61

135

Gastrointestinal stromal tumor and sarcoma

281

1.52

1.63

2.0

3.0

202.46

203.74

ng/l

0.01

252

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

490

4406

1.12

1.63

3.0

2.8

197.73

167.87

ng/l

0.64

438

3942

Burn and corrosion of hip and lower limb, except ankle and foot

456

1.39

1.63

3.1

3.0

150.11

198.86

ng/l

0.67

407

Leiomyoma of uterus

1434

7579

1.07

1.62

2.6

160.42

161.24

ng/l

0.02

1298

6869

Disorders of optic nerve, not elsewhere classified

536

1.36

1.61

3.9

3.3

281.66

220.01

ng/l

0.35

493

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

152

1254

1.22

1.61

2.1

2.8

149.83

154.47

ng/l

0.05

132

1119

Other and unspecified granulomatous disorders of skin and subcutaneous tissue

2.15

1.60

5.2

3.0

300.92

95.50

ng/l

1.30

Laparoscopic right hemicolectomy

207

1765

1.19

1.60

2.6

3.0

203.83

223.61

ng/l

0.34

191

1618

Hypertrichosis

239

1.53

1.60

3.5

2.5

63.68

106.01

ng/l

1.25

211

Other specific arthropathies, wide

450

1.38

1.58

2.6

2.8

177.40

188.31

ng/l

0.07

415

Hypertrophy of tongue papillae

241

1.54

1.58

2.4

3.5

126.24

203.77

ng/l

1.13

217

Congenital malformations of the nervous system

314

1.46

1.58

2.0

3.6

76.46

153.07

ng/l

2.04

283

Pyoderma

434

1.39

1.57

2.6

3.5

185.06

189.53

ng/l

0.04

399

Impacted cerumen

276

3158

0.86

1.57

3.4

3.0

211.81

229.75

ng/l

0.29

248

2881

Wide developmental disorders

322

1.44

1.57

3.2

4.0

72.89

137.48

ng/l

1.61

272

Benign neoplasm: Conjunctiva

776

1.29

1.56

2.7

3.0

204.31

201.69

ng/l

0.02

718

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

156

1295

1.21

1.55

2.3

2.6

72.20

104.53

ng/l

2.25

137

1149

Other facial nerve disorders

609

1.32

1.53

2.9

156.73

210.99

ng/l

0.92

562

Tuberculosis, wide

297

2609

1.15

1.53

3.8

3.1

209.95

275.02

ng/l

2.58

275

2380

Maternal care for known or suspected malpresentation of fetus

191

1682

0.84

1.53

2.0

2.3

46.10

71.84

ng/l

2.46

158

1499

Measles

162

1.64

1.53

3.0

2.3

250.90

79.24

ng/l

1.02

137

Torsion of ovary, ovarian pedicle and fallopian tube

333

1.43

1.53

2.4

3.1

118.71

128.32

ng/l

0.09

295

Testicular dysfunction

724

1.29

1.52

2.9

2.8

200.42

159.71

ng/l

0.34

638

Dermatitis herpetiformis

429

1.39

1.51

5.3

2.9

137.32

178.13

ng/l

0.49

395

Malignant neoplasm of other connective and soft tissue

639

1.31

1.51

2.5

3.2

277.59

242.95

ng/l

0.27

587

Other congenital malformations of face and neck

488

1.35

1.50

2.8

3.0

172.57

162.10

ng/l

0.08

431

Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

466

4210

1.12

1.49

2.4

3.1

235.17

228.97

ng/l

0.11

420

3873

Benign neoplasm: Floor of mouth

2.14

1.49

2.5

2.2

157.13

231.28

ng/l

0.42

Malignant neoplasm of kidney, except renal pelvis

341

3030

1.14

1.49

2.9

319.55

230.56

ng/l

1.37

321

2770

Carcinoma in situ of skin of eyelid, including canthus

2.29

1.48

2.7

2.0

334.45

227.83

ng/l

0.29

Benign neoplasm: Anus and anal canal

101

810

1.27

1.48

2.8

3.1

284.59

224.14

ng/l

0.62

753

Rheumatic heart disease, other

2.43

1.47

1.6

2.2

267.67

247.41

ng/l

—

Benign neoplasm: Conjunctiva

783

1.27

1.46

2.7

3.0

204.31

210.54

ng/l

0.04

715

Polyhydramnios

516

1.33

1.45

1.9

2.4

78.75

83.76

ng/l

0.09

453

Puerperal sepsis

317

2803

1.14

1.45

2.2

2.6

113.89

133.05

ng/l

0.51

299

2559

Varicose veins of other sites

193

1649

1.18

1.44

3.1

2.9

105.98

179.21

ng/l

5.37

172

1488

Maternal care for known or suspected fetal abnormality and damage

220

1683

1.17

1.44

2.2

2.3

67.22

74.46

ng/l

0.28

186

1501

Bilateral sagittal split ramus osteotomy operation

474

1.35

1.44

1.8

2.6

68.80

119.36

ng/l

2.17

413

119

969

1.23

1.44

2.0

2.2

145.71

59.82

ng/l

0.85

849

Cholesteatoma of middle ear

184

1570

1.19

1.43

4.0

3.0

235.61

222.85

ng/l

0.09

173

1434

Benign neoplasm: Tongue

688

1.29

1.43

2.7

3.0

261.70

186.56

ng/l

0.46

635

Childhood allergy (age < 16)

173

1201

1.19

1.42

3.8

3.6

78.85

116.96

ng/l

1.06

138

1007

Gastrointestinal stromal tumor and sarcoma, excluding all cancers (controls excluding all cancers)

290

1.47

1.42

2.0

3.3

202.46

192.80

ng/l

0.07

268

Spermatocele

279

2455

1.15

1.42

3.4

2.9

186.19

254.30

ng/l

2.63

259

2249

Supervision of normal pregnancy

284

1853

0.87

1.42

2.0

2.2

57.91

77.09

ng/l

1.38

260

1627

HSIL lesion of the cervix uteri, vagina or vulva

362

3229

1.13

1.42

2.3

2.5

150.59

120.31

ng/l

0.70

319

2891

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

156

1309

1.20

1.41

2.3

2.5

72.20

100.51

ng/l

1.89

137

1180

Aphakia

374

1.39

1.40

3.1

2.9

282.07

201.63

ng/l

0.85

347

Sequelae of other accidents

332

1.42

1.40

2.9

2.8

190.13

195.19

ng/l

0.04

297

Residual foreign body in soft tissue

128

1057

1.23

1.40

3.4

2.8

153.69

180.71

ng/l

0.41

114

957

Toxic effect of alcohol

452

1.35

1.39

2.9

3.1

175.25

185.74

ng/l

0.09

408

Other and unspecified myoneural disorders

2.01

1.39

3.7

2.7

87.08

99.29

ng/l

0.17

Malignant neoplasm of anus and anal canal, excluding all cancers (controls excluding all cancers)

317

1.43

1.38

2.6

3.4

141.51

218.41

ng/l

1.55

292

Unspecified transport accident

1.99

1.37

2.8

3.2

92.15

107.78

ng/l

0.13

Other maternal disorders predominantly related to pregnancy

1387

8228

1.06

1.37

2.2

2.4

93.93

121.89

ng/l

3.22

1246

7423

Polycythaemia vera

129

1073

1.23

1.36

3.8

3.2

279.25

231.93

ng/l

0.47

118

983

Sequelae of other and unspecified effects of external causes

1.88

1.36

5.9

2.4

160.90

176.49

ng/l

—

Patellar tendinitis

241

1.48

1.35

1.6

2.8

83.89

168.72

ng/l

1.59

206

Other disorders of the genitourinary system

442

4009

1.11

1.35

2.8

2.9

196.44

197.09

ng/l

0.01

410

3652

Non-small cell lung cancer, adenocarcinoma

237

2074

1.16

1.35

2.9

234.36

236.94

ng/l

0.03

214

1901

Non-small cell lung cancer, adenocarcinoma, helper endpoint

237

2074

1.16

1.35

2.9

234.36

236.94

ng/l

0.03

214

1901

Follicular lymphoma, hilmo

147

1239

1.21

1.34

2.5

2.8

267.73

205.21

ng/l

0.83

134

1131

Other abortion

121

1.70

1.34

2.3

2.9

103.40

152.99

ng/l

0.38

105

Melanocytic naevi of lower limb, including hip

110

900

1.24

1.33

2.9

2.8

127.16

166.25

ng/l

1.28

104

816

Disorders of eyelid in diseases classified elsewhere

739

1.26

1.33

3.9

2.9

194.75

208.28

ng/l

0.10

675

Parkinson's disease, strict definition

560

5144

1.10

1.32

3.1

221.47

249.95

ng/l

0.92

507

4743

Female infertility

571

3850

0.91

1.32

2.2

2.5

96.20

138.61

ng/l

3.95

522

3497

Foreign body on external eye

412

3726

1.11

1.31

2.9

2.8

161.02

171.21

ng/l

0.16

360

3329

Other rupture of muscle

115

1.71

1.29

3.3

3.0

138.05

163.88

ng/l

0.25

Triptan medication for migraine, min. 3 purchases

1347

10051

1.06

1.29

2.2

2.5

87.59

127.03

ng/l

6.54

1180

8984

Inflammatory disease of cervix uteri

142

1678

0.84

1.28

2.4

2.9

227.74

183.09

ng/l

0.51

126

1526

Unattended death

189

0.51

1.28

4.0

2.9

358.10

243.12

ng/l

—

167

Use of levodopa decarboxylase inhibitor

530

4867

1.10

1.28

3.2

3.1

214.23

253.01

ng/l

1.39

480

4485

Benign neoplasm: Floor of mouth

2.00

1.27

2.5

4.1

157.13

223.23

ng/l

0.37

Melanoma of uvea

246

1.47

1.27

2.0

3.0

269.17

208.49

ng/l

0.26

220

Other articular cartilage disorders

592

1.29

1.27

2.4

2.7

99.97

190.84

ng/l

3.11

538

Complications associated with artificial fertilization

162

1.56

1.27

1.6

3.2

39.37

91.57

ng/l

2.19

137

Diabetes mellitus in pregnancy

488

2879

1.10

1.27

1.9

2.3

82.13

79.56

ng/l

0.07

428

2536

Female infertility, cervigal, vaginal, other or unspecified origin

512

3751

0.91

1.27

2.2

2.5

99.62

136.43

ng/l

2.74

467

3409

Malignant neoplasm of vagina

2.34

1.27

2.5

2.2

522.50

92.12

ng/l

—

Other specified/unspecified disorders of bone/cartilage

592

1.29

1.26

2.2

2.9

137.05

183.84

ng/l

0.60

532

Other and unspecified disorders of globe

2.31

1.26

3.1

1.8

109.13

111.20

ng/l

—

Gluteal tendinitis

763

1.25

2.8

95.66

185.05

ng/l

5.11

675

Single delivery by caesarean section

238

1571

0.87

1.24

1.9

2.4

71.40

100.25

ng/l

1.41

206

1365

Other superficial injuries of ankle and foot

1.85

1.24

4.3

3.1

161.57

160.74

ng/l

0.00

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

101

825

1.23

1.8

2.2

55.45

68.92

ng/l

0.59

731

Hyperchylomicronaemia

2.24

1.23

2.6

1.9

94.88

120.61

ng/l

—

Congenital absence, atresia and stenosis of small intestine

2.50

1.23

2.8

2.5

430.83

141.65

ng/l

—

Other effects of reduced temperature

2.23

1.22

4.4

2.3

216.50

124.82

ng/l

—

Caries in Clefts patients

101

1.72

1.22

2.8

2.7

72.50

103.79

ng/l

0.35

Arthropathic psoriasis

318

2852

1.12

1.21

3.0

2.8

196.05

171.12

ng/l

0.39

281

2590

Other surgical follow-up care

631

1.27

1.21

3.0

2.6

271.37

185.81

ng/l

0.39

569

Use of donepezil

764

7862

0.93

1.21

2.8

3.3

236.82

291.29

ng/l

2.55

686

7218

Traumatic amputation of wrist and hand

139

1179

1.20

3.3

2.9

236.42

208.76

ng/l

0.28

127

1072

Contact with hot air and gases

126

1.64

1.19

2.3

3.2

409.69

148.90

ng/l

0.71

109

Bullous pemphigoid

654

1.27

1.19

4.2

3.2

244.04

255.68

ng/l

0.11

600

Guttate psoriasis

249

1.44

1.18

2.6

3.0

174.86

175.36

ng/l

0.00

220

Sequelae of infectious and parasitic diseases

227

1999

1.15

1.18

3.2

2.9

202.34

219.35

ng/l

0.27

201

1796

Chromophobe cell carcinoma of kidney

119

1.68

1.18

3.2

3.3

323.37

191.05

ng/l

0.46

109

Pemphigoid

817

1.24

1.18

4.1

3.1

224.14

246.72

ng/l

0.29

753

IBD (strict) with PSC

126

1.62

1.17

3.0

2.7

84.75

109.04

ng/l

0.30

111

Dental pulpitis 3

140

851

1.19

1.17

2.7

3.3

110.20

80.58

ng/l

0.36

111

709

Fistulae involving female genital tract

344

1.37

1.17

2.5

2.9

156.00

188.20

ng/l

0.19

310

Disorders of puberty, all

174

1.51

1.17

6.2

3.0

196.33

132.68

ng/l

0.29

156

Chronic nephritic syndrome

121

1017

1.21

1.16

3.5

2.9

452.31

196.44

ng/l

3.58

111

925

Pregnancy examination and test

235

1288

1.14

1.16

1.9

2.1

83.52

72.38

ng/l

0.19

192

1133

Melanocytic naevi of lower limb, including hip

110

916

1.22

1.16

2.9

2.8

127.16

175.83

ng/l

1.74

104

838

Medical treatment for female infertility

243

2738

0.88

1.16

2.0

2.2

60.58

77.50

ng/l

1.07

223

2413

Ovarian hyperstimulation (induction)

142

1.57

1.15

1.6

2.5

41.19

70.35

ng/l

0.75

118

Carcinoma in situ of penis

2.44

1.15

2.1

2.4

106.14

223.35

ng/l

—

Polyarteritis with lung involvement [Churg-Strauss]/EGPA

1.86

1.15

2.3

3.0

99.31

175.84

ng/l

0.81

Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)

218

1921

1.15

2.7

3.2

271.35

257.97

ng/l

0.10

202

1765

Other and unspecified diseases of spleen

1.81

1.13

4.9

3.5

210.43

124.72

ng/l

0.37

Multiple delivery

128

1508

0.84

1.12

2.1

2.5

88.57

128.18

ng/l

2.12

118

1360

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

241

2140

1.14

1.12

2.7

2.9

156.87

181.22

ng/l

0.45

206

1943

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

111

930

1.21

1.12

3.9

3.0

187.42

208.27

ng/l

0.24

845

Postpartum care and examination

196

1088

1.15

1.12

2.1

74.31

69.48

ng/l

0.06

168

949

Benign neoplasm: Pituitary gland, craniopharyngeal duct

136

1159

1.19

1.12

2.8

2.9

122.84

182.68

ng/l

1.96

122

1056

Cerebral arteritis

2.04

1.12

2.9

2.1

71.38

95.91

ng/l

—

Retinoschisis and retinal cysts

659

1.25

1.11

3.4

3.0

161.73

224.39

ng/l

1.23

610

Use of glatiramer acetate

193

1.47

1.11

1.7

2.4

67.76

74.61

ng/l

0.14

170

Cachexia

1.71

1.11

3.5

2.7

664.65

164.39

ng/l

1.33

Drug-induced neutropenia

208

1832

1.15

1.11

3.0

2.9

163.06

181.91

ng/l

0.36

192

1654

Embedded and impacted teeth

428

3326

1.10

1.09

2.9

2.7

137.32

121.69

ng/l

0.38

392

2852

Other demyelinating diseases of the central nervous system

568

1.26

1.09

2.2

2.9

79.62

145.32

ng/l

2.37

502

Separation of retinal layers (serosa)

115

969

1.20

1.09

3.3

2.9

219.87

176.47

ng/l

0.40

103

885

Ulcerative rectosigmoiditis

212

1870

1.14

1.09

2.5

2.7

180.62

171.64

ng/l

0.12

187

1682

Malignant neoplasm of palate

2.12

1.09

1.7

2.0

85.56

114.87

ng/l

—

Sleepwalking [somnambulism]

2.21

1.08

1.3

2.1

40.14

126.75

ng/l

—

Pregnancy with abortive outcome

2133

10714

1.04

1.08

2.5

2.7

148.04

168.56

ng/l

1.81

1937

9747

Other and unspecified water transport accidents

1.92

1.06

3.1

3.9

147.00

124.23

ng/l

0.15

Disorders of aromatic amino-acid metabolism

2.04

1.06

6.6

3.4

316.56

131.20

ng/l

—

HSIL lesion of the cervix uteri

299

2693

1.11

1.06

2.3

2.5

137.96

107.78

ng/l

0.63

264

2398

Other specified/unspecified disorders of middle ear and mastoid

2.02

1.06

2.9

2.0

95.22

238.27

ng/l

—

Use of antiglaucoma preparations and miotics

324

2940

1.11

1.06

3.3

3.2

302.84

252.06

ng/l

0.97

291

2689

Colorectal neuroendocrine tumor and carcinoma

281

1.38

1.06

4.6

3.4

140.67

175.13

ng/l

0.42

259

L02BG Aromatase inhibitors

876

9288

0.94

1.05

2.4

2.8

168.83

174.70

ng/l

0.21

795

8514

Malignant neoplasm of anus and anal canal

107

1.66

1.05

2.6

2.0

196.67

167.84

ng/l

0.16

Malignant neoplasm of eye and adnexa, excluding all cancers (controls excluding all cancers)

440

1.30

1.04

2.6

3.9

333.74

235.12

ng/l

0.66

409

Acne varioliformis

1.97

1.04

1.6

2.3

303.89

199.82

ng/l

—

Other endophthalmitis

107

1.65

1.04

3.3

2.7

255.29

214.10

ng/l

0.10

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

364

3325

1.10

1.04

2.4

3.0

236.11

227.71

ng/l

0.13

325

3049

malignant neoplasm of female genital organs

454

4918

0.92

1.03

2.6

2.9

212.69

199.50

ng/l

0.25

413

4483

Superficial injuries involving multiple body regions

511

1.27

1.03

4.4

2.9

245.69

190.89

ng/l

0.26

457

Other leukaemias of specified cell type

1.93

1.02

1.8

2.8

296.89

276.30

ng/l

—

Other bursitis of knee

309

1.36

1.02

5.4

3.2

272.37

189.75

ng/l

0.53

278

Crushing injury of ankle and foot

1.88

1.02

4.5

3.5

147.45

219.86

ng/l

0.41

Dislocation, sprain and strain of joints and ligaments of elbow

136

1169

1.17

1.02

3.0

2.7

162.35

159.37

ng/l

0.03

124

1045

Ulcerative colitis (strict definition, all Crohn cases excluded)

371

3391

1.10

1.01

3.1

2.9

199.97

169.38

ng/l

0.54

336

3029

Dyslexia and other symbolic dysfunctions, not elsewhere classified

1.87

1.01

3.5

2.3

185.91

131.28

ng/l

0.33

Examination and encounter for administrative purposes

121

1032

1.19

1.01

2.3

2.4

162.51

192.48

ng/l

0.65

113

962

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

449

1.28

1.01

2.4

3.0

120.24

156.87

ng/l

0.38

400

Personality and behavioural disorders due to brain disease, damage and dysfunction

353

1.33

1.01

1.6

3.3

221.87

229.78

ng/l

0.03

319

Parkinson's disease, including avohilmo

616

5759

1.08

1.00

3.1

220.23

246.32

ng/l

0.90

558

5300

Vestibular neuronitis

276

2492

1.12

0.99

3.0

2.9

206.75

196.38

ng/l

0.14

255

2267

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

174

1.48

0.99

1.5

4.0

127.42

238.03

ng/l

1.53

160

Benign neoplasm: other/unspecified salivary gland

742

1.22

0.98

2.8

3.1

289.76

230.73

ng/l

0.39

681

Parkinson's disease

590

5513

1.08

0.98

3.1

221.37

246.66

ng/l

0.82

534

5076

Non-small cell lung cancer, squamous, helper endpoint

137

1579

0.86

0.98

2.8

3.1

176.87

303.93

ng/l

6.22

128

1448

Non-small cell lung cancer, squamous

137

1579

0.86

0.98

2.8

3.1

176.87

303.93

ng/l

6.22

128

1448

Oral lichen ruber planus, hypothyreosis or thyroxin

329

1.33

0.98

1.7

2.8

124.61

160.47

ng/l

0.21

304

Rickettsioses

2.00

0.97

3.7

157.86

185.95

ng/l

—

Sequelae of tuberculosis

598

1.24

0.97

5.0

3.3

278.53

312.72

ng/l

0.34

548

Psoriatic arthropathies, ICD10

288

2609

1.11

0.97

3.1

2.9

206.32

168.16

ng/l

0.60

250

2366

Malignant neoplasm of heart, mediastinum and pleura, excluding all cancers (controls excluding all cancers)

490

1.27

0.97

2.4

3.3

182.50

270.17

ng/l

1.66

458

Special screening examination for infectious and parasitic diseases

464

3203

1.09

0.96

2.0

2.3

138.83

118.81

ng/l

0.58

369

2823

Glaucoma, exfoliation

465

4312

1.09

0.96

3.7

3.1

250.40

261.54

ng/l

0.17

428

3941

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

110

938

1.19

0.95

4.2

3.1

230.96

261.90

ng/l

0.43

102

864

Disorders of muscle in diseases classified elsewhere

2.31

0.95

6.2

2.0

646.83

155.96

ng/l

—

Other and unspecified degenerative diseases of nervous system

709

1.22

0.95

2.2

3.0

151.27

276.39

ng/l

4.77

653

Malignant neoplasm of breast, HER-negative

633

6743

0.93

0.95

2.6

2.9

202.86

190.43

ng/l

0.29

577

6150

Malignant neoplasm of nasal cavity and middle ear, excluding all cancers (controls excluding all cancers)

176

1.47

0.95

2.5

3.5

212.92

203.55

ng/l

0.03

158

Adenocarcinoma and papilloma adenocarcinoma of rectum

347

3180

1.10

0.95

2.3

2.9

234.43

228.45

ng/l

0.09

310

2918

Other psoriatic arthropathies

278

2519

1.11

0.94

3.1

2.8

204.59

167.00

ng/l

0.56

240

2283

Carcinoma in situ of skin of eyelid, including canthus

1.87

0.93

2.7

2.4

334.45

210.90

ng/l

0.35

Intentional self-harm by other and unspecified firearm discharge

2.19

0.92

3.5

2.3

534.50

61.17

ng/l

—

Other disorders of prostate

1066

0.83

0.92

3.1

2.9

272.88

256.85

ng/l

0.11

979

Complications predominantly related to the puerperium

522

4862

1.08

0.92

2.2

2.4

102.71

117.20

ng/l

0.48

482

4378

Intrahepatic Cholestasis of Pregnancy (ICP)

101

856

1.19

0.91

1.8

2.4

55.45

70.32

ng/l

0.82

747

Glaucoma-related operations

212

1904

1.13

0.89

2.7

3.0

210.21

230.59

ng/l

0.50

192

1747

Benign neoplasm: Pituitary gland, craniopharyngeal duct

136

1186

1.16

0.88

2.8

122.84

191.70

ng/l

2.42

122

1072

Tic and related disorders

144

1.48

0.88

3.7

3.3

64.93

144.86

ng/l

1.59

126

Other orthopaedic follow-up care

147

1289

1.15

0.88

2.4

2.5

287.72

180.13

ng/l

1.04

132

1156

Benign neoplasm: Skin, unspecified

110

945

1.18

0.88

3.0

2.8

193.77

191.24

ng/l

0.02

865

Placenta praevia

516

0.77

0.88

2.6

2.5

97.69

72.51

ng/l

0.35

454

Benign neoplasm: Ribs, sternum and clavicle

1.86

0.87

2.4

124.25

133.28

ng/l

—

Bitten or struck by other mammals

242

2188

1.11

0.86

2.6

2.8

183.87

156.77

ng/l

0.34

220

1953

Loose body in joint

561

1.23

0.85

2.4

2.8

235.26

187.02

ng/l

0.30

516

Maternal care related to the fetus and amniotic cavity and possible delivery problems

822

5112

0.94

0.85

2.2

2.4

80.50

108.46

ng/l

3.76

731

4596

Chalazion

312

2860

1.10

0.85

2.4

2.9

179.30

179.74

ng/l

0.01

280

2590

Torsion of testis

274

1.33

0.85

3.2

3.6

133.79

151.70

ng/l

0.11

227

Other papulosquamous disorders

214

1.38

0.85

2.7

2.8

85.58

189.46

ng/l

2.24

195

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

571

1.23

0.85

2.7

3.0

135.19

202.45

ng/l

1.12

525

Cleft lip, lip and palate or palate

205

1.38

0.84

2.3

3.1

79.10

104.12

ng/l

0.37

183

Urticaria due to cold and heat

113

1.53

0.84

2.7

2.9

217.50

132.76

ng/l

0.22

103

Correction of physiology of bite - very demanding therapy visit

462

1.25

0.84

2.5

2.7

90.72

131.91

ng/l

0.91

409

Malignant neoplasm of other and unspecified female genital organs, excluding all cancers (controls excluding all cancers)

729

1.20

0.83

1.9

2.9

161.79

175.75

ng/l

0.21

662

Benign neoplasm: Ribs, sternum and clavicle

1.78

0.83

2.4

3.2

124.25

124.02

ng/l

—

Pustular psoriasis

124

1081

1.16

0.83

4.1

3.0

170.97

182.33

ng/l

0.16

116

979

Other specified disorders of external ear

122

1064

1.16

0.83

3.3

2.9

307.76

222.40

ng/l

0.55

112

965

Fetus and newborn affected by noxious influences transmitted via placenta or breast milk

0.00

0.83

0.0

5.8

—

171.52

—

Burn and corrosion of wrist and hand

700

1.20

0.83

2.4

3.0

161.43

163.26

ng/l

0.02

622

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

573

1.22

0.83

2.7

3.0

135.19

192.97

ng/l

0.92

532

Alzheimer’s disease (Early onset), excluding more controls

105

1147

0.86

0.82

2.6

2.8

249.97

325.42

ng/l

1.00

1031

Transient global amnesia

328

3024

1.09

0.82

3.2

3.0

147.78

211.26

ng/l

2.65

308

2758

Rare circulating lymphoid malignancy, excluding all cancers (controls excluding all cancers)

823

1.18

0.81

2.8

3.5

223.56

239.35

ng/l

0.13

765

Other helminthiases

0.00

0.81

0.0

1.8

—

131.90

—

Degenerative myopia

148

1.46

0.81

3.0

3.2

280.38

188.90

ng/l

0.46

131

Macular cyst

732

1.19

0.81

2.6

3.0

222.61

228.51

ng/l

0.04

678

Other disorders of carbohydrate metabolism

1.67

0.80

2.2

3.6

187.83

134.60

ng/l

0.21

Covid-19 suspected case

484

4526

1.07

0.80

3.2

2.7

201.71

158.51

ng/l

1.41

437

4017

Malignant neoplasm of heart, mediastinum and pleura

341

1.29

0.80

2.0

3.1

180.32

245.84

ng/l

0.83

310

Mandibular retrognathia AND surgery (BSSRO)

357

1.27

0.80

1.9

2.7

64.51

121.55

ng/l

2.16

314

Infectious mononucleosis

120

1045

1.15

0.80

3.3

2.7

100.72

114.31

ng/l

0.30

903

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

560

5845

0.94

0.79

2.6

2.9

205.12

191.13

ng/l

0.33

511

5328

Other osteochondropathies

177

1584

1.12

0.79

3.1

2.8

209.05

162.89

ng/l

0.68

155

1436

All dysplastic lesions of the cervix uteri

444

4133

1.07

0.78

2.3

2.4

141.63

108.70

ng/l

0.89

391

3687

Benign neoplasm: Long bones of lower limb

594

1.21

0.78

2.5

2.7

169.13

145.90

ng/l

0.19

531

Disorders of parathyroid gland, other and/or unspecified

175

1.41

0.78

3.5

2.5

409.06

222.79

ng/l

0.61

160

Benign neoplasm: Eye, unspecified

1.59

0.78

3.5

5.5

440.00

294.23

ng/l

0.32

Use of galantamine

248

2709

0.91

0.77

2.5

3.2

208.66

301.13

ng/l

4.51

224

2470

Allergic contact dermatitis

332

3068

1.09

0.77

2.8

2.7

153.31

151.02

ng/l

0.04

306

2773

Malignant neoplasm of vagina, excluding all cancers (controls excluding all cancers)

1.62

0.76

2.3

3.7

449.23

175.81

ng/l

0.44

Disorder of the sleep-wake schedule

280

1.30

0.76

2.5

2.6

88.52

161.98

ng/l

1.53

248

Twin gestation

131

1154

1.14

0.75

2.0

2.3

55.16

88.81

ng/l

2.11

115

1031

Colorectal neuroendocrine tumor and carcinoma, excluding all cancers (controls excluding all cancers)

299

1.29

0.75

4.6

3.4

140.67

173.01

ng/l

0.38

281

Hereditary corneal dystrophies

100

868

1.17

0.74

2.4

2.9

214.63

200.30

ng/l

0.16

795

Contact with other sharp object(s)

131

1156

1.14

0.74

2.2

2.8

145.20

150.22

ng/l

0.04

116

1031

Glycosuria

2.08

0.74

1.0

2.2

204.20

219.34

ng/l

—

Benign neoplasm: Skin of trunk

113

989

1.15

0.74

3.4

3.0

181.29

193.60

ng/l

0.13

102

908

Rare circulating lymphoid malignancy

831

1.17

0.74

2.8

3.3

223.56

234.45

ng/l

0.09

762

Brain meningioma, excluding all cancers (controls excluding all cancers)

157

1405

1.13

0.73

2.4

3.0

160.35

187.99

ng/l

0.57

144

1289

Other abnormal findings of blood chemistry

116

1018

1.15

0.73

3.1

3.0

286.34

196.55

ng/l

1.05

110

928

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

851

6772

1.05

0.73

3.0

3.2

230.46

253.72

ng/l

0.81

794

6222

Benign neoplasm: Skin, unspecified

110

963

1.15

0.72

3.0

2.9

193.77

192.62

ng/l

0.01

884

Use of bromocriptine

2.01

0.72

2.0

2.5

213.60

117.05

ng/l

—

Benign neoplasm: other/unspecified salivary gland

768

1.17

0.72

2.8

3.2

289.76

227.26

ng/l

0.42

711

Severe bullous disorders, KELA reimbursement

1.78

0.72

2.7

2.0

209.43

107.60

ng/l

—

Melanoma of uvea

275

1.30

0.72

2.0

3.5

269.17

241.39

ng/l

0.10

254

Narcolepsy and cataplexy

1.53

0.71

3.8

3.3

127.71

186.46

ng/l

0.41

Endometriosis diagnosis and infertility diagnosis occurring together

176

1587

1.11

0.70

2.2

2.5

74.80

96.25

ng/l

1.14

165

1402

Laparoscopic left hemicolectomy

429

1.23

0.70

1.8

3.1

236.49

194.28

ng/l

0.28

390

Malignant neoplasm of eye, brain and central nervous system

118

1041

1.14

0.70

1.9

3.3

169.13

217.77

ng/l

0.62

105

953

Female infertility, tubal origin

703

1.17

0.70

2.4

2.7

87.92

108.23

ng/l

0.36

626

Other and unspecified injuries of ankle and foot

705

1.17

0.68

3.1

2.9

217.65

159.26

ng/l

0.68

629

Malignant melanoma, excluding all cancers (controls excluding all cancers)

610

5789

1.06

0.68

2.4

3.0

237.29

223.63

ng/l

0.29

546

5303

Systemic atrophies primarily affecting the central nervous system

129

1148

1.14

0.68

2.6

3.3

163.39

224.18

ng/l

0.93

123

1056

Tic disorders

153

1.39

0.68

3.7

3.1

64.93

125.07

ng/l

1.61

134

Psoriasis (vulgaris), strict definition

626

0.82

0.68

2.4

2.8

122.14

171.22

ng/l

0.98

570

L02BA Anti-estrogens

429

4565

0.94

0.68

2.2

2.8

152.12

168.09

ng/l

0.54

391

4153

Type1 diabetes, definitions combined, early onset

829

0.85

0.67

2.9

3.3

295.34

108.31

ng/l

1.30

714

Syndrome of inappropriate secretion of antidiuretic hormone

129

1.44

0.66

2.3

2.4

254.75

207.57

ng/l

0.17

111

Respiratory tuberculosis, not confirmed

151

1360

1.12

0.66

3.7

3.1

206.69

268.95

ng/l

1.62

141

1247

Benign mammary dysplasia

455

4288

1.07

0.66

2.5

2.8

159.87

182.92

ng/l

0.95

405

3919

Other and unspecified injuries of shoulder and upper arm

672

1.17

0.65

2.6

2.7

119.01

188.95

ng/l

1.10

612

Pustulosis palmaris et plantaris

105

925

1.14

0.65

3.1

2.8

168.01

168.91

ng/l

0.01

842

Burn and corrosion confined to eye and adnexa

423

1.22

0.65

3.5

2.6

134.80

150.97

ng/l

0.17

373

Left side

102

0.57

0.65

7.0

3.1

175.67

214.78

ng/l

—

Benign neoplasm: Peripheral nerves and autonomic nervous system

342

1.25

0.64

3.3

3.1

120.81

180.80

ng/l

0.96

313

Labour and delivery complicated by umbilical cord complications

763

0.85

0.64

1.9

2.7

87.33

101.34

ng/l

0.25

678

Obstructed labour due to malposition and malpresentation of fetus

317

3207

0.93

0.64

2.1

2.3

81.74

83.25

ng/l

0.04

280

2855

Chromophobe cell carcinoma of kidney, excluding all cancers (controls excluding all cancers)

139

1.42

0.64

3.2

3.6

323.37

224.05

ng/l

0.32

127

Spinal enthesopathy

105

926

1.14

0.63

3.3

3.1

206.60

336.98

ng/l

2.85

100

834

Complications following abortion and ectopic and molar pregnancy

781

0.85

0.62

2.5

2.9

117.33

158.11

ng/l

0.96

705

Benign neoplasm: Skin of trunk

113

1004

1.14

0.62

3.4

3.0

181.29

196.64

ng/l

0.16

102

922

Benign neoplasm: Other specified/unspecified intrathoracic organs (+ respiratory system NOS of Icd-9)

1.62

0.62

4.3

2.6

132.63

133.51

ng/l

—

Crushing injury of lower leg

1.71

0.62

1.2

2.0

26.40

152.04

ng/l

—

Congenital malformations of ovaries, fallopian tubes and broad ligaments

824

1.15

0.62

2.4

2.8

123.72

115.39

ng/l

0.07

726

Burns and corrosions of multiple and unspecified body regions

444

1.21

0.62

2.1

2.9

285.78

184.67

ng/l

0.70

399

Varus deformity, not elsewhere classified

218

1.30

0.62

2.9

80.38

203.57

ng/l

3.62

201

N06DA Anticholinesterases

1376

11496

0.97

0.61

2.8

3.2

222.29

285.11

ng/l

6.48

1248

10581

Use of anticholinesterases

1376

11496

0.97

0.61

2.8

3.2

222.29

285.11

ng/l

6.48

1248

10581

Mesial bite

122

1.41

0.61

2.5

2.3

88.75

92.43

ng/l

0.02

115

Fetus and newborn affected by complications of placenta, cord and membranes

0.00

0.60

0.0

6.3

—

227.73

—

Abnormalities of ear ossicles

1.84

0.60

2.8

1.9

164.00

223.38

ng/l

—

Melanoma in situ

133

1198

1.12

0.60

2.4

3.0

215.65

232.45

ng/l

0.17

118

1110

Obstructed labour due to maternal pelvic abnormality

328

3504

0.93

0.60

2.3

2.6

123.71

134.24

ng/l

0.22

292

3200

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

462

4363

1.06

0.60

3.3

267.69

280.92

ng/l

0.25

425

4038

Atopic dermatitis

1477

12213

1.03

0.59

2.4

2.7

167.07

155.17

ng/l

0.50

1312

10911

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

499

4737

1.06

0.59

2.4

3.0

233.26

223.26

ng/l

0.18

448

4343

Other disorders of skin and subcutaneous tissue related to radiation

1.74

0.59

2.8

3.1

105.00

166.78

ng/l

—

Leiomyoma of uterus

2058

11398

1.03

0.58

2.6

2.7

168.08

172.01

ng/l

0.15

1866

10376

Endovascular or surgical operations to intracerebral aneurysms

154

1692

0.90

0.58

2.7

2.9

232.43

188.70

ng/l

0.53

139

1530

Procedures for purposes other than remedying health state

429

1.20

0.58

2.5

2.2

105.66

144.80

ng/l

0.84

393

Contact with nonpowered hand tool

110

982

1.13

0.57

3.0

2.9

126.00

180.16

ng/l

1.02

100

884

Non-seminoma of testis

1.53

0.57

3.6

2.9

57.27

147.27

ng/l

1.07

Other leukaemias of specified cell type

1.58

0.57

1.8

3.5

296.89

310.06

ng/l

—

Small cell lung cancer

719

0.85

0.57

2.3

3.1

228.16

273.96

ng/l

0.38

655

Small cell lung cancer, helper endpoint

719

0.85

0.57

2.3

3.1

228.16

273.96

ng/l

0.38

655

Anisometropia and aniseikonia

730

0.86

0.56

2.7

3.1

105.50

199.66

ng/l

4.15

673

Benign lipomatous neoplasm of intrathoracic organs

1.65

0.56

1.3

3.5

47.33

137.03

ng/l

—

Foreign body entering into or through eye or natural orifice

209

1929

1.09

0.56

4.1

2.9

155.36

187.02

ng/l

0.90

190

1740

Abrasion of teeth

857

6058

1.04

0.56

2.5

2.7

128.51

167.60

ng/l

3.65

775

5520

Carcinoma in situ of breast, intraductal

200

2167

0.92

0.56

2.4

2.8

132.43

161.38

ng/l

0.81

175

1984

Other specified acquired deformities of limbs

1.50

0.56

1.9

2.4

81.42

158.53

ng/l

1.13

Exposure to sunlight

1.62

0.55

7.0

2.3

239.67

211.08

ng/l

—

Diabetic retinopathy, strict definition

625

5249

1.05

0.55

4.2

3.3

391.84

228.84

ng/l

6.73

593

4759

Vertical strabismus

768

1.14

0.55

2.4

3.0

160.49

179.87

ng/l

0.21

706

Malignant neoplasm of cervix uteri, excluding all cancers (controls excluding all cancers)

553

1.17

0.55

3.0

294.90

192.21

ng/l

0.70

505

Non-small cell lung cancer, squamous, excluding all cancers (controls excluding all cancers)

137

1507

0.90

0.54

2.8

3.2

176.87

293.01

ng/l

5.27

128

1385

Multiple gestation

132

1194

1.11

0.54

2.0

2.3

54.78

87.37

ng/l

2.07

116

1070

Benign neoplasm: Connective and other soft tissue, unspecified

241

1.26

0.54

2.9

2.8

212.63

205.67

ng/l

0.05

220

Infections of genitourinary tract in pregnancy

184

1693

1.09

0.54

2.3

2.7

123.15

134.13

ng/l

0.18

169

1536

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1662

13198

1.03

0.53

2.7

168.49

168.52

ng/l

0.00

1509

11961

Malignant neoplasm of rectum

337

3177

1.07

0.53

2.4

2.9

229.57

227.59

ng/l

0.03

306

2914

Congenital malformations of uterus and cervix

223

1.26

0.53

2.9

2.7

160.71

111.63

ng/l

0.51

191

Seminoma of testis

170

1.31

0.53

2.6

3.1

86.55

149.49

ng/l

0.96

147

Other sexually transmitted chlamydial diseases

686

1.14

0.51

1.9

2.7

117.02

82.49

ng/l

0.43

571

Non-seminoma of testis, excluding all cancers (controls excluding all cancers)

1.49

0.51

3.6

2.8

57.27

180.72

ng/l

1.30

Small cell lung cancer, excluding all cancers (controls excluding all cancers)

712

0.86

0.51

2.3

3.3

228.16

305.87

ng/l

0.74

662

Otosclerosis

204

2198

0.92

0.51

3.0

2.9

165.71

198.20

ng/l

0.61

181

2010

Tic and related disorders

162

1.31

0.51

3.7

3.9

64.93

124.09

ng/l

1.58

142

Malignant neoplasm, without specification of site, excluding all cancers (controls excluding all cancers)

133

1456

0.91

0.50

2.8

3.2

260.15

278.56

ng/l

0.12

123

1332

Sequelae of other and unspecified infectious and parasitic diseases

121

1097

1.11

0.50

2.5

2.8

137.25

166.10

ng/l

0.45

104

976

Other intracranial haemorrhages

107

966

1.12

0.50

3.4

3.1

336.68

248.96

ng/l

0.58

101

888

Subarachnoid haemorrhage

344

3253

1.06

0.50

3.0

2.8

269.11

219.32

ng/l

1.14

302

2951

Other infective (teno)synovitis

1.48

0.49

8.0

2.8

117.09

92.65

ng/l

0.27

Type 1 diabetes, strict definition

1058

0.89

0.49

2.5

3.1

207.29

93.79

ng/l

1.10

905

Hallux rigidus

444

4232

1.05

0.48

2.4

2.7

189.08

198.60

ng/l

0.18

397

3886

LSIL lesion of the cervix uteri, vagina or vulva

251

2351

1.07

0.48

2.2

2.6

174.72

122.04

ng/l

0.90

220

2100

Gastrojejunal ulcer

291

1.22

0.48

2.9

3.1

275.58

216.04

ng/l

0.38

268

Benign neoplasm: Long bones of lower limb

626

1.14

0.48

2.5

3.0

169.13

162.80

ng/l

0.05

571

Postpartum haemorrhage due to retained placenta

147

1600

0.92

0.47

1.8

2.2

57.42

70.90

ng/l

0.54

132

1419

Dysplasia of cervi uteri

522

3863

1.05

0.46

2.4

2.6

145.32

155.40

ng/l

0.22

466

3492

Other and unspecified hydrocephalus

469

1.16

0.46

3.1

169.36

204.47

ng/l

0.33

426

Benign neoplasm: Rectum/anal canal icd-9

256

1.23

0.46

2.8

3.1

274.75

270.47

ng/l

0.02

237

Other contact dermatitis

205

1912

1.08

0.46

3.4

2.8

174.55

179.34

ng/l

0.06

187

1716

Qualitative platelet defects

1.49

0.45

3.3

2.5

122.00

189.36

ng/l

—

Carcinoma in situ of other and unspecified sites

119

1087

1.11

0.45

3.6

3.1

301.45

247.90

ng/l

0.56

110

1022

TMD related pain

553

1.15

0.45

1.9

2.6

45.63

152.21

ng/l

10.45

494

Abnormal findings on diagnostic imaging of central nervous system

102

923

1.11

0.45

3.2

2.7

141.10

194.39

ng/l

0.89

832

Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)

290

2740

1.06

0.45

3.3

3.2

198.16

241.03

ng/l

1.06

267

2516

Uterine polyps

255

2398

1.07

0.45

2.6

2.8

145.40

185.14

ng/l

1.17

225

2191

Bacterial meningitis

762

1.12

0.45

3.1

2.9

160.93

185.14

ng/l

0.24

693

Calculus of lower urinary tract

175

1626

1.08

0.45

2.7

3.1

288.70

254.05

ng/l

0.29

161

1496

Iridocyclitis in diseases classified elsewhere

386

1.18

0.45

3.5

3.1

151.00

201.60

ng/l

0.75

350

Premature rupture of membranes

284

2214

0.94

0.45

2.3

2.4

77.53

88.92

ng/l

0.26

253

1968

Other acantholytic disorders

1.50

0.44

4.4

2.1

171.13

238.49

ng/l

—

Traumatic secondary and recurrent haemorrhage

1.68

0.44

5.0

3.7

189.60

173.88

ng/l

—

Dementia due to Parkinsons disease, excluding more controls

660

1.13

0.44

2.3

2.9

238.53

279.84

ng/l

0.30

604

Melanoma in situ

133

1224

1.10

0.44

2.4

3.0

215.65

230.30

ng/l

0.15

118

1130

Pneumoconiosis due to asbestos and other mineral fibres

727

1.13

0.44

3.6

3.1

225.41

294.24

ng/l

1.12

657

Radiodermatitis

1.45

0.44

1.3

3.2

115.63

200.44

ng/l

—

Exposure to other and unspecified man-made environmental factors

267

1.21

0.43

2.5

2.9

157.30

180.06

ng/l

0.22

235

Retained placenta and membranes, without haemorrhage

261

2462

1.06

0.42

2.6

2.5

93.98

122.70

ng/l

1.54

243

2238

Hookworm diseases

0.00

0.42

0.0

2.5

—

330.37

—

Demyelinating diseases of the central nervous system

174

1619

1.08

0.42

2.3

2.9

99.10

149.22

ng/l

2.64

148

1442

Malignant neoplasm of pancreas

190

2030

0.93

0.42

2.7

3.1

214.10

248.21

ng/l

0.57

173

1865

Sequelae of burns, corrosions and frostbite

1.39

0.41

2.3

2.6

111.42

134.14

ng/l

0.23

Brain meningioma

150

1392

1.08

0.41

2.3

2.9

158.41

200.86

ng/l

1.00

138

1274

Benign neoplasm: Eye, unspecified

106

1.35

0.41

3.5

5.3

440.00

256.65

ng/l

0.43

Crohn disease (strict definition, all UC cases excluded)

102

930

1.10

0.40

2.1

2.8

132.43

156.88

ng/l

0.33

831

Carcinoma in situ of cervix uteri

142

1314

1.08

0.40

2.3

2.7

163.40

126.22

ng/l

0.58

124

1160

Carcinoma in situ of other and unspecified genital organs

372

1.17

0.40

2.3

2.8

245.73

172.65

ng/l

0.38

345

Cyst of Bartholin Gland

664

1.12

0.40

1.7

3.1

95.41

154.71

ng/l

2.00

595

Other congenital malformations of limb(s)

1.39

0.39

3.7

2.9

147.47

114.61

ng/l

0.10

Benign neoplasm of breast

313

3286

0.95

0.39

2.3

2.8

207.29

170.31

ng/l

0.77

276

2993

Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)

207

1948

1.07

0.38

2.2

3.2

177.49

220.06

ng/l

0.94

185

1786

Unspecified protein-energy malnutrition

125

1.31

0.38

5.3

2.9

367.00

233.16

ng/l

0.68

112

Seminoma of testis, excluding all cancers (controls excluding all cancers)

179

1.24

0.38

2.6

3.2

86.55

174.28

ng/l

1.47

159

Hydrocephalus in other diseases

115

0.68

0.38

2.4

2.3

143.63

173.13

ng/l

—

105

Malignant neoplasm of larynx, excluding all cancers (controls excluding all cancers)

582

1.13

0.38

2.6

3.1

326.77

266.34

ng/l

0.28

542

Testicular dysfunction, other/unspecified

1.32

0.38

2.6

3.5

344.67

190.48

ng/l

—

Triptan medication for migraine, single purchase ok

2197

15143

0.98

0.38

2.4

2.7

97.20

150.44

ng/l

18.80

1931

13624

Migraine, single triptan purchase ok & required. ICD-code if available is included

2197

15143

0.98

0.38

2.4

2.7

97.20

150.44

ng/l

18.80

1931

13624

Sudden idiopathic hearing loss

321

3062

1.05

0.38

3.6

2.8

193.17

204.33

ng/l

0.20

302

2785

Carcinoma in situ of breast, intraductal

200

2124

0.94

0.38

2.4

2.8

132.43

155.82

ng/l

0.61

175

1932

Dental caries 1 and operation codes, only avohilmo

1046

5400

0.97

0.38

2.8

3.3

169.75

188.23

ng/l

0.78

933

4939

Other noninflammatory disorders of vagina

200

1883

1.07

0.37

2.6

2.8

181.86

196.23

ng/l

0.17

180

1709

Renal cell carcinoma of kidney, excluding all cancers (controls excluding all cancers)

100

1088

0.91

0.37

3.1

3.2

348.23

273.64

ng/l

0.62

1010

Benign neoplasm: Peripheral nerves and autonomic nervous system

366

1.16

0.36

3.3

3.4

120.81

196.45

ng/l

1.29

342

Chondrosarcoma, excluding all cancers (controls excluding all cancers)

108

1.32

0.36

1.9

4.5

266.21

209.91

ng/l

0.13

Psoas tendinitis

0.63

0.36

3.6

2.3

172.20

82.72

ng/l

—

Endometriosis ASRM stages 3,4

606

5863

1.04

0.36

2.7

2.6

122.15

158.04

ng/l

3.06

557

5317

Female infertility, uterine origin

1.45

0.36

1.3

3.2

26.67

176.72

ng/l

—

Supernumerary teeth EXCLUDE clefts and syndromes

1.44

0.36

1.2

2.5

36.00

94.11

ng/l

—

Transient acantholytic dermatosis [Grover]

1.41

0.36

3.2

1.9

71.67

218.16

ng/l

—

Other cestode infections

1.40

0.36

1.6

2.1

94.20

240.26

ng/l

—

Malignant neoplasm, without specification of site

940

0.91

0.35

3.0

3.3

286.67

273.62

ng/l

0.06

861

ILD medications: acetylcysteine

200

1.21

0.34

2.4

2.7

151.88

215.54

ng/l

0.50

183

Cervical root disorders

136

1.27

0.34

2.3

2.8

147.12

188.79

ng/l

0.26

124

Sexual dysfunction

265

1.18

0.34

2.5

3.0

130.48

131.86

ng/l

0.01

235

Other deformity of hallux (acquired)

182

1.23

0.34

3.0

2.9

156.64

196.64

ng/l

0.35

172

Prolonged pregnancy

170

1650

0.94

0.34

1.8

2.3

49.64

78.67

ng/l

1.95

145

1462

Other conditions related to polyarteritis nodosa

1.33

0.34

5.0

2.2

667.50

153.98

ng/l

—

Benign neoplasm: Cranial nerves

739

0.90

0.33

2.9

3.0

126.66

206.13

ng/l

1.68

681

Abnormal findings in cerebrospinal fluid

1.32

0.33

3.3

2.4

232.83

95.00

ng/l

—

Congenital malformations of ear causing impairment of hearing

1.32

0.33

1.8

2.5

100.00

160.32

ng/l

—

conjunctival degenerations and deposits

512

1.12

0.33

2.8

2.9

153.89

210.38

ng/l

0.91

468

Carcinoma in situ of cervix uteri

142

1329

1.07

0.33

2.3

2.7

163.40

130.25

ng/l

0.50

124

1175

Melanoma in situ of other and unspecified parts of face

333

1.16

0.32

2.0

3.0

304.41

244.46

ng/l

0.22

304

Oesophagitis, drug-induced

1.41

0.32

2.4

2.6

137.00

247.79

ng/l

—

Malignant neoplasm of oropharynx

399

1.14

0.32

2.8

2.9

236.74

206.68

ng/l

0.21

358

Benign neoplasm of male genital organs

590

0.89

0.32

2.6

3.0

307.68

228.73

ng/l

0.39

534

Unspecified urinary incontinence

270

2580

1.05

0.32

3.3

2.9

204.29

200.25

ng/l

0.07

239

2347

Other and unspecified cicatricial alopecia

1.35

0.32

1.7

2.7

95.29

82.33

ng/l

—

Excessive attrition of teeth

1258

6683

1.02

0.31

2.8

2.7

143.06

168.58

ng/l

2.14

1119

6058

Malignant neoplasm of tonsil

343

1.15

0.31

2.9

3.0

260.85

193.13

ng/l

0.51

306

LSIL lesion of the cervix uteri

157

1667

0.94

0.31

2.3

2.6

164.82

106.46

ng/l

0.71

139

1478

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

572

5231

1.03

0.31

2.9

3.2

191.42

258.28

ng/l

3.85

532

4811

Alzheimer’s disease (Atypical or mixed)

359

3447

1.04

0.31

3.9

3.3

277.00

324.80

ng/l

1.25

331

3124

Occupant of special vehicle mainly used on industrial premises injured in transport accident

1.33

0.31

3.3

3.6

80.36

238.50

ng/l

1.87

Other disorders of amniotic fluid and membranes

158

1661

0.94

0.30

2.1

2.4

51.97

81.11

ng/l

2.85

135

1479

Congenital hydrocephalus

1.29

0.30

1.7

2.0

32.57

113.17

ng/l

—

Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx, excluding all cancers (controls excluding all cancers)

1.27

0.30

3.7

3.5

473.00

169.96

ng/l

—

Renal cell carcinoma of kidney

100

1074

0.92

0.29

3.1

348.23

254.91

ng/l

0.86

985

Benign neoplasm: Connective and other soft tissue, unspecified

260

1.17

0.29

2.9

3.4

212.63

201.57

ng/l

0.08

240

Other and unspecified disease of Bartholin gland

691

0.91

0.29

3.0

152.84

185.41

ng/l

0.45

632

Benign neoplasm: Brain, supratentorial

307

1.15

0.29

2.9

3.0

173.50

168.38

ng/l

0.02

270

Type 1 diabetes, strict definition, subgroup 1

970

0.92

0.29

2.5

3.0

186.01

94.62

ng/l

0.84

826

Malignant neoplasm of tonsil, excluding all cancers (controls excluding all cancers)

450

1.12

0.29

2.8

3.0

243.71

213.40

ng/l

0.23

417

Pre-eclampsia superimposed on chronic hypertension

1.24

0.29

2.1

2.6

54.14

77.02

ng/l

—

Pneumoconiosis due to dust containing silica

1.32

0.29

2.5

3.5

298.82

256.77

ng/l

0.11

Tonsillectomy and adenotomy

1328

9073

1.02

0.29

2.5

2.8

103.48

133.15

ng/l

2.84

1147

8041

Endometroid carcinoma of ovary

214

1.18

0.29

4.7

3.1

112.25

212.49

ng/l

1.02

201

Benign neoplasm: Other specified/unspecified intrathoracic organs (+ respiratory system NOS of Icd-9)

1.29

0.29

4.2

2.8

132.63

145.71

ng/l

—

Carcinoma in situ of other and unspecified sites

119

1117

1.07

0.28

3.6

3.1

301.45

246.12

ng/l

0.59

110

1019

Malignant neoplasm of bone and articular cartilage, excluding all cancers (controls excluding all cancers)

471

1.11

0.27

3.7

3.1

169.26

199.16

ng/l

0.27

439

Chorioretinal scars

0.69

0.27

4.2

3.7

421.20

146.13

ng/l

—

Mononeuritis multiplex

1.27

0.26

1.8

2.1

104.22

117.31

ng/l

—

Dental pulpitis 3, only avohilmo

115

787

1.07

0.26

2.5

3.2

111.84

80.65

ng/l

0.29

656

Melanoma in situ, other sites/unspecified

1.26

0.26

2.7

3.4

142.44

223.34

ng/l

—

Spontaneous abortion

1136

7579

1.02

0.26

2.4

2.5

106.92

131.88

ng/l

2.26

1046

6857

Mumps

549

1.10

0.26

2.1

2.5

81.73

157.94

ng/l

3.42

490

Other crystal arthropathies

512

1.10

0.25

3.4

2.8

355.06

250.05

ng/l

0.57

476

Benign neoplasm of breast

313

3242

0.96

0.25

2.3

2.8

207.29

170.92

ng/l

0.75

276

2945

Brain glioblastoma and astrocytoma

359

1.12

0.25

2.0

3.2

53.35

188.01

ng/l

8.86

323

Malignant neoplasm of oropharynx, excluding all cancers (controls excluding all cancers)

551

1.10

0.25

2.8

3.1

216.59

205.49

ng/l

0.09

509

Benign neoplasm: Testis

1.28

0.25

3.4

2.3

301.36

235.76

ng/l

0.15

Infections specific to the perinatal period

148

0.81

0.25

8.2

5.8

111.83

177.47

ng/l

0.54

139

Malignant melanoma

503

4897

1.03

0.25

2.3

3.0

243.29

214.34

ng/l

0.64

448

4483

Haemorrhagic and haematological disorders of fetus and newborn

252

1.14

0.25

3.7

7.3

175.72

232.44

ng/l

0.32

233

Renal agenesis and other reduction defects of kidney

1.18

0.24

1.6

2.7

583.44

138.38

ng/l

—

Benign neoplasm of thyroid gland

793

1.08

0.24

3.8

3.0

115.27

197.81

ng/l

3.99

723

Enteritis due to Yersinia enterocolitica

1.30

0.24

4.1

2.1

113.80

132.13

ng/l

—

Hereditary retinal dystrophy

293

1.13

0.24

2.4

4.1

118.78

194.05

ng/l

1.61

264

Communicating hydrocephalus

546

0.91

0.23

2.5

3.3

195.75

235.00

ng/l

0.35

502

All dysplastic lesions of the vagina

476

1.10

0.23

2.8

2.6

108.54

147.15

ng/l

1.09

439

Sixth [abducent] nerve palsy

893

1.07

0.23

2.9

3.0

268.09

228.43

ng/l

0.19

825

Carcinoma in situ, eye

0.00

0.23

0.0

1.9

—

191.44

—

Malignant neoplasm of bladder

244

2530

0.96

0.23

2.9

3.1

254.26

293.69

ng/l

0.79

222

2319

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

1008

8034

1.02

0.23

2.4

2.7

163.20

171.73

ng/l

0.35

919

7320

Benign neoplasm: Cranial nerves

721

0.92

0.23

2.9

126.66

193.81

ng/l

1.34

663

Endometriosis of rectovaginal septum and vagina

213

2049

1.04

0.22

3.0

2.8

133.83

193.41

ng/l

3.24

192

1876

Toxic effect of other inorganic substances

0.00

0.22

0.0

1.7

—

166.55

—

Carcinoma in situ of other/unspecified female genital organs

0.00

0.22

0.0

2.3

—

84.83

—

Spotted fever [tick-borne rickettsioses]

0.00

0.22

0.0

1.9

—

134.58

—

Thyrotoxicosis from ectopic thyroid tissue

0.00

0.22

0.0

2.3

—

199.30

—

Malignant neoplasm of stomach

169

1619

1.05

0.22

2.6

3.0

298.43

267.15

ng/l

0.21

156

1483

Microcephaly

0.00

0.22

0.0

4.4

—

283.17

—

Malignant neoplasm of larynx

450

1.10

0.21

2.5

3.2

351.60

246.47

ng/l

0.45

411

Ulcerative colitis (strict) with PSC

1.23

0.21

3.8

3.1

117.42

128.78

ng/l

0.08

Trichomoniasis

173

1.17

0.21

4.0

3.1

334.65

161.59

ng/l

0.70

161

Carcinoma in situ, bladder

107

1014

1.06

0.21

3.7

3.1

319.23

249.74

ng/l

0.71

100

953

Intentional self-harm by jumping or lying before moving object

0.00

0.21

0.0

2.2

—

49.62

—

Diseases of thymus

1.27

0.20

2.5

1.8

248.83

130.78

ng/l

—

Melanoma in situ of other and unspecified parts of face

346

1.11

0.20

2.0

3.5

304.41

232.91

ng/l

0.27

324

Benign lipomatous neoplasm of other sites/unspecified

274

2827

0.97

0.20

3.0

267.77

216.48

ng/l

0.73

256

2578

Carcinoma in situ of other and unspecified genital organs

394

1.10

0.20

2.3

3.0

245.73

183.25

ng/l

0.31

367

Male infertility

717

0.93

0.20

4.1

2.8

141.51

146.88

ng/l

0.04

609

Pneumonia due to Haemophilus influenzae

1.21

0.20

1.7

1.9

178.17

186.17

ng/l

—

Vitreous prolapse

1.19

0.20

2.0

2.8

505.67

172.32

ng/l

—

Malignant neoplasm of breast, HER2-negative

1628

11814

1.01

0.20

2.5

2.8

178.89

179.68

ng/l

0.03

1483

10781

Disorder of carbohydrate metabolism, other/unspecified

1.19

0.19

2.3

3.0

52.50

103.19

ng/l

—

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, excluding all cancers (controls excluding all cancers)

289

1.12

0.19

2.0

3.3

122.78

197.49

ng/l

1.25

263

Impacted teeth

229

2205

0.97

0.19

2.8

2.7

159.51

117.76

ng/l

0.73

212

1870

Viral conjunctivitis

337

1.10

0.19

2.4

2.9

179.19

158.54

ng/l

0.11

298

Crystal arthropathies, rheuma endpoint

522

1.08

0.18

3.4

2.8

355.06

243.39

ng/l

0.63

485

Dementia in other diseases classified elsewhere

137

1428

0.96

0.18

2.2

3.1

245.87

269.74

ng/l

0.27

123

1303

Colour vision deficiencies

1.17

0.18

2.4

2.1

113.14

132.57

ng/l

—

Contraceptive management

946

6549

1.02

0.18

2.8

2.5

103.42

118.33

ng/l

0.80

857

5810

Mesothelioma

378

1.09

0.17

2.0

3.2

166.83

243.18

ng/l

1.05

343

Paralytic strabismus

213

2063

1.04

0.17

3.3

2.9

259.61

215.95

ng/l

0.46

192

1867

Primary angle-closure glaucoma

150

1444

1.04

0.17

2.9

3.0

239.63

237.04

ng/l

0.02

138

1332

Benign neoplasm: Rectum/anal canal icd-9

282

1.11

0.17

2.8

3.6

274.75

293.21

ng/l

0.10

261

Mesothelioma, excluding all cancers (controls excluding all cancers)

379

1.09

0.17

2.0

3.1

166.83

241.99

ng/l

1.01

353

Benign neoplasm: Brain, supratentorial

321

1.10

0.16

2.9

3.1

173.50

184.83

ng/l

0.05

295

Optic atrophy

401

0.92

0.16

3.0

3.2

356.54

213.02

ng/l

0.50

364

Brain glioblastoma and astrocytoma, excluding all cancers (controls excluding all cancers)

370

1.09

0.16

2.0

3.2

53.35

185.98

ng/l

8.03

341

Other noninflammatory disorders of cervix uteri

140

1348

1.04

0.16

3.0

2.8

280.52

205.38

ng/l

0.87

124

1234

Melanoma in situ, other sites/unspecified

1.17

0.16

2.7

3.1

142.44

224.71

ng/l

—

Type 1 diabetes, strict (exclude DM2)

165

1590

1.04

0.16

2.7

3.0

205.44

126.50

ng/l

1.25

153

1390

Malignant cancer of tonsil and base of tongue, excluding all cancers (controls excluding all cancers)

624

1.06

0.15

2.6

3.1

261.36

206.84

ng/l

0.41

580

Placental disorders

1.16

0.15

1.6

2.5

19.89

111.80

ng/l

—

Other symptoms and signs involving the digestive system and abdomen

462

4535

1.02

0.15

3.2

2.6

193.50

188.53

ng/l

0.07

420

4121

therapeutic use

798

0.95

0.14

2.9

2.8

262.48

197.42

ng/l

0.55

742

Toxic effect of contact with venomous animals

880

1.05

0.14

2.9

183.58

176.55

ng/l

0.04

801

Palindromic rheumatism

227

1.11

0.14

2.0

2.7

136.75

179.50

ng/l

0.29

212

MS-disease / Multiple Sclerosis

133

1283

1.04

0.14

2.2

2.9

97.71

138.61

ng/l

1.59

112

1143

Other disorders of breast and lactation associated with childbirth

181

0.88

0.14

1.9

2.5

44.73

97.10

ng/l

2.02

153

Benign neoplasm: Skin of ear and external auricular canal

115

1107

1.04

0.14

4.5

3.1

252.01

242.44

ng/l

0.08

105

1027

Carcinoma in situ, bladder

107

1029

1.04

0.14

3.7

3.1

319.23

241.93

ng/l

0.83

100

936

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

721

7022

0.99

0.14

2.7

2.8

194.30

183.94

ng/l

0.26

661

6403

Use of rasagiline

725

0.95

0.14

2.8

3.0

183.15

204.21

ng/l

0.24

667

Other or unspecified paralytic strabismus

128

0.85

0.14

3.2

2.6

282.82

173.87

ng/l

0.22

114

Adenocarcinoma and ductal carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

105

1010

1.04

0.14

2.5

3.2

240.92

235.54

ng/l

0.04

944

Benign neoplasm of brain and other parts of central nervous system

172

1670

1.03

0.13

2.9

3.1

135.39

197.27

ng/l

1.91

152

1525

Alzheimer’s disease (Late onset)

921

7982

0.99

0.13

3.2

3.3

271.28

304.06

ng/l

1.23

839

7319

Benign neoplasm of thyroid gland

815

1.05

0.13

3.8

3.0

115.27

180.58

ng/l

2.94

745

Rubella [German measles]

727

1.05

0.12

2.9

2.7

104.80

133.32

ng/l

0.50

640

Malignant neoplasm of breast

1661

11883

1.01

0.12

2.5

2.8

179.09

178.81

ng/l

0.01

1515

10836

Type 1 diabetes, definitions combined

165

1599

1.03

0.12

2.7

2.9

205.44

123.98

ng/l

1.31

153

1395

Dementia due to Parkinson's disease

773

0.95

0.12

2.3

2.9

238.53

263.28

ng/l

0.17

706

Benign neoplasm of male genital organs

559

0.94

0.12

2.6

3.2

307.68

249.49

ng/l

0.26

520

176

1799

0.97

0.11

4.4

3.3

260.53

314.63

ng/l

0.81

165

1631

Malignant neoplasm of base of tongue, excluding all cancers (controls excluding all cancers)

198

0.90

0.11

1.8

3.4

277.44

203.52

ng/l

0.19

181

Malignant neoplasm of brain, excluding all cancers (controls excluding all cancers)

123

1267

0.97

0.11

1.9

3.2

98.04

219.93

ng/l

9.38

109

1164

Motorcycle rider injured in noncollision transport accidents

485

0.95

0.11

3.2

2.9

148.82

154.60

ng/l

0.06

425

Benign neoplasm: Brain, unspecified

115

1.14

0.11

2.7

3.5

71.54

210.19

ng/l

2.80

103

Use of interferon beta-1a

309

1.07

0.10

2.1

2.6

78.85

88.28

ng/l

0.15

268

Miliary tuberculosis

1.12

0.10

2.8

3.1

191.80

230.14

ng/l

—

Malignant neoplasm of ovary

127

1236

1.03

0.10

2.7

3.0

123.35

194.29

ng/l

3.82

115

1129

Carcinoma in situ of breast

1.16

0.09

1.1

2.7

51.60

126.70

ng/l

—

Use of entacapone

217

0.92

0.09

2.4

3.1

124.60

236.41

ng/l

1.76

190

Optic neuritis

733

1.04

0.09

2.4

2.9

165.79

147.32

ng/l

0.23

657

Adenocarcinoma and ductal carcinoma of pancreas

105

1020

1.03

0.09

2.5

3.0

240.92

243.15

ng/l

0.02

940

Other inflammation of vagina/vulva

507

1.05

0.09

2.6

2.7

136.21

128.20

ng/l

0.05

457

Adenocarcinoma and papillary adenocarcinoma of stomach, excluding all cancers (controls excluding all cancers)

813

1.04

0.09

2.4

3.2

259.47

281.52

ng/l

0.17

758

Other specified/unspecified hearing loss

253

2488

1.02

0.09

2.8

2.9

165.56

239.76

ng/l

3.00

236

2264

Alzheimer’s disease, wide definition

1009

8501

0.99

0.08

3.2

3.3

270.34

296.43

ng/l

0.95

916

7797

Premature separation of placenta [abruptio placentae]

292

1.06

0.08

2.1

2.8

68.97

99.53

ng/l

0.48

262

Other obstructed labour

131

1342

0.98

0.08

2.3

2.7

139.03

109.29

ng/l

0.47

117

1216

Benign neoplasm: Brain, unspecified

144

0.90

0.08

2.7

3.9

71.54

210.65

ng/l

2.95

130

Nontoxic single thyroid nodule

183

1866

0.98

0.08

3.3

2.7

201.73

174.63

ng/l

0.39

166

1699

Chondrosarcoma

1.10

0.08

1.6

2.0

433.29

144.72

ng/l

—

Sequelae of inflammatory diseases of the central nervous system

1.08

0.08

3.7

1.8

465.71

119.04

ng/l

—

Maternal care for other known or suspected fetal problems

298

1940

0.98

0.08

2.0

2.3

70.34

72.55

ng/l

0.07

262

1711

Malignant neoplasm of other and unspecified major salivary glands

0.82

0.08

3.3

2.1

65.50

125.48

ng/l

—

Benign neoplasm: Testis

1.13

0.08

3.4

3.8

301.36

235.80

ng/l

0.15

Use of riluzole

1.04

0.07

2.3

2.5

296.13

233.91

ng/l

—

Malignant neoplasm of base of tongue

122

0.90

0.07

1.4

3.3

372.27

192.72

ng/l

0.29

102

Benign neoplasm: Pancreas

731

0.97

0.07

2.7

3.1

206.98

210.85

ng/l

0.03

674

Pneumoconiosis due to other inorganic dusts

0.86

0.07

4.6

2.8

198.75

211.70

ng/l

—

Gender identity disorders

0.85

0.06

1.3

3.1

27.75

57.91

ng/l

—

Benign neoplasm of other and unspecified female genital organs

108

1057

1.02

0.06

2.8

2.9

275.27

182.18

ng/l

0.52

102

958

Hydatidiform mole

203

0.93

0.06

1.8

2.4

53.84

129.03

ng/l

1.78

175

Benign neoplasm of other and unspecified female genital organs

108

1058

1.02

0.06

2.8

3.0

275.27

173.43

ng/l

0.59

102

950

Supervision of high-risk pregnancy

308

1841

1.01

0.06

2.3

2.2

75.78

79.19

ng/l

0.10

274

1620

Other puerperal infections

831

1.02

0.05

1.6

2.5

36.52

77.01

ng/l

4.78

716

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

999

0.98

0.05

2.9

2.7

131.86

129.05

ng/l

0.04

909

Endometroid carcinoma of ovary, excluding all cancers (controls excluding all cancers)

238

1.05

0.05

4.7

3.5

112.25

221.09

ng/l

1.15

218

Other disorders of choroid

357

1.04

0.05

3.4

3.1

199.10

223.46

ng/l

0.15

326

Dislocation, sprain and strain of joints and ligaments of head

704

1.02

0.04

2.6

3.1

130.83

153.96

ng/l

0.36

626

Acute appendicitis, with complications

598

5945

1.01

0.04

2.7

2.9

213.32

195.70

ng/l

0.18

533

5397

Deep endometriosis

229

2267

1.01

0.04

2.9

128.06

170.84

ng/l

2.11

206

2048

Infections of breast associated with childbirth

427

1.03

0.04

2.6

2.7

106.59

90.44

ng/l

0.18

369

Maternal care for known or suspected abnormality of pelvic organs

387

2689

0.99

0.04

2.0

2.4

83.02

93.50

ng/l

0.30

330

2402

Other appendicitis

203

2051

0.99

0.04

2.4

2.8

196.52

177.38

ng/l

0.22

178

1861

Motorcycle rider injured in other and unspecified transport accidents

974

1.02

0.04

3.1

2.9

187.01

147.55

ng/l

0.35

850

Adenomyosis (Endometriosis of uterus)

380

3775

1.01

0.04

2.4

2.8

121.77

195.01

ng/l

8.22

338

3449

Other benign neoplasm of uterus: Cervix uteri

121

1.08

0.04

2.8

2.4

117.54

150.15

ng/l

0.28

108

Ulcerative ileocolitis

766

1.02

0.03

2.4

2.8

217.31

159.57

ng/l

0.35

681

Dermatitis due to ingested food

403

1.03

0.03

4.9

5.7

105.73

176.31

ng/l

1.13

354

Benign neoplasm: Skin of ear and external auricular canal

115

1135

1.01

0.03

4.5

3.0

252.01

237.26

ng/l

0.13

105

1043

Use of levodopa decarbox-comt-inhibitor

100

986

1.02

0.03

2.7

3.1

242.90

229.05

ng/l

0.11

907

Medical abortion

1943

10584

1.00

0.03

2.5

2.7

164.96

166.54

ng/l

0.06

1755

9629

Malignant neoplasm of brain

757

1.02

0.03

1.7

3.1

82.09

206.59

ng/l

6.80

692

Dental caries 3 and operation codes, only avohilmo

1186

5939

1.00

0.03

2.8

3.3

175.45

184.13

ng/l

0.25

1061

5421

Malignant melanoma of skin

366

3680

0.99

0.03

2.2

3.0

243.03

218.14

ng/l

0.42

326

3361

Malignant neoplasm of uterus, part unspecified, excluding all cancers (controls excluding all cancers)

148

0.94

0.02

4.6

3.7

787.93

314.73

ng/l

0.96

138

Adenocarcinoma and papillary adenocarcinoma of stomach

829

1.01

0.02

2.4

3.1

259.47

266.58

ng/l

0.05

754

Peripheral retinal degeneration

770

1.01

0.02

2.6

3.0

130.96

202.16

ng/l

2.06

707

Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)

179

1802

0.99

0.02

2.6

2.9

121.64

177.11

ng/l

3.72

162

1645

Use of rivastigmine

561

5581

1.00

0.02

2.9

3.2

200.39

292.06

ng/l

8.55

513

5094

Malignant neoplasm of bone and articular cartilage of other and unspecified sites

113

1.07

0.02

1.2

2.8

155.83

191.63

ng/l

0.19

Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)

105

1060

0.99

0.02

2.3

3.2

241.13

241.66

ng/l

0.00

988

Benign lipomatous neoplasm of other sites/unspecified

274

2728

1.00

0.01

3.0

267.77

215.11

ng/l

0.76

256

2495

Eustachian salpingitis and obstruction

128

1289

0.99

0.01

2.4

2.7

152.59

130.26

ng/l

0.25

113

1119

Degeneration of nervous system due to alcohol

607

0.99

0.01

4.0

2.9

189.51

216.77

ng/l

0.23

549

Senile degeneration of the brain, not elsewhere classified

1.07

0.00

2.8

3.1

114.48

352.11

ng/l

—

Frontotemporal dementia

136

0.95

0.00

1.6

2.9

148.31

220.16

ng/l

0.50

119

Degeneration of the brain due to alcohol

606

0.99

0.00

4.0

2.9

189.51

225.42

ng/l

0.32

548

Non-small cell lung cancer

572

5713

1.00

0.00

2.9

3.1

191.42

262.44

ng/l

4.40

532

5249

Maternal care for cervical incompetence

764

1.01

0.00

3.0

2.8

150.28

142.93

ng/l

0.10

699

Persons encountering health services in other circumstances

1122

11217

1.00

0.00

2.9

2.8

234.12

188.51

ng/l

1.76

992

10202

Desensitization to allergens

685

0.99

0.00

2.7

2.8

100.08

94.51

ng/l

0.09

589

Unspecified maternal hypertension

105

1.05

0.00

2.9

2.5

47.00

76.97

ng/l

1.28

Malignant neoplasm of other and ill-defined sites, excluding all cancers (controls excluding all cancers)

446

1.01

0.00

2.5

3.3

200.13

284.73

ng/l

0.81

413

Microscopic polyangiitis

146

1.03

0.00

4.1

3.3

561.73

183.21

ng/l

0.63

132

Carcinoma in situ of breast

101

0.99

0.00

1.1

2.7

51.60

157.33

ng/l

—

Benign neoplasm of brain and other parts of central nervous system

172

1716

1.00

0.00

2.9

135.39

196.28

ng/l

1.91

152

1557

Benign neoplasm: Pancreas

712

1.00

0.00

2.7

3.0

206.98

203.24

ng/l

0.02

658

Erosion and ectropion of cervix uteri

723

1.00

0.00

3.2

2.8

274.37

206.83

ng/l

0.63

660

Other benign neoplasm of uterus: Cervix uteri

133

0.98

0.00

2.8

2.9

117.54

185.41

ng/l

0.67

122

Malignant neoplasm of other and ill-defined digestive organs, excluding all cancers (controls excluding all cancers)

482

0.99

0.00

3.3

121.50

261.42

ng/l

4.02

448

Follicular adenocarcinoma of thyroid gland

116

1.04

0.00

2.5

3.1

337.78

226.30

ng/l

0.18

105

Frontotemporal dementia, wide, incl. Pick's disease

162

0.99

0.00

1.7

2.8

146.88

228.27

ng/l

0.73

143

Brain medulloblastoma

0.00

0.0

7.8

—

86.50

—

Taeniasis

0.00

0.0

2.0

—

360.00

—

Other transitory neonatal endocrine disorders

0.00

0.0

1.2

—

113.00

—

Macular hole, drug-induced

0.00

0.0

2.7

—

268.33

—

Toxic liver disease with acute hepatitis, drug-induced

0.00

0.0

1.6

—

223.75

—

Carcinoma in situ of respiratory system, other/unspecified

0.00

0.0

9.9

—

384.14

—

Drug-induced folate deficiency anaemia

0.00

0.0

3.0

—

205.60

—

Carcinoma in situ of respiratory system, other/unspecified

0.00

0.0

4.1

—

438.00

—

Mental and behavioural disorders due to hallucinogens

1.00

0.00

3.0

2.2

38.60

107.22

ng/l

—

Retained (old) foreign body following penetrating wound of orbit

0.00

0.0

2.0

—

142.67

—

Haemophagocytic syndrome, infection-associated

0.00

0.0

1.6

—

85.00

—

Brain medulloblastoma, excluding all cancers (controls excluding all cancers)

0.00

0.0

7.8

—

86.50

—

Malignant neoplasm of placenta

0.00

0.0

1.5

—

136.63

—

Protrusioacetabuli

0.00

0.0

1.6

—

62.80

—

Drowning and submersion in swimming-pool or bath

0.00

0.0

1.5

—

109.17

—

Peroneal tendinitis

250

1.00

0.00

1.6

2.8

82.25

164.45

ng/l

1.85

229

Dietary selenium deficiency

0.00

0.0

1.8

—

266.80

—

Crushing injury of shoulder and upper arm

0.00

0.0

2.4

—

81.00

—

Intracranial laceration and haemorrhage due to birth injury

0.00

0.0

2.6

—

188.50

—

Diastrofic dysplasy

0.00

0.0

1.4

—

35.57

—

Exposure to ignition of highly flammable material

0.97

0.00

3.7

2.3

84.71

152.70

ng/l

—

Benign neoplasm: Pluriglandular involvement

0.00

0.0

2.2

—

487.17

—

Use of dimethyl fumarate

1.01

0.00

1.6

2.3

89.15

62.63

ng/l

—

Pediculosis and phthiriasis

0.94

0.00

1.6

3.3

173.44

164.01

ng/l

—

Monkeypox

0.00

0.0

2.5

—

318.50

—

Diphyllobothriasis and sparganosis

0.00

0.0

2.2

—

130.60

—

Other congenital malformations of female genitalia

1.00

0.00

5.4

2.2

133.88

102.84

ng/l

—

Hereditary factor XI deficiency

0.00

0.0

2.4

—

31.80

—

Malignant neoplasm of trachea

0.00

0.0

1.6

—

121.00

—

Fetal blood loss

0.00

0.0

4.9

—

324.00

—

Post-traumatic hydrocephalus, unspecified

0.89

0.00

2.2

3.1

75.40

269.97

ng/l

—

Defects in glycoprotein degradation

0.00

0.0

3.9

—

210.22

—

Other early complications of trauma

0.00

0.0

2.9

—

71.14

—

Other congenital infectious and parasitic diseases

0.00

0.0

7.8

—

349.40

—

Hypervitaminosis D

0.00

0.0

2.2

—

356.83

—

Asymptomatic human immunodeficiency virus [HIV] infection status

0.95

0.00

2.0

2.1

452.44

125.71

ng/l

—

Carcinoma in situ, eye

0.00

0.0

2.0

—

223.86

—

Toxic effect of metals

0.00

0.0

2.2

—

182.44

—

Unspecified visual impairment

0.00

0.0

1.6

—

304.20

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Natriuretic peptide B [Mass/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS